Pyridazine derivative and composition containing same

Abstract

The present invention provides: a compound that has an excellent control effect against weed and that is represented by formula (I) [in the formula, R1 represents an isopropyl group or the like, R2 represents a C1-C8 chain hydrocarbon group or the like, R3 represents a phenyl group or the like, X1 and X2 are the same or different from each other and each represent an oxygen atom or the like, Y1 represents OR15 or the like, Z1 and Z2 are the same or different from each other and each represent an oxygen atom or the like, and R15 represents a C1-C10 chain hydrocarbon group or the like that is optionally substituted with one or more halogen atoms]; or a salt thereof.

Description

TITLE OF THE INVENTION: PYRIDAZINE DERIVATIVE AND COMPOSITION CONTAINING SAME TECHNICAL FIELD

[0001] This application claims priority to and the benefit of Japanese Patent Application No. 2024-084647 filed May 24, 2024, the entire contents of which are incorporated herein by reference. The present invention relates to pyridazine derivatives and a herbicide composition comprising the same. BACKGROUND ART

[0002] To date, in order to control weeds, some compounds have been studied, and put to practical use. It is also known that certain class of compounds have the effect of inducing male sterility (see Patent Document 1). CITATION LIST PATENT LITERATURE

[0003] Patent Literature 1: US 4345934 B2 SUMMARY OF THE INVENTION (PROBLEMS TO BE SOLVED BY INVENTION)

[0004] An object of the present invention is to provide a compound having excellent efficacy for controlling weeds. (MEANS TO SOLVE PROBLEMS)

[0005] The present inventors have intensively studied to find out a compound having an excellent efficacy for controlling weeds, and as a result, found that a compound represented by the following formula (I) has an excellent efficacy for controlling weeds. That is, the present invention encompasses the followings. [1] A compound represented by formula (I): X1 X2 I R3 [wherein, R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G1, a C4-C8 alkyl group which may be optionally substituted with one or more substituents selected from Group G1, a C2-C8 alkenyl group which may be optionally substituted with one or more substituents selected from Group G1, a C2-C8 alkynyl group which may be optionally substituted with one or more substituents selected from Group G1, a C3-C8 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G2, a three(3) - eight(8) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G2 {the heteroatom(s) which constitutes the three(3) - eight(8) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G1, OR16, S(O)mR17, or NR18R19, R2 represents a C1-C8 chain hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G3, a C3-C8 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G4, a halogen atom, a cyano group, OR10, C(=Z1)R11, C(=Z1)OR12, C(=Z1)NR11R12, S(O)pR13, or NR11R14, R3 represents a phenyl group which may be optionally substituted with one or more substituents selected from Group G5, a five(5) - six(6) membered aromatic heterocyclic group which may be optionally substituted with one or more 5 substituents selected from Group G5, an aromatic fused heterocyclic group which may be optionally substituted with one or more substituents selected from Group G5, or any group represented by the following formula, 10          (• represents a binding position to a nitrogen atom) a combination of G7a, G7b and G7c represents: a combination wherein G7a represents C=O or CR26aR27a, G7b represents C=O or CR26bR27b, and G7c represents C=O or CR26cR27c, a combination wherein G7a represents C=O or CR26aR27a, G7b 15 represents C=O or CR26bR27b, and G7c represents NR28c, an oxygen atom, a sulfur atom, S=O, or S=O2, a combination wherein G7a represents C=O or CR26aR27a, G7b represents NR28b, an oxygen atom, a sulfur atom, S=O, or S=O2, and G7c represents C=O or CR26cR27c, a combination wherein G7a represents NR28a, an oxygen atom, a sulfur atom, S=O, or S=O2, G7b represents C=O or CR26bR27b, and G7c represents C=O or CR26cR27c, or, a combination wherein G7a represents NR28a, an oxygen atom, a sulfur atom, S=O, or S=O2, G7b represents C=O or CR26bR27b, and G7c represents NR28c, an oxygen atom, a sulfur atom, S=O, or S=O2, a combination of G7d, G7e, G7f and G7g represents a combination wherein G7d represents C=O or CR26dR27d, G7e represents C=O or CR26eR27e, G7f represents C=O or CR26fR27f, and G7g represents C=O or CR26gR27g, a combination wherein G7d represents C=O or CR26dR27d, G7e represents C=O or CR26eR27e, G7f represents C=O or CR26fR27f, and G7g represents NR28g, an oxygen atom, a sulfur atom, S=O, or S=O2, a combination wherein G7d represents C=O or CR26dR27d, G7e represents C=O or CR26eR27e, G7f represents NR28f, an oxygen atom, a sulfur atom, S=O, or S=O2, and G7g represents C=O or CR26gR27g, a combination wherein G7d represents C=O or CR26dR27d, G7e represents NR28e, an oxygen atom, a sulfur atom, S=O, or S=O2, G7f represents C=O or CR26fR27f, and G7g represents C=O or CR26gR27g, a combination wherein G7d represents C=O or CR26dR27d, G7e represents NR28e, an oxygen atom, a sulfur atom, S=O, or S=O2, G7f represents C=O or CR26fR27f, and G7g represents NR28g, an oxygen atom, a sulfur atom, S=O, or S=O2, a combination wherein G7d represents NR28d, an oxygen atom, a sulfur atom, S=O, or S=O2, G7e represents C=O or CR26eR27e, G7f represents C=O or CR26fR27f, and G7g represents C=O or CR26gR27g, a combination wherein G7d represents NR28d, an oxygen atom, a sulfur atom, S=O, or S=O2, G7e represents C=O or CR26eR27e, G7f represents C=O or CR26fR27f, and G7g represents NR28g, an oxygen atom, a sulfur atom, S=O, or S=O2, or, a combination wherein G7d represents NR28d, an oxygen atom, a sulfur atom, S=O, or S=O2, G7e represents C=O or CR26eR27e, and G7f represents NR28f, an oxygen atom, a sulfur atom, S=O, or S=O2, and G7g represents C=O or CR26gR27g, X1 and X2 are identical to or different from each other, and each represents an oxygen atom or a sulfur atom, Y1 represents OR15 or SR15, Z1 and Z2 are identical to or different from each other, and each represents an oxygen atom or a sulfur atom, m, p and q each independently represents 0, 1, or 2, R10, R13 and R23 are identical to or different from each other, and each represents a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, or a phenyl group which may be optionally substituted with one or more substituents selected from Group G6, R11 and R21 are identical to or different from each other, and each represents, a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, a phenyl group which may be optionally substituted with one or more substituents selected from Group G6, or a hydrogen atom, R12, R16, R19, R20 and R22 are identical to or different from each other, and each represents a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom, R14, R17, R18 and R24 are identical to or different from each other, and each represents a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more halogen atoms, or a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, R15 represents a C1-C10 chain hydrocarbon group which may be optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, a benzyl group which may be optionally substituted with one or more substituents selected from Group G6, or a hydrogen atom, R25 represents a C1-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G56, R26a, R26b, R26c, R26d, R26e, R26f, R26g, R27a, R27b, R27c, R27d, R27e, R27f, and R27g are identical to or different from each other, and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom, R28a, R28b, R28c, R28d, R28e, R28f, and R28g are identical to or different from each other, and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, or a (C1-C3 alkyl)carbonyl group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom, R29a, R29b, R29c, R29d, R29e, and R29f are identical to or different from each other and each represents a C1-C3 alkyl group which may be optionally substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom, R57 represents a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G571, or a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom, R58 represents a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G571, or a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom; Group G1 is a group consisting of a C1-C3 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group which may be optionally substituted with one or more halogen atom, a C1-C3 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a halogen atom, a cyano group, a hydroxy group, and a mercapto group; Group G2 is a group consisting of a C1-C3 alkyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group which may be optionally substituted with one or more halogen atom, a C1-C3 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, an oxo group, a thioxo group, a halogen atom, a cyano group, a hydroxy group, and a mercapto group; Group G3 is a group consisting of a C1-C3 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group which may be optionally substituted with one or more halogen atom, a C1-C3 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a halogen atom, a cyano group, a hydroxy group, and a mercapto group; Group G4 is a group consisting of a C1-C3 alkyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group which may be optionally substituted with one or more halogen atom, a C1-C3 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, an oxo group, a thioxo group, a halogen atom, a cyano group, a hydroxy group, and a mercapto group; Group G5 is a group consisting of a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G54, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G52, a OR20 group, a OR25 group, C(=Z2)R21, C(=Z2)OR22, C(=Z2)NR21R22, C(R57)=N-OR58, S(O)qR23, NR20R24, a phenyl group which may be optionally substituted with one or more substituents selected from Group G52, a three(3) - ten(10) membered heterocyclic group which may be optionally substituted with one or more substituents selected from Group G52, a nitro group, a halogen atom, a SF5 group and a cyano group; Group G6 is a group consisting of a C1-C3 alkyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group which may be optionally substituted with one or more halogen atom, a C1-C3 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a halogen atom, a cyano group, a nitro group, a hydroxy group, and a mercapto group; Group G52 is a group consisting of a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkylthio group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkyl) carbonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkoxy)carbonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)carbonyl group which may be optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)carbonyl group which may be optionally substituted with one or more halogen atoms, a C1-C6 an alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)sulfonyl group which may be optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)sulfonyl group which may be optionally substituted with one or more halogen atoms, a cyano group, a nitro group, a hydroxy group, an amino group, a formyl group, a halogen atom, and a SF5 group; Group G54 is a group consisting of a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkylthio group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkyl) carbonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkoxy)carbonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)carbonyl group which may be optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)carbonyl group which may be optionally substituted with one or more halogen atoms, a C1-C6 an alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)sulfonyl group which may be optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)sulfonyl group which may be optionally substituted with one or more halogen atoms, a cyano group, a nitro group, a hydroxy group, an amino group, a formyl group, a halogen atom, and a SF5 group; Group G56 is a group consisting of a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkylthio group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkyl) carbonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkoxy)carbonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)carbonyl group which may be optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)carbonyl group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)sulfonyl group which may be optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)sulfonyl group which may be optionally substituted with one or more halogen atoms, C(R561)=N-OR562, a cyano group, a nitro group, a hydroxy group, an amino group, a formyl group, and a SF5 group; R561 represents a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, a phenyl group which may be optionally substituted with one or more halogen atoms, an aromatic heterocyclic group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom; R562 represents a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more halogen atoms, or a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom; Group G571 is a group consisting of a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, a phenyl group which may be optionally substituted with one or more halogen atoms, a five(5) - six(6) membered heterocyclic group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkylthio group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkyl) carbonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkoxy)carbonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)carbonyl group which may be optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)carbonyl group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)sulfonyl group which may be optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)sulfonyl group which may be optionally substituted with one or more halogen atoms, a cyano group, a nitro group, a hydroxy group, an amino group, a formyl group, a halogen atom, and a SF5 group.] (hereinafter, referred to as "Present compound N" or "Compound N of the present invention"), or a salt thereof (hereinafter, "Compound represented by formula (I) or a salt thereof is referred to as "Present compound" or "Compound of the present invention"). [2] The compound according to [1] or a salt thereof, wherein R3 represents a phenyl group which may be optionally substituted with one or more substituents selected from Group G5, or a five(5) - six(6) membered aromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G5, and Group G5 is a group consisting of a C1-C3 alkyl group which may be optionally substituted with one or more halogen atoms, a OR20 group, C(=Z2)R21, C(=Z2)OR22, C(=Z2)NR21R22, S(O)qR23, NR20R24, a nitro group, a halogen atom, and a cyano group. [3] The compound according to [1] or [2] or a salt thereof, wherein X1 and X2 represents an oxygen atom. [4] The compound according to any one of [1] to [3] or a salt thereof, wherein Y1 represents a OR15 group. [5] The compound according to any one of [1] to [4] or a salt thereof, wherein R2 represents a C1-C4 alkyl group which may be optionally substituted with one or more substituents selected from Group G3, a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G4, a halogen atom, a cyano group, OR10, or S(O)pR13, R10  represents  a  C1-C3  alkyl  group  which  may  be optionally substituted with one or more halogen atoms, R13  represents  a  C1-C3  alkyl  group  which  may  be optionally substituted with one or more halogen atoms. [6] The compound according to [5] or a salt thereof, wherein R2 represents a C1-C3 alkyl group which may be optionally substituted with one or more halogen atoms. [7] The compound according to any one of [1] to [6] or a salt thereof, wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G11, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G11, a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G21, a three(3) - six(6) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G21 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G11, OR16, S(O)mR17, or NR18R19, R16, R17 and R18 are identical to or different from each other, and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, R19 represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom, Group G11 is a group consisting of a C1-C3 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group which may be optionally substituted with one or more halogen atom, a C1-C3 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a halogen atom, and a cyano group; and Group G21 is a group consisting of a C1-C3 alkyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group which may be optionally substituted with one or more halogen atom, a C1-C3 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a halogen atom, and a cyano group. [8] The compound according to [7] or a salt thereof, wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G11, a butyl group which may be optionally substituted with one or more substituents selected from G11, an ethyl group which is substituted with one or more substituents selected from G11, a n-propyl group which is substituted with one or more substituents selected from G11, a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G21, or a three(3) - six(6) membered saturated heterocyclic group which may be optionally substituted with one or more substituents selected from Group G21 {the heteroatom(s) which constitutes of the three(3) - six(6) membered saturated heterocyclic group represents an oxygen atom}; Group G11 is a group consisting of a C1-C3 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group which may be optionally substituted with one or more halogen atom, a C1-C3 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a halogen atom, and a cyano group; and Group G21 is a group consisting of a C1-C3 alkyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group which may be optionally substituted with one or more halogen atom, a C1-C3 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a halogen atom, and a cyano group. [9] The compound according to [8] or a salt thereof, wherein R1 represents an isopropyl group, or a sec-butyl group.

[10] The compound according to any one of [1] to [9] or a salt thereof, wherein R3 represents a phenyl group which may be optionally substituted with one to three substituents selected from Group G5, or a five(5) - six(6) membered aromatic heterocyclic group which may be optionally substituted with one to three substituents selected from Group G5.

[11] The compound according to any one of [1] to [9] or a salt thereof, wherein R3 represents a phenyl group which is substituted with one to three substituents selected from Group G5, or a five(5) - six(6) membered aromatic heterocyclic group which may be optionally substituted with one to three substituents selected from Group G5.

[12] The compound according to any one of [1] to [9] or a salt thereof, wherein R3 represents a phenyl group which may be optionally substituted with one to three substituents selected from Group G5.

[13] The compound according to any one of [1] to [9] or a salt thereof, wherein R3 represents a phenyl group which is substituted with one to three substituents selected from Group G5.

[14] The compound according to

[13] or a salt thereof, wherein R3 represents a phenyl group which is substituted with one to two substituents selected from Group G5.

[15] The compound according to

[14] or a salt thereof, wherein R3 represents a phenyl group which is substituted with one to two substituents selected from the group consisting of a cyano group, a halogen atom, a C1-C3 alkyl group, a C1-C3 haloalkyl group, and a C3-C6 cycloalkyl group.

[16] The compound according to any one of [1] to [9] or a salt thereof, wherein R3 represents a five(5) - six(6) membered aromatic heterocyclic group which may be optionally substituted with one to two substituents selected from Group G5.

[17] The compound according to

[16] or a salt thereof, wherein R3 represents a five(5) membered aromatic heterocyclic group which may be optionally substituted with one to two substituents selected from the group consisting of a halogen atom, a C1-C3 alkyl group, a C1-C3 haloalkyl group and a C3-C6 cycloalkyl group.

[18] The compound according to

[16] or a salt thereof, wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one substituent selected from the group consisting of a halogen atom, a C1-C3 alkyl group, a C1-C3 haloalkyl group and a C3- C6 cycloalkyl group.

[19] The compound according to any one of [1] or [3] to [9] or a salt thereof, wherein R3 represents any group represented by the following formula: 10

[20] The compound according to

[19] or a salt thereof, wherein R3 represents any group represented by the following formula: B-1                         B-2 15

[21] The compound according to

[19] or a salt thereof, wherein R3 represents a group represented by the following formula: B-1 .

[22] The compound according to

[19] or a salt thereof, wherein 5         R3 represents a group represented by the following formula: ^^"Af .

[23] The compound according to any one of [1] or [3] to [9] or a salt thereof, 10 wherein R3 represents an aromatic fused heterocyclic group which may be optionally substituted with one or more substituents selected from Group G5.

[24] The compound according to

[23] or a salt thereof, 15 wherein R3 represents an eight(8) - ten(10) membered aromatic fused heterocyclic group which may be optionally substituted with one or more substituents selected from a halogen atom, a C1-C3 alkyl group, a C1-C3 haloalkyl group and a C3-C6 cycloalkyl group.

[25] A herbicide composition comprising the compound according to any one of [1] to

[24] or a salt thereof and an inert carrier.

[26] A method for controlling weeds which comprises a step of applying the compound according to any one of [1] to

[24] or a salt thereof to a weed or a soil where a weed is grown.

[27] Use  of the compound according  to  [1]  to

[24] for controlling a weed.

[28] A composition  comprising one  or  more  ingredients selected from Group  (d) and Group  (f)  and the compound according to any one of [1] to

[24] or a salt thereof: Group (d): a phytotoxicity reducing ingredient: Group (f): a herbicidal active ingredient. [EFFECT OF INVENTION]

[0006] The present invention can control weeds. MODE FOR CARRYING OUT THE INVENTION

[0007] The substituent(s) as described herein is / are explained. The term "halogen atom" represents fluorine atom, chlorine atom, bromine atom, or iodine atom. When a substituent is substituted with two or more halogen atoms or two or more substituents, the halogen atoms or the substituents may be identical to or different from each other. The expression of "which may be optionally substituted with one or more substituents selected from Group X" represents that when two or more of the substituents selected from Group X exist, these substituents may be identical to or different from each other. The expression of "CX-CY" as used herein represents that the number of carbon atom is from X to Y. For example, the expression of "C1-C8" represents that the number of carbon atom is from 1 to 8. The term of "chain hydrocarbon group" represents an alkyl group, an alkenyl group, or an alkynyl group. Example of "alkyl group" include methyl group, ethyl group, propyl group, isopropyl group, 1,1-dimethylpropyl group, 1,2-dimethylpropyl group, 1-ethylpropyl group, butyl group, sec-butyl group, tert-butyl group, pentyl group, hexyl group, and octyl group. Example of "alkenyl group" include vinyl group, 1-propenyl group, 2-propenyl group, 1-methyl-1-propenyl group, 1-methyl-2-propenyl group, 1,2-dimethyl-1-propenyl group, 1-ethyl-1-propenyl group, 3-butenyl group, 4-pentenyl group, 5-hexenyl group, and 7-octenyl group. Example of "alkynyl group" includes ethynyl group, 1-propynyl group, 2-propynyl group, 1-methyl-2-propynyl group, 1,1-dimethyl-2-propynyl group, 1-ethyl-2-propynyl group, 2-butynyl group, 4-pentynyl group, 5-hexynyl group, and 7-octynyl group. Example of "alkoxy group" includes methoxy group, ethoxy group, propoxy group, isopropoxy group, butoxy group, tert-butoxy group, pentoxy group, hexyloxy group, and octyloxy group. Example of the "alkylsulfanyl group" includes methylsulfanyl group, ethylsulfanyl group, propylsulfanyl group, and isopropylsulfanyl group. Example of the "alkylsulfinyl group" includes methylsulfinyl group, ethylsulfinyl group, propylsulfinyl group, and isopropylsulfinyl group. Example of the "alkylsulfonyl group" includes methylsulfonyl group, ethylsulfonyl group, propylsulfonyl group, and isopropylsulfonyl group.

[0008] Example of the "alicyclic hydrocarbon group" includes cycloalkyl group and cycloalkenyl group. Example of the "cycloalkyl group" includes cyclopropyl group, cyclobutyl group, cyclopentyl group, cyclohexyl group, and cyclooctyl group. Example of the "cycloalkenyl group" includes cyclopentenyl group, cyclohexenyl group, and cyclooctenyl group.

[0009] Example of the "five (5) - six (6) membered aromatic heterocyclic group" includes pyrrolyl group, furyl group, thienyl group, pyrazolyl group, imidazolyl group, triazolyl group, tetrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl group, oxadiazolyl group, thiadiazolyl group, pyridyl group, pyridazinyl group, pyrimidinyl group, pyrazinyl group, triazinyl group, and tetrazinyl group. Example of the "three (3)  - eight (8) membered nonaromatic heterocyclic group {the heteroatom(s) which constitutes the three (3) - eight (8) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom} includes oxiranyl group, thiiranyl group, oxetanyl group, thetanyl group, dihydrofuranyl group, tetrahydrofuranyl group, tetrahydrothenyl group, pyranyl group, dihydropyranyl group, tetrahydropyranyl group, tetrahydrothiopyranyl group, oxepanyl group, thiepanyl group, oxocanyl group, thiocanyl group, dioxolyl group, dioxolanyl group, and dioxanyl group. Examples of the "aromatic fused heterocyclic group" include eight (8)  - ten (10) membered aromatic fused heterocyclic group. Examples of the "eight (8) - ten (10) membered aromatic fused heterocyclic group" include indolyl group, isoindolyl group, indolinyl group, indolizinyl group, benzimidazolyl group, qunolyl group, isoquinoly group, indazolyl group, benzotriazolyl group, imidazolyl group, pyrazolopyridyl group, benzooxazolyl group, benzooxadiazolyl group, benzothiazolyl group, benzothiadiazolyl group, imidazothiadiazolyl group, benzofuryl group, and benzothienyl group. Examples of the "three (3)  - ten (10) membered heterocyclic group" include pyrrolyl group, furyl group, thienyl group, pyrazolyl group, imidazolyl group, triazolyl group, tetrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl group, oxadiazolyl group, thiadiazolyl group, pyridyl group, pyridadinyl group, pyrimidinyl group, pyrazinyl group, triazinyl group, tetrazinyl group, quinoly group, aziridinyl group, oxiranyl group, thiranyl group, azetidinyl group, oxetanyl group, thetanyl group, pyrrolidinyl group, tetrahydrofuranyl group, tetrahydrothenyl group, pyrazolinyl group, pyrazolidinyl group, imidazolynyl group, imidazolidinyl group, oxazolynyl group, thiazolynyl group, oxazolidinyl group, thiazolidinyl group, isooxazolinyl group, isooxazolidinyl group, isothiazolinyl group, isothiazolidinyl group, dioxolanyl group, dioxanyl group, piperidyl group, dihydrofuranyl group, tetrahydrofuranyl group, tetrahydrothenyl group, pyranyl group, dihydropyranyl group, tetrahydropyranyl group, tetrahydrothiopyranyl group, oxepanyl group, thiepanyl group, oxocanyl group, thiocanyl group, dioxolyl group, dioxolanyl group, and dioxanyl group. piperazinyl group, morpholinyl group, thiomorpholinyl group, pyranyl group, dihydropyranyl group, tetrahydropyranyl group, tetrahydrothiopyranyl group, azepanyl group, oxetanyl group, and thiepanyl group.

[0010] The present compound may be existed as one or more stereoisomers.    Examples of the stereoisomer include enantiomer, diastereoisomer, atropisomer, and geometric isomer. Each stereoisomer, and stereoisomer mixture(s) in an arbitrary ratio thereof are included in the present compound.

[0011] The present compound may be mixed with a base (such as isopropyl amine, dimethyl amine, sodium carbonate, and potassium carbonate) to form a base addition salt (such as isopropyl amine salt, dimethyl amine salt, sodium salt and potassium salt). The present compound may be mixed with an acid (such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, acetic acid, and benzoic acid) to form an acid addition salt (such as hydrochloride, sulfate, nitrate, phosphate, and acetate). The present compound may be existed as a zwitter ion. Also, in the present compound, at least one nitrogen atom which is contained in the compound represented by formula (I) is substituted with an oxo group to form a N-oxide structure.

[0012] Embodiments of the compound N of the present invention include the following compounds. [Embodiment 1] The compound of the present invention wherein X1 represents an oxygen atom. [Embodiment 2] The compound of the present invention wherein X1 represents an oxygen atom and R15 represents a hydrogen atom. [Embodiment 3] The compound of the present invention wherein X1 represents an oxygen atom and R15 represents a C1-C10 chain hydrocarbon group. [Embodiment 4] The compound of the present invention wherein X1 represents an oxygen atom and R15 represents a C3-C6 alicyclic hydrocarbon group. [Embodiment 5] The compound of the present invention wherein X1 represents an oxygen atom and R15 represents a benzyl group which may be optionally substituted with one or more substituents selected from Group G6. [Embodiment 6] The compound of the present invention wherein X1 represents an oxygen atom and R15 represents a benzyl group. [Embodiment 7] The compound of the present invention wherein X2 represents an oxygen. [Embodiment 8] The compound of the present invention wherein Y1 represents OR15. [Embodiment 9] The compound of the present invention wherein X1 and X2 represents an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment 10] The compound of the present invention wherein X1 and X2 represents an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment 11] The compound of the present invention wherein R2 represents a C1-C4 chain hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G3, a C3-C6 alicyclic hydrocarbon group which is substituted with one or more substituents selected from Group G4, a halogen atom, a cyano group, OR10, C(=Z1)R11, C(=Z1)OR12, C(=Z1)NR11R12, S(O)pR13, or NR10R14. [Embodiment 12] The compound of the present invention wherein R2 represents a C1-C4 alkyl group which may be optionally substituted with one or more substituents selected from Group G3, a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G4, a halogen atom, a cyano group, OR10, or S(O)pR13. [Embodiment 13] The compound of the present invention wherein R2 represents a C1-C4 alkyl group which may be optionally substituted with one or more substituents selected from Group G3, OR10, or S(O)pR13, R10 and R13 are identical to or different from each other and each represents a C1-C3 alkyl group which may be optionally substituted with one or more halogen atoms. [Embodiment 14] The compound of the present invention wherein R2 represents a C1-C4 alkyl group which may be optionally substituted with one or more substituents selected from Group G3. [Embodiment 15] The compound of the present invention wherein R2 represents an isopropyl group, an ethyl group, or a methyl group. [Embodiment 16] The compound of the present invention wherein R2 represents an isopropyl group. [Embodiment 17] The compound of the present invention wherein R2 represents an ethyl group. [Embodiment 18] The compound of the present invention wherein R2 represents a methyl group. [Embodiment 19] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G1, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G1, a C2-C6 alkenyl group which may be optionally substituted with one or more substituents selected from Group G1, a C2-C6 alkynyl group which may be optionally substituted with one or more substituents selected from Group G1, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G2, a three(3) - six(6) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G2 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G1, OR16, S(O)mR17, or NR18R19. [Embodiment 20] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G1, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G1, a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G2, a three(3) - six(6) membered saturated nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G2 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G1, OR16, S(O)mR17, or NR18R19. [Embodiment 21] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G1, a butyl group which may be optionally substituted with one or more substituents selected from Group G1, an ethyl group which is substituted with one or more substituents selected from Group G1, a n-propyl group which is substituted with one or more substituents selected from Group G1, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G2. [Embodiment 22] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G1, a butyl group which may be optionally substituted with one or more substituents selected from Group G1, an ethyl group which is substituted with one or more substituents selected from Group G1, a n-propyl group which is substituted with one or more substituents selected from Group G1, or a C3-C6 cycloalkyl group. [Embodiment 23] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one substituent selected from Group G1, a butyl group which may be optionally substituted with one substituent selected from Group G1, an ethyl group which is substituted with one substituent selected from Group G1, a n-propyl group which is substituted with one substituent selected from Group G1, or a C3-C6 cycloalkyl group. [Embodiment 24] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one substituent selected from Group G1, a butyl group which may be optionally substituted with one substituent selected from Group G1, or a C5-C6 cycloalkyl group. [Embodiment 25] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G11, a C4-C8 alkyl group which may be optionally substituted with one or more substituents selected from Group G11, a C2-C8 alkenyl group which may be optionally substituted with one or more substituents selected from Group G11, a C2-C8 alkynyl group which may be optionally substituted with one or more substituents selected from Group G11, a C3-C8 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G21, a three(3) - eight(8) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G21 {the heteroatom which constitutes the three(3) - eight(8) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G11, OR16, S(O)mR17, or NR18R19. [Embodiment 26] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G11, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G11, a C2-C6 alkenyl group which may be optionally substituted with one or more substituents selected from Group G11, a C2-C6 alkynyl group which may be optionally substituted with one or more substituents selected from Group G11, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G21, a three(3) - six(6) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G21 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G11, OR16, S(O)mR17, or NR18R19. [Embodiment 27] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G11, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G11, a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G21, a three(3) - six(6) membered saturated nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G21 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G11, OR16, S(O)mR17, or NR18R19. [Embodiment 28] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G11, a butyl group which may be optionally substituted with one or more substituents selected from G11, an ethyl group which is substituted with one or more substituents selected from G11, a n-propyl group which is substituted with one or more substituents selected from G11, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G21. [Embodiment 29] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G11, a butyl group which may be optionally substituted with one or more substituents selected from G11, an ethyl group which is substituted with one or more substituents selected from G11, a n-propyl group which is substituted with one or more substituents selected from G11, or a C3-C6 cycloalkyl group. [Embodiment 30] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one substituent selected from Group G11, a butyl group which may be optionally substituted with one substituent selected from Group G11, an ethyl group which is substituted with one substituent selected from Group G11, a n-propyl group which is substituted with one substituent selected from Group G11, or a C3-C6 cycloalkyl group. [Embodiment 31] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one substituent selected from Group G11, a butyl group which may be optionally substituted with one substituent selected from Group G11, or a C5-C6 cycloalkyl group. [Embodiment 32] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G12, a C4-C8 alkyl group which may be optionally substituted with one or more substituents selected from Group G12, a C2-C8 alkenyl group which may be optionally substituted with one or more substituents selected from Group G12, a C2-C8 alkynyl group which may be optionally substituted with one or more substituents selected from Group G12, a C3-C8 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G21, a three(3) - eight(8) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G21 {the heteroatom which constitutes the three(3) - eight(8) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G12, OR16, S(O)mR17, or NR18R19; Group G12 is a group consisting of a cyano group, a methoxy group, a methylthio group, a methysulfinyl group, and methylsulfonyl group. [Embodiment 33] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G12, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G12, a C2-C6 alkenyl group which may be optionally substituted with one or more substituents selected from Group G12, a C2-C6 alkynyl group which may be optionally substituted with one or more substituents selected from Group G12, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G21, a three(3) - six(6) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G2 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G12, OR16, S(O)mR17, or NR18R19. [Embodiment 34] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G12, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G12, a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G2, a three(3) - six(6) membered saturated nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G2 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G12, OR16, S(O)mR17, or NR18R19. [Embodiment 35] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G12, a butyl group which may be optionally substituted with one or more substituents selected from Group G12, an ethyl group which is substituted with one or more substituents selected from Group G12, a n-propyl group which is substituted with one or more substituents selected from Group G12, or a C3-C6 cycloalkyl which may be optionally substituted with one or more substituents selected from Group G2. [Embodiment 36] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G12, a butyl group which may be optionally substituted with one or more substituents selected from Group G12, an ethyl group which is substituted with one or more substituents selected from Group G12, a n-propyl group which is substituted with one or more substituents selected from Group G12, or a C3-C6 cycloalkyl group. [Embodiment 37] The compound of the present invention wherein R1 represents an isopropyl group which is substituted with one substituent selected from Group G12, a butyl group which is substituted with one substituent selected from Group G12, an ethyl group which is substituted with one substituent selected from Group G12, a n-propyl group which is substituted with one substituent selected from Group G12, or a C3-C6 cycloalkyl group. [Embodiment 38] The compound of the present invention wherein R1 represents an isopropyl group which is substituted with one substituent selected from Group G12, a butyl group which is substituted with one substituent selected from Group G12, or a C5-C6 cycloalkyl group. [Embodiment 39] The compound of the present invention wherein R16, R17 and R18 are identical to or different from each other and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, and R19 represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom. [Embodiment 40] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G1, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G1, a C2-C6 alkenyl group which may be optionally substituted with one or more substituents selected from Group G1, a C2-C6alkynyl group which may be optionally substituted with one or more substituents selected from Group G1, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G2, a three(3) - six(6) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G2 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G1, OR16, S(O)mR17, or NR18R19, R16, R17 and R18 are identical to or different from each other and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, and R19 represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom. [Embodiment 41] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G1, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G1, a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G2, a three(3) - six(6) membered saturated nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G2 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G1, OR16, S(O)mR17, or NR18R19, R16, R17 and R18 are identical to or different from each other and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, and R19 represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom. [Embodiment 42] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G11, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G11, a C2-C6 alkenyl group which may be optionally substituted with one or more substituents selected from Group G11, a C2-C6 alkynyl group which may be optionally substituted with one or more substituents selected from Group G11, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G21, a three(3) - six(6) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G21 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G11, OR16, S(O)mR17, or NR18R19, R16, R17 and R18 are identical to or different from each other and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, and R19 represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom. [Embodiment 43] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G11, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G11, a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G21, a three(3) - six(6) membered saturated nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G21 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G11, OR16, S(O)mR17, or NR18R19, R16, R17 and R18 are identical to or different from each other and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, and R19 represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom. [Embodiment 44] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G12, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G12, a C2-C6 alkenyl group which may be optionally substituted with one or more substituents selected from Group G12, a C2-C6 alkynyl group which may be optionally substituted with one or more substituents selected from Group G12, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G21, a three(3) - six(6) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G2 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G12, OR16, S(O)mR17, or NR18R19, R16, R17 and R18 are identical to or different from each other and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, and R19 represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom. [Embodiment 45] The compound of the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G12, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G12, a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G2, a three(3) - six(6) membered saturated nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G2 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G12, OR16, S(O)mR17, or NR18R19, R16, R17 and R18 are identical to or different from each other and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, and R19 represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom. [Embodiment 46] The compound of the present invention wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or trisubstituted carbon atom. [Embodiment 47] The compound of the present invention wherein R1 represents an isopropyl group, a tert-butyl group, or a sec-butyl group. [Embodiment 48] The compound of the present invention wherein R1 represents an isopropyl group, or a tert-butyl group. [Embodiment 49] The compound of the present invention wherein R1 represents an isopropyl group. [Embodiment 50] The compound of the present invention wherein R1 represents a tert-butyl group. [Embodiment 51] The compound of the present invention wherein R1 represents a cyclopentyl group. [Embodiment 52] The compound of the present invention wherein R1 represents a cyclohexyl group. [Embodiment 53] The compound of the present invention wherein R1 represents OR16, S(O)mR17, or NR18R19, R16, R17 and R18 are identical to or different from each other and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, and R19 represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom. [Embodiment 54] The compound of the present invention wherein R1 represents OR16, S(O)mR17, or NR18R19, R16, R17 and R18 are identical to or different from each other and each represents C1-C6 alkyl group, or a C3-C6 cycloalkyl group, and R19 represents a C1-C6 alkyl group, a C3-C6 cycloalkyl group, or a hydrogen atom. [Embodiment 55] The compound of the present invention wherein R3 represents a phenyl group which may be optionally substituted with one to three substituents selected from Group G5, or a five(5) or six(6) membered aromatic heterocyclic group which may be optionally substituted with one to three substituents selected from Group G5. [Embodiment 56] The compound of the present invention wherein R3 represents a phenyl group which may be optionally substituted with one or two substituents selected from Group G51; Group G51 is a group consisting of a halogen atom, a methyl group, a trifluoromethyl group, a methoxy group, a trifluoromethoxy group, and a difluoromethoxy group. [Embodiment 57] The compound of the present invention wherein R3 represents a phenyl group which may be optionally substituted with one or more halogen atoms. [Embodiment 58] The compound of the present invention wherein R3 represents a phenyl group which may be optionally substituted with one or two halogen atoms. [Embodiment 59] The compound of the present invention wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two substituents selected from Group G51. [Embodiment 60] The compound of the present invention wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two halogen atoms. [Embodiment 61] The compound of the present invention wherein R3 represents a phenyl group which may be optionally substituted with one or two substituents selected from Group G82; Group G82 is a group consisting of a halogen atom, a methyl group, a difluoromethyl group, a trifluoromethyl group, an ethyl group, a cyclopropyl group, a methoxy group, a trifluoromethoxy group, and a difluoromethoxy group. [Embodiment 62] The compound of the present invention wherein R3 represents a phenyl group which may be optionally substituted with one substituent selected from Group G82. [Embodiment 63] The compound of the present invention wherein R3 represents a phenyl group which may be optionally substituted with one difluoromethyl group. [Embodiment 64] The compound of the present invention wherein R3 represents a phenyl group which may be optionally substituted with one trifluoromethyl group. [Embodiment 65] The compound of the present invention wherein R3 represents a phenyl group which may be optionally substituted with one cyclopropyl group. [Embodiment 66] The compound of the present invention wherein R3 represents a phenyl group which may be optionally substituted with one trifluoromethoxy group. [Embodiment 67] The compound of the present invention wherein R3 represents a pyridyl group which may be optionally substituted with one difluoromethoxy group. [Embodiment 68] The compound of the present invention wherein R3 represents a pyridyl group which may be optionally substituted with one difluoromethyl group. [Embodiment 69] The compound of the present invention wherein R3 represents a pyridyl group which may be optionally substituted with one trifluoromethyl group. [Embodiment 70] The compound of the present invention wherein R3 represents a pyridyl group which may be optionally substituted with one cyclopropyl group. [Embodiment 71] The compound of the present invention wherein R3 represents a pyridyl group which may be optionally substituted with one trifluoromethoxy group. [Embodiment 72] The compound of the present invention wherein R3 represents a pyridyl group which may be optionally substituted with one difluoromethoxy group. [Embodiment 73] The compound of the present invention wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two substituents selected from Group G82. [Embodiment 74] The compound of the present invention wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one substituent selected from Group G82. [Embodiment 75] The compound of the present invention wherein R3 represents a five(5) membered aromatic heterocyclic group which may be optionally substituted with one or two substituents selected from Group G82o [Embodiment 76] The compound of the present invention wherein R3 represents a five(5) membered aromatic heterocyclic group which may be optionally substituted with one substituent selected from Group G82. [Embodiment 77] The compound of the present invention wherein R3 represents a pyrazolyl group which may be optionally substituted with one or two substituents selected from Group G82. [Embodiment 78] The compound of the present invention wherein R3 represents a triazolyl group which may be optionally substituted with one or two substituents selected from Group G82. [Embodiment 79] The compound of the present invention wherein R3 represents a five(5) membered aromatic heterocyclic group which may be optionally substituted with one halogen atom. [Embodiment 80] The compound of the present invention wherein R3 represents any group represented by the following formula. B-2 [Embodiment 81] The compound of the present invention wherein R3 represents any group represented by the following formula. [Embodiment 82] The compound of the present invention wherein R3 represents any group represented by the following formula. [Embodiment 83] The compound of the present invention wherein 10 R3 represents any group represented by the following formula. [Embodiment 84] The compound of the present invention wherein R3 represents an aromatic fused heterocyclic group which may be optionally substituted with one or two substituents selected from Group G5. [Embodiment 85] The compound of the present invention wherein R3 represents an aromatic fused heterocyclic group which may be optionally substituted with one substituent selected from Group G5. [Embodiment 86] The compound of the present invention wherein R3 represents an aromatic fused heterocyclic group which may be optionally substituted with one or two substituents selected from Group G82. [Embodiment 87] The compound of the present invention wherein R3 represents an eight(8) membered aromatic fused heterocyclic group which may be optionally substituted with one or two substituents selected from Group G82. [Embodiment 88] The compound of the present invention wherein R3 represents a nine(9) membered aromatic fused heterocyclic group which may be optionally substituted with one or two substituents selected from Group G82. [Embodiment 89] The compound of the present invention wherein R3 represents a ten(10) membered aromatic fused heterocyclic group which may be optionally substituted with one or two substituents selected from Group G82. [Embodiment 90] The compound of the present invention wherein R3 represents any group represented by the following formula: R30b R30c R30d R30f R30e B-5 R30g R30a r30c R30g R30f R30e B-9 R30b R30c R30g R30d R30b R30b R R30f R30b R30S B-11 R30a R30c R30e 30f B-10 B-12 wherein, R30a, R30b, R30c, R30d, R30e, R30f, and R30g are identical to or different from each other and each represents a halogen atom, 10 a cyano group, a methyl group, a difluoromethyl group, a trifluoromethyl group, cyclopropyl group, difluoromethoxy group, a trifluoromethoxy group, or SCF3 group. [Embodiment 91] The compound of the present invention wherein 15 R3 represents any group represented by the following formula: [Embodiment 92] The compound of the present invention wherein R3 represents any group represented by the following formula: B-13 B-14 10 wherein, R30d, R30e, R30f, and R30g are identical to or different from each other and each represents a halogen atom, a cyano group, a methyl group, a difluoromethyl group, a trifluoromethyl group, a cyclopropyl group, a difluoromethoxy group, a trifluoromethoxy group, or SCF3 group. [Embodiment 93] The compound of the present invention wherein R3 represents any group represented by the following formula: [Embodiment 94] The compound of the present invention wherein group represented by the following formula: R3 represents any B-21 wherein 10 R30a, R30b R30c and R30d are identical to or different each other and each represents a halogen atom, a methyl group, from a cyano group, a difluoromethyl group, a trifluoromethyl group, a cyclopropyl group, a difluoromethoxy group, a trifluoromethoxy group, or SCF3 group, R31 represents a hydrogen atom, a methyl group, a difluoromethyl group, a trifluoromethyl group, an ethyl group, a difluoroethyl group, a cyclopropyl group, or an isopropyl group. [Embodiment 95] The compound of the present invention wherein R3 represents any group represented by the following formula: B-34 10 wherein R30d and R30e are identical to or different from each other and each represents a halogen atom, a cyano group, a methyl group, a difluoromethyl group, a trifluoromethyl group, a cyclopropyl group, a difluoromethoxy group, a trifluoromethoxy group, or SCF3 group. 0 [Embodiment 96] The compound of the present invention wherein R3 represents any group represented by the following formula:

[0013] [Embodiment C1] The compound of the present invention wherein 5    R2 represents a C1-C4 chain hydrocarbon group which is substituted with one or more substituents selected from Group G3, a C3-C6 alicyclic hydrocarbon group which is substituted with one or more substituents selected from Group G4, a halogen atom, a cyano group, OR10, C(=Z1)R11, C(=Z1)OR12, 10     C(=Z1)NR11R12, S(O)pR13, or NR10R14. [Embodiment C2] The compound of the present invention wherein R2 represents a C1-C4 alkyl group which is substituted with one or more substituents selected from Group G3, a C3-C6 cycloalkyl group which is substituted with one or more 15 substituents selected from Group G4, a halogen atom, a cyano group, OR10, or S(O)pR13 group. [Embodiment C3] The compound of the present invention wherein R2 represents a C1-C4 alkyl group which is substituted with one or more substituents selected from Group G3, OR10, or S(O)pR13, R10 and R13 are identical to or different from each other and each represents a C1-C3 alkyl group which may be optionally substituted with one or more halogen atoms. [Embodiment C4] The compound of the present invention wherein R2 represents a C1-C4 alkyl group which is substituted with one or more substituents selected from Group G3. [Embodiment C5] The compound of the present invention wherein R2 represents an isopropyl group, an ethyl group, or a methyl group. [Embodiment C6] The compound of the present invention wherein R2 represents an isopropyl group. [Embodiment C7] The compound of the present invention wherein R2 represents an ethyl group. [Embodiment C8] The compound of the present invention wherein R2 represents a methyl group. [Embodiment C9] The compound of the present invention wherein R3 represents a phenyl group which may be optionally substituted with one to three substituents selected from Group G5, or a five(5) or six(6) membered aromatic heterocyclic group which may be optionally substituted with one to three substituents selected from Group G5. [Embodiment C10] The compound of the present invention wherein R3 represents a phenyl group which may be optionally substituted with one or two substituents selected from Group G51. [Embodiment C11] The compound of the present invention wherein R3 represents a phenyl group which may be optionally substituted with one or more halogen atoms. [Embodiment C12] The compound of the present invention wherein R3 represents a phenyl group which may be optionally substituted with one or two halogen atoms. [Embodiment C13] The compound of the present invention wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two substituents selected from Group G51. [Embodiment C14] The compound of the present invention wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two halogen atoms. [Embodiment C15] The compound of Embodiment C1 wherein R3 represents a phenyl group which may be optionally substituted with one to three substituents selected from Group G5, or a five(5) or six(6) membered aromatic heterocyclic group which may be optionally substituted with one to three substituents selected from Group G5. [Embodiment C16] The compound of Embodiment C1 wherein R3 represents a phenyl group which may be optionally substituted with one or two substituents selected from Group G51. [Embodiment C17] The compound of Embodiment C1 wherein R3 represents a phenyl group which may be optionally substituted with one or more halogen atoms. [Embodiment C18] The compound of Embodiment C1 wherein R3 represents a phenyl group which may be optionally substituted with one or two halogen atoms. [Embodiment C19] The compound of Embodiment C1 wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two substituents selected from Group G51. [Embodiment C20] The compound of Embodiment C1 wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two halogen atoms. [Embodiment C21] The compound of Embodiment C2 wherein R3 represents a phenyl group which may be optionally substituted with one to three substituents selected from Group G5, or a five(5) or six(6) membered aromatic heterocyclic group which may be optionally substituted with one to three substituents selected from Group G5. [Embodiment C22] The compound of Embodiment C2 wherein R3 represents a phenyl group which may be optionally substituted with one or two substituents selected from Group G51. [Embodiment C23] The compound of Embodiment C2 wherein R3 represents a phenyl group which may be optionally substituted with one or more halogen atoms. [Embodiment C24] The compound of Embodiment C2 wherein R3 represents a phenyl group which may be optionally substituted with one or two halogen atoms. [Embodiment C25] The compound of Embodiment C2 wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two substituents selected from Group G51. [Embodiment C26] The compound of Embodiment C2 wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two halogen atoms. [Embodiment C27] The compound of Embodiment C3 wherein R3 represents a phenyl group which may be optionally substituted with one to three substituents selected from Group G5, or a five(5) or six(6) membered aromatic heterocyclic group which may be optionally substituted with one to three substituents selected from Group G5. [Embodiment C28] The compound of Embodiment C3 wherein R3 represents a phenyl group which may be optionally substituted with one or two substituents selected from Group G51. [Embodiment C29] The compound of Embodiment C3 wherein R3 represents a phenyl group which may be optionally substituted with one or more halogen atoms. [Embodiment C30] The compound of Embodiment C3 wherein R3 represents a phenyl group which may be optionally substituted with one or two halogen atoms. [Embodiment C31] The compound of Embodiment C3 wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two substituents selected from Group G51. [Embodiment C32] The compound of Embodiment C3 wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two halogen atoms. [Embodiment C33] The compound of Embodiment C4 wherein R3 represents a phenyl group which may be optionally substituted with one to three substituents selected from Group G5, or a five(5) or six(6) membered aromatic heterocyclic group which may be optionally substituted with one to three substituents selected from Group G5. [Embodiment C34] The compound of Embodiment C4 wherein R3 represents a phenyl group which may be optionally substituted with one or two substituents selected from Group G51. [Embodiment C35] The compound of Embodiment C4 wherein R3 represents a phenyl group which may be optionally substituted with one or more halogen atoms. [Embodiment C36] The compound of Embodiment C4 wherein R3 represents a phenyl group which may be optionally substituted with one or two halogen atoms. [Embodiment C37] The compound of Embodiment C4 wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two substituents selected from Group G51. [Embodiment C38] The compound of Embodiment C4 wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two halogen atoms. [Embodiment C39] The compound of Embodiment C5 wherein R3 represents a phenyl group which may be optionally substituted with one to three substituents selected from Group G5, or a five(5) or six(6) membered aromatic heterocyclic group which may be optionally substituted with one to three substituents selected from Group G5. [Embodiment C40] The compound of Embodiment C5 wherein R3 represents a phenyl group which may be optionally substituted with one or two substituents selected from Group G51. [Embodiment C41] The compound of Embodiment C5 wherein R3 represents a phenyl group which may be optionally substituted with one or more halogen atoms. [Embodiment C42] The compound of Embodiment C5 wherein R3 represents a phenyl group which may be optionally substituted with one or two halogen atoms. [Embodiment C43] The compound of Embodiment C5 wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two substituents selected from Group G51. [Embodiment C44] The compound of Embodiment C5 wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two halogen atoms. [Embodiment C45] The compound of Embodiment C6 wherein R3 represents a phenyl group which may be optionally substituted with one to three substituents selected from Group G5, or a five(5) or six(6) membered aromatic heterocyclic group which may be optionally substituted with one to three substituents selected from Group G5. [Embodiment C46] The compound of Embodiment C6 wherein R3 represents a phenyl group which may be optionally substituted with one or two substituents selected from Group G51. [Embodiment C47] The compound of Embodiment C6 wherein R3 represents a phenyl group which may be optionally substituted with one or more halogen atoms. [Embodiment C48] The compound of Embodiment C6 wherein R3 represents a phenyl group which may be optionally substituted with one or two halogen atoms. [Embodiment C49] The compound of Embodiment C6 wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two substituents selected from Group G51. [Embodiment C50] The compound of Embodiment C6 wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two halogen atoms. [Embodiment C51] The compound of Embodiment C7 wherein R3 represents a phenyl group which may be optionally substituted with one to three substituents selected from Group G5, or a five(5) or six(6) membered aromatic heterocyclic group which may be optionally substituted with one to three substituents selected from Group G5. [Embodiment C52] The compound of Embodiment C7 wherein R3 represents a phenyl group which may be optionally substituted with one or two substituents selected from Group G51. [Embodiment C53] The compound of Embodiment C7 wherein R3 represents a phenyl group which may be optionally substituted with one or more halogen atoms. [Embodiment C54] The compound of Embodiment C7 wherein R3 represents a phenyl group which may be optionally substituted with one or two halogen atoms. [Embodiment C55] The compound of Embodiment C7 wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two substituents selected from Group G51. [Embodiment C56] The compound of Embodiment C7 wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two halogen atoms. [Embodiment C57] The compound of Embodiment C8 wherein R3 represents a phenyl group which may be optionally substituted with one to three substituents selected from Group G5, or a five(5) or six(6) membered aromatic heterocyclic group which may be optionally substituted with one to three substituents selected from Group G5. [Embodiment C58] The compound of Embodiment C8 wherein R3 represents a phenyl group which may be optionally substituted with one or two substituents selected from Group G51. [Embodiment C59] The compound of Embodiment C8 wherein R3 represents a phenyl group which may be optionally substituted with one or more halogen atoms. [Embodiment C60] The compound of Embodiment C8 wherein R3 represents a phenyl group which may be optionally substituted with one or two halogen atoms. [Embodiment C61] The compound of Embodiment C8 wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two substituents selected from Group G51. [Embodiment C62] The compound of Embodiment C8 wherein R3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one or two halogen atoms. [Embodiment C63] The compound of the present invention wherein X1 represents an oxygen atom. [Embodiment C64]  The compound of the present  invention wherein X1 and X2 represent an oxygen atom. [Embodiment C65]  The compound of the present  invention wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C66] The compound of the present invention wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C67] The compound of Embodiment C1 wherein X1 represents an oxygen atom. [Embodiment C68] The compound of of Embodiment C1 wherein X1 and X2 represent an oxygen atom. [Embodiment C69] The compound of of Embodiment C1 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C70] The compound of Embodiment C1 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C71] The compound of Embodiment C2 wherein X1 represents an oxygen atom. [Embodiment C72] The compound of of Embodiment C2 wherein X1 and X2 represent an oxygen atom. [Embodiment C73] The compound of of Embodiment C2 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C74] The compound of Embodiment C2 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C75] The compound of Embodiment C3 wherein X1 represents an oxygen atom. [Embodiment C76] The compound of of Embodiment C3 wherein X1 and X2 represent an oxygen atom. [Embodiment C77] The compound of of Embodiment C3 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C78] The compound of Embodiment C3 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C79] The compound of Embodiment C4 wherein X1 represents an oxygen atom. [Embodiment C80] The compound of of Embodiment C4 wherein X1 and X2 represent an oxygen atom. [Embodiment C81] The compound of of Embodiment C4 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C82] The compound of Embodiment C4 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C83] The compound of Embodiment C5 wherein X1 represents an oxygen atom. [Embodiment C84] The compound of of Embodiment C5 wherein X1 and X2 represent an oxygen atom. [Embodiment C85] The compound of of Embodiment C5 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C86] The compound of Embodiment C5 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C87] The compound of Embodiment C6 wherein X1 represents an oxygen atom. [Embodiment C88] The compound of of Embodiment C6 wherein X1 and X2 represent an oxygen atom. [Embodiment C89] The compound of of Embodiment C6 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C90] The compound of Embodiment C6 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C91] The compound of Embodiment C7 wherein X1 represents an oxygen atom. [Embodiment C92] The compound of of Embodiment C7 wherein X1 and X2 represent an oxygen atom. [Embodiment C93] The compound of of Embodiment C7 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C94] The compound of Embodiment C7 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C95] The compound of Embodiment C8 wherein X1 represents an oxygen atom. [Embodiment C96] The compound of of Embodiment C8 wherein X1 and X2 represent an oxygen atom. [Embodiment C97] The compound of of Embodiment C8 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C98] The compound of Embodiment C8 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C99] The compound of Embodiment C9 wherein X1 represents an oxygen atom. [Embodiment C100] The compound of of Embodiment C9 wherein X1 and X2 represent an oxygen atom. [Embodiment C101] The compound of of Embodiment C9 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C102] The compound of Embodiment C9 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C103] The compound of Embodiment C10 wherein X1 represents an oxygen atom. [Embodiment C104] The compound of of Embodiment C10 wherein X1 and X2 represent an oxygen atom. [Embodiment C105] The compound of of Embodiment C10 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C106] The compound of Embodiment C10 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C107] The compound of Embodiment C11 wherein X1 represents an oxygen atom. [Embodiment C108] The compound of of Embodiment C11 wherein X1 and X2 represent an oxygen atom. [Embodiment C109] The compound of of Embodiment C11 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C110] The compound of Embodiment C11 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C111] The compound of Embodiment C12 wherein X1 represents an oxygen atom. [Embodiment C112] The compound of of Embodiment C12 wherein X1 and X2 represent an oxygen atom. [Embodiment C113] The compound of of Embodiment C12 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C114] The compound of Embodiment C12 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C115] The compound of Embodiment C13 wherein X1 represents an oxygen atom. [Embodiment C116] The compound of of Embodiment C13 wherein X1 and X2 represent an oxygen atom. [Embodiment C117] The compound of of Embodiment C13 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C118] The compound of Embodiment C13 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C119] The compound of Embodiment C14 wherein X1 represents an oxygen atom. [Embodiment C120] The compound of of Embodiment C14 wherein X1 and X2 represent an oxygen atom. [Embodiment C121] The compound of of Embodiment C14 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C122] The compound of Embodiment C14 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C123] The compound of Embodiment C15 wherein X1 represents an oxygen atom. [Embodiment C124] The compound of of Embodiment C15 wherein X1 and X2 represent an oxygen atom. [Embodiment C125] The compound of of Embodiment C15 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C126] The compound of Embodiment C15 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C127] The compound of Embodiment C16 wherein X1 represents an oxygen atom. [Embodiment C128] The compound of of Embodiment C16 wherein X1 and X2 represent an oxygen atom. [Embodiment C129] The compound of of Embodiment C16 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C130] The compound of Embodiment C16 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C131] The compound of Embodiment C17 wherein X1 represents an oxygen atom. [Embodiment C132] The compound of of Embodiment C17 wherein X1 and X2 represent an oxygen atom. [Embodiment C133] The compound of of Embodiment C17 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C134] The compound of Embodiment C17 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C135] The compound of Embodiment C18 wherein X1 represents an oxygen atom. [Embodiment C136] The compound of of Embodiment C18 wherein X1 and X2 represent an oxygen atom. [Embodiment C137] The compound of of Embodiment C18 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C138] The compound of Embodiment C18 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C139] The compound of Embodiment C19 wherein X1 represents an oxygen atom. [Embodiment C140] The compound of of Embodiment C19 wherein X1 and X2 represent an oxygen atom. [Embodiment C141] The compound of of Embodiment C19 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C142] The compound of Embodiment C19 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C143] The compound of Embodiment C20 wherein X1 represents an oxygen atom. [Embodiment C144] The compound of of Embodiment C20 wherein X1 and X2 represent an oxygen atom. [Embodiment C145] The compound of of Embodiment C20 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C146] The compound of Embodiment C20 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C147] The compound of Embodiment C21 wherein X1 represents an oxygen atom. [Embodiment C148] The compound of of Embodiment C21 wherein X1 and X2 represent an oxygen atom. [Embodiment C149] The compound of of Embodiment C21 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C150] The compound of Embodiment C21 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C151] The compound of Embodiment C22 wherein X1 represents an oxygen atom. [Embodiment C152] The compound of of Embodiment C22 wherein X1 and X2 represent an oxygen atom. [Embodiment C153] The compound of of Embodiment C22 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C154] The compound of Embodiment C22 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C155] The compound of Embodiment C23 wherein X1 represents an oxygen atom. [Embodiment C156] The compound of of Embodiment C23 wherein X1 and X2 represent an oxygen atom. [Embodiment C157] The compound of of Embodiment C23 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C158] The compound of Embodiment C23 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C159] The compound of Embodiment C24 wherein X1 represents an oxygen atom. [Embodiment C160] The compound of of Embodiment C24 wherein X1 and X2 represent an oxygen atom. [Embodiment C161] The compound of of Embodiment C24 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C162] The compound of Embodiment C24 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C163] The compound of Embodiment C25 wherein X1 represents an oxygen atom. [Embodiment C164] The compound of of Embodiment C25 wherein X1 and X2 represent an oxygen atom. [Embodiment C165] The compound of of Embodiment C25 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C166] The compound of Embodiment C25 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C167] The compound of Embodiment C26 wherein X1 represents an oxygen atom. [Embodiment C168] The compound of of Embodiment C26 wherein X1 and X2 represent an oxygen atom. [Embodiment C169] The compound of of Embodiment C26 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C170] The compound of Embodiment C26 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C171] The compound of Embodiment C27 wherein X1 represents an oxygen atom. [Embodiment C172] The compound of of Embodiment C27 wherein X1 and X2 represent an oxygen atom. [Embodiment C173] The compound of of Embodiment C27 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C174] The compound of Embodiment C27 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C175] The compound of Embodiment C28 wherein X1 represents an oxygen atom. [Embodiment C176] The compound of of Embodiment C28 wherein X1 and X2 represent an oxygen atom. [Embodiment C177] The compound of of Embodiment C28 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C178] The compound of Embodiment C28 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C179] The compound of Embodiment C29 wherein X1 represents an oxygen atom. [Embodiment C180] The compound of of Embodiment C29 wherein X1 and X2 represent an oxygen atom. [Embodiment C181] The compound of of Embodiment C29 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C182] The compound of Embodiment C29 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C183] The compound of Embodiment C30 wherein X1 represents an oxygen atom. [Embodiment C184] The compound of of Embodiment C30 wherein X1 and X2 represent an oxygen atom. [Embodiment C185] The compound of of Embodiment C30 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C186] The compound of Embodiment C30 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C187] The compound of Embodiment C31 wherein X1 represents an oxygen atom. [Embodiment C188] The compound of of Embodiment C31 wherein X1 and X2 represent an oxygen atom. [Embodiment C189] The compound of of Embodiment C31 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C190] The compound of Embodiment C31 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C191] The compound of Embodiment C32 wherein X1 represents an oxygen atom. [Embodiment C192] The compound of of Embodiment C32 wherein X1 and X2 represent an oxygen atom. [Embodiment C193] The compound of of Embodiment C32 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C194] The compound of Embodiment C32 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C195] The compound of Embodiment C33 wherein X1 represents an oxygen atom. [Embodiment C196] The compound of of Embodiment C33 wherein X1 and X2 represent an oxygen atom. [Embodiment C197] The compound of of Embodiment C33 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C198] The compound of Embodiment C33 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C199] The compound of Embodiment C34 wherein X1 represents an oxygen atom. [Embodiment C200] The compound of of Embodiment C34 wherein X1 and X2 represent an oxygen atom. [Embodiment C201] The compound of of Embodiment C34 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C202] The compound of Embodiment C34 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C203] The compound of Embodiment C35 wherein X1 represents an oxygen atom. [Embodiment C204] The compound of of Embodiment C35 wherein X1 and X2 represent an oxygen atom. [Embodiment C205] The compound of of Embodiment C35 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C206] The compound of Embodiment C35 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C207] The compound of Embodiment C36 wherein X1 represents an oxygen atom. [Embodiment C208] The compound of of Embodiment C36 wherein X1 and X2 represent an oxygen atom. [Embodiment C209] The compound of of Embodiment C36 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C210] The compound of Embodiment C36 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C211] The compound of Embodiment C37 wherein X1 represents an oxygen atom. [Embodiment C212] The compound of of Embodiment C37 wherein X1 and X2 represent an oxygen atom. [Embodiment C213] The compound of of Embodiment C37 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C214] The compound of Embodiment C37 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C215] The compound of Embodiment C38 wherein X1 represents an oxygen atom. [Embodiment C216] The compound of of Embodiment C38 wherein X1 and X2 represent an oxygen atom. [Embodiment C217] The compound of of Embodiment C38 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C218] The compound of Embodiment C38 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C219] The compound of Embodiment C39 wherein X1 represents an oxygen atom. [Embodiment C220] The compound of of Embodiment C39 wherein X1 and X2 represent an oxygen atom. [Embodiment C221] The compound of of Embodiment C39 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C222] The compound of Embodiment C39 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C223] The compound of Embodiment C40 wherein X1 represents an oxygen atom. [Embodiment C224] The compound of of Embodiment C40 wherein X1 and X2 represent an oxygen atom. [Embodiment C225] The compound of of Embodiment C40 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C226] The compound of Embodiment C40 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C227] The compound of Embodiment C41 wherein X1 represents an oxygen atom. [Embodiment C228] The compound of of Embodiment C41 wherein X1 and X2 represent an oxygen atom. [Embodiment C229] The compound of of Embodiment C41 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C230] The compound of Embodiment C41 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C231] The compound of Embodiment C42 wherein X1 represents an oxygen atom. [Embodiment C232] The compound of of Embodiment C42 wherein X1 and X2 represent an oxygen atom. [Embodiment C233] The compound of of Embodiment C42 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C234] The compound of Embodiment C42 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C235] The compound of Embodiment C43 wherein X1 represents an oxygen atom. [Embodiment C236] The compound of of Embodiment C43 wherein X1 and X2 represent an oxygen atom. [Embodiment C237] The compound of of Embodiment C43 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C238] The compound of Embodiment C43 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C239] The compound of Embodiment C44 wherein X1 represents an oxygen atom. [Embodiment C240] The compound of of Embodiment C44 wherein X1 and X2 represent an oxygen atom. [Embodiment C241] The compound of of Embodiment C44 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C242] The compound of Embodiment C44 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C243] The compound of Embodiment C45 wherein X1 represents an oxygen atom. [Embodiment C244] The compound of of Embodiment C45 wherein X1 and X2 represent an oxygen atom. [Embodiment C245] The compound of of Embodiment C45 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C246] The compound of Embodiment C45 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C247] The compound of Embodiment C46 wherein X1 represents an oxygen atom. [Embodiment C248] The compound of of Embodiment C46 wherein X1 and X2 represent an oxygen atom. [Embodiment C249] The compound of of Embodiment C46 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C250] The compound of Embodiment C46 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C251] The compound of Embodiment C47 wherein X1 represents an oxygen atom. [Embodiment C252] The compound of of Embodiment C47 wherein X1 and X2 represent an oxygen atom. [Embodiment C253] The compound of of Embodiment C47 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C254] The compound of Embodiment C47 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C255] The compound of Embodiment C48 wherein X1 represents an oxygen atom. [Embodiment C256] The compound of of Embodiment C48 wherein X1 and X2 represent an oxygen atom. [Embodiment C257] The compound of of Embodiment C48 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C258] The compound of Embodiment C48 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C259] The compound of Embodiment C49 wherein X1 represents an oxygen atom. [Embodiment C260] The compound of of Embodiment C49 wherein X1 and X2 represent an oxygen atom. [Embodiment C261] The compound of of Embodiment C49 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C262] The compound of Embodiment C49 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C263] The compound of Embodiment C50 wherein X1 represents an oxygen atom. [Embodiment C264] The compound of of Embodiment C50 wherein X1 and X2 represent an oxygen atom. [Embodiment C265] The compound of of Embodiment C50 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C266] The compound of Embodiment C50 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C267] The compound of Embodiment C51 wherein X1 represents an oxygen atom. [Embodiment C268] The compound of of Embodiment C51 wherein X1 and X2 represent an oxygen atom. [Embodiment C269] The compound of of Embodiment C51 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C270] The compound of Embodiment C51 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C271] The compound of Embodiment C52 wherein X1 represents an oxygen atom. [Embodiment C272] The compound of of Embodiment C52 wherein X1 and X2 represent an oxygen atom. [Embodiment C273] The compound of of Embodiment C52 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C274] The compound of Embodiment C52 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C275] The compound of Embodiment C53 wherein X1 represents an oxygen atom. [Embodiment C276] The compound of of Embodiment C53 wherein X1 and X2 represent an oxygen atom. [Embodiment C277] The compound of of Embodiment C53 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C278] The compound of Embodiment C53 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C279] The compound of Embodiment C54 wherein X1 represents an oxygen atom. [Embodiment C280] The compound of of Embodiment C54 wherein X1 and X2 represent an oxygen atom. [Embodiment C281] The compound of of Embodiment C54 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C282] The compound of Embodiment C54 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C283] The compound of Embodiment C55 wherein X1 represents an oxygen atom. [Embodiment C284] The compound of of Embodiment C55 wherein X1 and X2 represent an oxygen atom. [Embodiment C285] The compound of of Embodiment C55 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C286] The compound of Embodiment C55 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C287] The compound of Embodiment C56 wherein X1 represents an oxygen atom. [Embodiment C288] The compound of of Embodiment C56 wherein X1 and X2 represent an oxygen atom. [Embodiment C289] The compound of of Embodiment C56 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C290] The compound of Embodiment C56 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C291] The compound of Embodiment C57 wherein X1 represents an oxygen atom. [Embodiment C292] The compound of of Embodiment C57 wherein X1 and X2 represent an oxygen atom. [Embodiment C293] The compound of of Embodiment C57 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C294] The compound of Embodiment C57 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C295] The compound of Embodiment C58 wherein X1 represents an oxygen atom. [Embodiment C296] The compound of of Embodiment C58 wherein X1 and X2 represent an oxygen atom. [Embodiment C297] The compound of of Embodiment C58 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C298] The compound of Embodiment C58 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C299] The compound of Embodiment C59 wherein X1 represents an oxygen atom. [Embodiment C300] The compound of of Embodiment C59 wherein X1 and X2 represent an oxygen atom. [Embodiment C301] The compound of of Embodiment C59 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C302] The compound of Embodiment C59 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C303] The compound of Embodiment C60 wherein X1 represents an oxygen atom. [Embodiment C304] The compound of of Embodiment C60 wherein X1 and X2 represent an oxygen atom. [Embodiment C305] The compound of of Embodiment C60 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C306] The compound of Embodiment C60 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C307] The compound of Embodiment C61 wherein X1 represents an oxygen atom. [Embodiment C308] The compound of of Embodiment C61 wherein X1 and X2 represent an oxygen atom. [Embodiment C309] The compound of of Embodiment C61 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C310] The compound of Embodiment C61 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C311] The compound of Embodiment C62 wherein X1 represents an oxygen atom. [Embodiment C312] The compound of of Embodiment C62 wherein X1 and X2 represent an oxygen atom. [Embodiment C313] The compound of of Embodiment C62 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Embodiment C314] The compound of Embodiment C62 wherein X1 and X2 represent an oxygen atom, Y1 represents OR15, and R15 represents a hydrogen atom. [Embodiment C315] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G1, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G1, a C2-C6 alkenyl group which may be optionally substituted with one or more substituents selected from Group G1, a C2-C6 alkynyl group which may be optionally substituted with one or more substituents selected from Group G1, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G2, a three(3) - six(6) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G2 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G1, OR16, S(O)mR17, or NR18R19. [Embodiment C316] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G1, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G1, a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G2, a three(3) - six(6) membered saturated nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G2 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G1, OR16, S(O)mR17, or NR18R19. [Embodiment C317] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G1, a butyl group which may be optionally substituted with one or more substituents selected from Group G1, an ethyl group which is substituted with one or more substituents selected from Group G1, a n-propyl group which is substituted with one or more substituents selected from Group G1, or a C3-C6 cycloalkyl which may be optionally substituted with one or more substituents selected from Group G2. [Embodiment C318] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G1, a butyl group which may be optionally substituted with one or more substituents selected from Group G1, an ethyl group which is substituted with one or more substituents selected from Group G1, a n-propyl group which is substituted with one or more substituents selected from Group G1, or a C3-C6 cycloalkyl group. [Embodiment C319] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one substituent selected from Group G1, a butyl group which may be optionally substituted with one substituent selected from Group G1, an ethyl group which is substituted with one substituent selected from Group G1, a n-propyl group which is substituted with one substituent selected from Group G1, or a C3-C6 cycloalkyl group. [Embodiment C320] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one substituent selected from Group G1, a butyl group which may be optionally substituted with one substituent selected from Group G1, or a C5-C6 cycloalkyl group. [Embodiment C321] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G11, a C4-C8 alkyl group which may be optionally substituted with one or more substituents selected from Group G11, a C2-C8 alkenyl group which may be optionally substituted with one or more substituents selected from Group G11, a C2-C8 alkynyl group which may be optionally substituted with one or more substituents selected from Group G11, a C3-C8 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G21, a three(3) - eight(8) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G21 {the heteroatom which constitutes the three(3) - eight(8) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G11, OR16, S(O)mR17, or NR18R19. [Embodiment C322] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G11, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G11, a C2-C6 alkenyl group which  may be  optionally  substituted with  one  or  more substituents selected from Group G11, a C2-C6 alkynyl group which  may be  optionally  substituted with  one  or  more substituents selected from Group G11, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G21, a three(3) - six(6) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G21 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G11, OR16, S(O)mR17, or NR18R19. [Embodiment C323] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G11, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G11, a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G21, a three(3) - six(6) membered saturated nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G21 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G11, OR16, S(O)mR17, or NR18R19. [Embodiment C324] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G11, a butyl group which may be optionally substituted with one or more substituents selected from G11, an ethyl group which is substituted with one or more substituents selected from G11, a n-propyl group which is substituted with one or more substituents selected from G11, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G21. [Embodiment C325] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G11, a butyl group which may be optionally substituted with one or more substituents selected from G11, an ethyl group which is substituted with one or more substituents selected from G11, a n-propyl group which is substituted with one or more substituents selected from G11, or a C3-C6 cycloalkyl group. [Embodiment C326] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one substituent selected from Group G11, a butyl group which may be optionally substituted with one substituent selected from Group G11, an ethyl group which is substituted with one substituent selected from Group G11, a n-propyl group which is substituted with one substituent selected from Group G11, or a C3-C6 cycloalkyl group. [Embodiment C327] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one substituent selected from Group G11, a butyl group which may be optionally substituted with one substituent selected from Group G11, or a C5-C6 cycloalkyl group. [Embodiment C328] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G12, a C4-C8 alkyl group which may be optionally substituted with one or more substituents selected from Group G12, a C2-C8 alkenyl group which  may be  optionally  substituted with  one  or  more substituents selected from Group G12, a C2-C8 alkynyl group which  may be  optionally  substituted with  one  or  more substituents selected from Group G12, a C3-C8 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G21, a three(3) - eight(8) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G21 {the heteroatom which constitutes the three(3) - eight(8) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G12, OR16, S(O)mR17, or NR18R19. [Embodiment C329] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G12, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G12, a C2-C6 alkenyl group which may be optionally substituted with one or more substituents selected from Group G12, a C2-C6 alkynyl group which may be optionally substituted with one or more substituents selected from Group G12, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G21, a three(3) - six(6) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G2 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G12, OR16, S(O)mR17, or NR18R19. [Embodiment C330] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G12, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G12, a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G2, a three(3) - six(6) membered saturated nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G2 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G12, OR16, S(O)mR17, or NR18R19. [Embodiment C331] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G12, a butyl group which may be optionally substituted with one or more substituents selected from Group G12, an ethyl group Which is substituted with one or more substituents selected from Group G12, a n-propyl group which is substituted with one or more substituents selected from Group G12, or a C3-C6 cycloalkyl which may be optionally substituted with one or more substituents selected from Group G2. [Embodiment C332] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G12, a butyl group which may be optionally substituted with one or more substituents selected from Group G12, an ethyl group which is substituted with one or more substituents selected from Group G12, a n-propyl group which is substituted with one or more substituents selected from Group G12, or a C3-C6 cycloalkyl group. [Embodiment C333] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which is substituted with one substituent selected from Group G12, a butyl group which is substituted with one substituent selected from Group G12, an ethyl group which is substituted with one substituent selected from Group G12, a n-propyl group which is substituted with one substituent selected from Group G12, or a C3-C6 cycloalkyl group. [Embodiment C334] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which is substituted with one substituent selected from Group G12, a butyl group which is substituted with one substituent selected from Group G12, or a C5-C6 cycloalkyl group. [Embodiment C335] The compound of any one of Embodiment C1 to 314 or the present invention wherein R16, R17 and R18 are identical to or different from each other and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, and R19 represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom. [Embodiment C336] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G1, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G1, a C2-C6 alkenyl group which may be optionally substituted with one or more substituents selected from Group G1, a C2-C6 alkynyl group which may be optionally substituted with one or more substituents selected from Group G1, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G2, a three(3) - six(6) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G2 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G1, OR16, S(O)mR17, or NR18R19, R16, R17 and R18 are identical to or different from each other and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, and R19 represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom. [Embodiment C337] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G1, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G1, a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G2, a three(3) - six(6) membered saturated nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G2 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G1, OR16, S(O)mR17, or NR18R19, R16, R17 and R18 are identical to or different from each other and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, and R19 represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom. [Embodiment C338] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G11, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G11, a C2-C6 alkenyl group which may be optionally substituted with one or more substituents selected from Group G11, a C2-C6 alkynyl group which may be optionally substituted with one or more substituents selected from Group G11, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G21, a three(3) - six(6) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G21 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G11, OR16, S(O)mR17, or NR18R19, R16, R17 and R18 are identical to or different from each other and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, and R19 represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom. [Embodiment C339] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G11, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G11, a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G21, a three(3) - six(6) membered saturated nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G21 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G11, OR16, S(O)mR17, or NR18R19, R16, R17 and R18 are identical to or different from each other and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, and R19 represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom. [Embodiment C340] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G12, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G12, a C2-C6 alkenyl group which may be optionally substituted with one or more substituents selected from Group G12, a C2-C6 alkynyl group which may be optionally substituted with one or more substituents selected from Group G12, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G21, a three(3) - six(6) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G2 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G12, OR16, S(O)mR17, or NR18R19, R16, R17 and R18 are identical to or different from each other and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, and R19 represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom. [Embodiment C341] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G12, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G12, a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G2, a three(3) - six(6) membered saturated nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G2 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G12, OR16, S(O)mR17, or NR18R19, R16, R17 and R18 are identical to or different from each other and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, and R19 represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom. [Embodiment C342] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group, a tert-butyl group, or a sec-butyl group. [Embodiment C343] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group, or a tert-butyl group. [Embodiment C344] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents an isopropyl group. [Embodiment C345] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents a tertbutyl group. [Embodiment C346] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents a cyclopentyl group. [Embodiment C347] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents a cyclohexyl group. [Embodiment C348] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents OR16, S(O)mR17, or NR18R19, R16, R17 and R18 are identical to or different from each other and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, and R19 represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom. [Embodiment C349] The compound of any one of Embodiment C1 to 314 or the present invention wherein R1 represents OR16, S(O)mR17, or NR18R19, R16, R17 and R18 are identical to or different from each other and each represents a C1-C6 alkyl group, or a C3-C6 cycloalkyl group, and R19 represents a C1-C6 alkyl group, a C3-C6 cycloalkyl group, or a hydrogen atom. [Embodiment C350] The compound of the present invention wherein R1 represents a group bounded through a carbon atom and wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C351] The compound of Embodiment C315 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C352] The compound of Embodiment C316 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C353] The compound of Embodiment C317 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C354] The compound of Embodiment C318 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C355] The compound of Embodiment C319 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C356] The compound of Embodiment C320 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C357] The compound of Embodiment C321 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C358] The compound of Embodiment C322 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C359] The compound of Embodiment C323 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C360] The compound of Embodiment C324 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C361] The compound of Embodiment C325 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C362] The compound of Embodiment C326 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C363] The compound of Embodiment C327 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C364] The compound of Embodiment C328 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C365] The compound of Embodiment C329 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C366] The compound of Embodiment C330 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C367] The compound of Embodiment C331 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C368] The compound of Embodiment C332 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C369] The compound of Embodiment C333 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C370] The compound of Embodiment C334 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C371] The compound of Embodiment C335 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C372] The compound of Embodiment C336 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C373] The compound of Embodiment C337 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C374] The compound of Embodiment C338 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C375] The compound of Embodiment C339 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C376] The compound of Embodiment C340 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C377] The compound of Embodiment C341 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C378] The compound of Embodiment C348 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom. [Embodiment C379] The compound of Embodiment C349 wherein R1 represents a group bounded through a carbon atom wherein the carbon atom represents a di-substituted or tri-substituted carbon atom.

[0014] Next, a process for preparing a compound of the present invention is explained.

[0015] Process A A compound represented by formula (I-1) (hereinafter, referred to as "Compound (I-1)") can be prepared by reacting a compound represented by formula (A1) (hereinafter, referred to as "Compound (A1)") with a compound represented by formula (M1) (hereinafter, referred to as "Compound (M1)") in the presence of a catalyst and a base. O O                                 0   0 ( A1 )                                                                         (I -1 ) [wherein, W1 represents a chlorine atom, a bromine atom, or an iodine atom, M1 represents B(OH)2, an alkoxy boranyl group (such as 4,4,5,5-tetramethyl-1,3,2-dioxaborolane-2-yl group), or a trifluoroborate salt (BF3-K+), R1a represents a C2-C8 alkenyl group which may be optionally substituted with one or more substituents selected from Group G1, a C3-C8 cycloalkenyl group which may be optionally substituted with one or more substituents selected from Group G2, a three(3) - eight(8) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G2 {the heteroatom which constitutes the three(3) - eight(8) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom} or a cyclopropyl group which may be optionally substituted with one or more substituents selected from Group G2, and R15a represents a C1-C10 chain hydrocarbon group which may be optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, a benzyl group which may be optionally substituted with one or more substituents selected from Group G6, and the other symbols are the same as defined above] The reaction is usually carried out in a solvent. Examples of the solvent to be used in the reaction include hydrocarbons such as hexane, toluene, and xylene (hereinafter, collectively referred to as "hydrocarbons"); ethers such as methyl tert-butyl ether (hereinafter, referred to as "MTBE"), tetrahydrofuran (hereinafter, referred to as "THF"), and 1,4-dioxane (hereinafter, collectively referred to as "ethers"); halogenated hydrocarbons such as dichloromethane, chloroform and chlorobenzene (hereinafter, collectively referred to as "halogenated hydrocarbons"); amides such as N, N-dimethylformamide (hereinafter, referred to as "DMF") (hereinafter, collectively referred to as amides); esters such as ethyl acetate (hereinafter, collectively referred to as esters); nitriles such as acetonitrile (hereinafter, collectively referred to as "nitriles"); water, and mixed solvents of two or more kinds of the solvents. Examples of the catalyst used in the reaction include palladium catalysts such as tetrakis(triphenylphosphine) palladium (0), palladium (II) acetate, tris(dibenzylideneacetone)dipalladium, and [1,1'-bis(diphenylphosphino)ferrocene]palladium (II) dichloride. Examples of the base used in the reaction include organic bases such as triethylamine, diisopropyl ethyl amine, 1,8-azabicyclo[5.4.0]undeca-7-ene (DBU), pyridine, 4-(dimethylamino)pyridine (hereinafter, collectively referred to as "organic bases"); alkali metal carbonates such as sodium carbonate and potassium carbonate (hereinafter, collectively referred to as "alkali metal carbonates"); alkali metal hydrocarbonates (such as potassium hydrocarbonates) (hereinafter, collectively referred to as "alkali metal hydrocarbonates"); alkaline earth metal carbonates such as magnesium carbonate, and calcium carbonate) (hereinafter, collectively referred to as "alkaline earth metal carbonates"); sodium fluoride and tripotassium phosphate. In the reaction, the compound (M1) is usually used within a range of 1 to 10 molar ratio(s), the catalyst is used within a range of 0.01 to 1 molar ratio(s), and the base is used within a range of 1 to 10 molar ratio(s), based on 1 mole of the compound (A1). The reaction temperature of the reaction is usually within a range of 0 to 150°C. The reaction period is usually within a range of 0.1 to 120 hours. When the reaction is completed, the reaction mixtures are mixed with water, and the reaction mixtures are then extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to obtain the compound (I-1). The compound (M1) is a commercially available compound or can be prepared according to a method described in Chemical Reviews, vol.95, pages 2457 - 2483 (1995) or similar method thereto. Also, as needed, the boronic acid ester which is obtained by these methods or a commercially available boronic acid ester may be subjected to a hydrolysis to produce a boronic acid derivative. Further, the abovementioned boronic acid ester may be subjected to a fluorination according to a method described in Accounts of Chemical Research) vol.40, pages 278-286 or the like to produce trifluoroborate salt (BF3-K+).

[0016] Process B A compound represented by formula (I-2) (hereinafter, referred to as "Compound (I-2)") can be prepared by reacting the Compound (A1) with a compound represented by formula (M2) (hereinafter, referred to as "Compound (M2)") in the presence of a catalyst and a base. I                                                                                                                                                                                                                                                                                                                 I R3                                                 R3 ( A1 ) (I-2) [wherein, R1b represents a C1-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G1 or a hydrogen atom, and the other symbols are the same as defined above] The reaction is usually carried out in a solvent. Examples of the solvents used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; amides; esters; nitriles; water; and mixed solvents of two or more kinds of the solvents. Examples of the catalyst used in the reaction include palladium catalysts such as tetrakis(triphenylphosphine) palladium (0), palladium (II) acetate, tris(dibenzylideneacetone)dipalladium, [1,1'-bis(diphenylphosphino)ferrocene]palladium (II) dichloride; and copper catalysts such as copper(I) iodide and copper(I) chloride. Examples of the bases used in the reaction includes organic bases; alkali metal carbonates; alkaline earth metal carbonates; alkali metal hydrocarbonates; and metal carbonates such as sodium acetate, potassium acetate, calcium acetate, and magnesium acetate (hereinafter, collectively referred to as "metal carbonates"); metal alkoxides such as sodium methoxide, potassium ethoxide, sodium tert-butoxide, potassium methoxide, or potassium tert-butoxide) (hereinafter, collectively referred to as "metal alkoxides"); metal hydroxides such as sodium hydroxide, potassium hydroxide, calcium hydroxide, and magnesium hydroxide (hereinafter, collectively referred to as "metal hydroxides"); and metal hydrides such as lithium hydride, sodium hydride, potassium hydride, and calcium hydride (hereinafter, collectively referred to as "metal hydrides"). In the reaction, the compound (M2) is usually used within a range of 1 to 10 molar ratio(s), the catalyst is used within a range of 0.01 to 1 molar ratio(s), and the base is used within a range of 1 to 10 molar ratio(s), based on 1 mole of the compound (A1). In the reaction, as needed, a ligand may be used. Examples of the ligand include triphenylphosphine, Xantphos, 2,2'-bis(diphenylphoshino)-1,1'-binaphthyl, 1,1'-bis(diphenylphoshino)ferrocene, 2-dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl, 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl, and 1,2-bis(diphenylphosphino)ethane. When a ligand is used in the reaction, the ligand is usually used within a range of 0.01 to 1 molar ratio(s) based on 1 mole of the compound (A1). The reaction temperature of the reaction is usually within a range of -20 to 200°C. The reaction period is usually within a range of 0.1 to 120 hours. When the reaction is completed, the reaction mixtures are mixed with water, and the reaction mixtures are then extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to isolate the compound (I-2). The compound (M2) is a commercially available compound or can be prepared according to a method described in Tetrahedron Lett. 1972, 13, 3769, Synlett 1996, 521 etc.

[0017] Process C A compound represented by formula (I-4) (hereinafter, referred to as "Compound (I-4)") can be prepared by reacting a compound represented by formula (I-3) (hereinafter, referred to as "Compound (I-3)") with hydrogen in the presence of a hydrogenation catalyst. (1-3)                                       (1-4) [wherein, R1c represents a 1-propen-2-yl group which may be optionally substituted with  one  or  more  substituents selected from Group G1, a C4-C8 alkenyl group which may be optionally substituted with  one  or  more  substituents selected from Group G1, a C4-C8 cycloalkenyl group which may be optionally substituted with one or more substituents selected from Group G2, a  four(4)  -  eight(8) membered unsaturated nonaromatic heterocyclic group which may be optionally substituted with  one  or  more  substituents selected from Group G2 {the heteroatom(s) which constitutes the four(4) - eight(8) membered unsaturated nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a vinyl group which is substituted with one or more substituents selected from Group G1, a 1-propan-1-yl group which is substituted with one or more substituents selected from Group G1, and R1d represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G1, a C4-C8 alkyl group which may be optionally substituted with one or more substituents selected from Group G1, a C4-C8 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G2, a four(4) - eight(8) membered saturated nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G2 {the heteroatom(s) which constitutes of the four(4) - eight(8) membered saturated nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom), an ethyl group which is substituted with one or more substituents selected from Group G1, or a n-propyl group which is substituted with one or more substituents selected from Group G1, and the other symbols are the same as defined above] The reaction is usually carried out in a solvent under 1 to 100 hydrogen atmosphere(s). The reaction is usually carried out in a solvent. Examples of the solvents in the reaction include alcohols such as methanol and ethanol (hereinafter, collectively referred to as "alcohols"); esters; halogenated hydrocarbons; ethers; hydrocarbons; water; and mixed solvents of two or more kinds of the solvents. Examples of the hydrogenation catalyst include transition metal catalyst such as palladium on carbon (Pd / C), platinum on carbon (Pt / C), rhodium on carbon (Rh / C), RANEY (trademark)-nickel, and palladium hydroxide. In the reaction, as needed, an acid or a base may be used. Examples of the acid include acetic acid and hydrochloric acid, and examples of the base include tertiary amines such as triethylamine, and magnesium oxide. In the reaction, the hydrogenation catalyst is usually used within a range of 0.001 to 1 molar ratio(s), the hydrogen is usually used within a range of 1 molar ratio or more, and when the acid is used, the acid is usually used within a range of 0.001 to 10 molar ratio(s), and the base is usually used within a range of 1 to 10 molar ratio(s), based on 1 mole of the compound (1-3). The reaction temperature of the reaction is usually within a range of -20 to 150°C. The reaction period is usually within a range of 0.1 to 120 hours. When the reaction is completed, the reaction mixtures are filtered, and the filtrates are worked up (for example, concentration) to isolate the compound (I-4).

[0018] Process D A compound represented by formula (I-5) (hereinafter, referred to as "Compound (I-5)") can be prepared by reacting a compound represented by formula (A2) (hereinafter, referred to as Compound (A2)) with a reducing agent. I R3 ( A2 ) [wherein, R1e represents a C1-C7 chain hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G1, and the other symbols are the same as defined above] The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; amides; esters; nitriles; alcohols; water; and mixed solvents of two or more kinds of the solvents. Examples of the reducing agent used in the reaction include borohydrides such as sodium borohydride and potassium borohydride (hereinafter, collectively referred to as "borohydrides"). In the reaction, the reducing agent is usually used within a range of 0.3 to 1.5 molar ratios, as opposed to 1 mole of the compound (A2). The reaction temperature of the reaction is usually within a range of -20 to 200°C. The reaction period is usually within a range of 0.1 to 120 hours. When the reaction is completed, the reaction mixtures are mixed with water, and the reaction mixtures are then extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to isolate the compound (I-5).

[0019] Process E A compound represented by formula (I-6) (hereinafter, referred to as "Compound (I-6)") can be prepared by reacting the Compound (I-5) with a compound represented by formula (M-3) (hereinafter, referred to as "Compound (M3)") in the presence of an acid. [wherein, G1a represents a C1-C3 alkyl group which may be optionally substituted with one or more halogen atoms, Z4 represents an oxygen atom or a sulfur atom, and the other symbols are the same as defined above] The reaction is usually carried out in a solvent. Examples of the solvents used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; amides; esters; nitriles; water; and mixed solvents of two or more kinds of the solvents. Examples of the acid used in the reaction include sulfonic acids such as methanesulfonic acid, p-toluene sulfonic acid (hereinafter, collectively referred to as "sulfonic acids"); and inorganic acids such as hydrochloric acid and sulfuric acid (hereinafter, collectively referred to as "inorganic acids"). In the reaction, the compound (M3) is usually used within a range of 1 molar ratio to the amount as solvent and the acid is usually used within a range of 0.01 to 10 molar ratio(s), based on 1 mole of the compound (I-5). The reaction temperature of the reaction is usually within a range of -20 to 200°C. The reaction period is usually within a range of 0.1 to 120 hours. When the reaction is completed, the reaction mixtures are mixed with water, and the reaction mixtures are then extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to isolate the compound (I-6). The compound (M3) is a commercially available compound or can be prepared according to a known method.

[0020] Process F The compound (I-6) can be prepared by reacting a compound represented by formula (A3) (hereinafter, referred to as "Compound (A3)") with the compound (M3) or a compound represented by formula (M5) (hereinafter, referred to as "Compound (M5)"). I                                                                                                                                                                                                                                                                                                                                                                                                                                          I R3                                                        R3 ( A3 )                                                                              (I - 6 ) [wherein, Q represents a paratoluenesulfonyl group, a methanesulfonyl group, or a trifluoromethanesulfonyl group, and M2 represents an alkali metal such as lithium, sodium or potassium), and the other symbols are the same as defined above] The reaction is usually carried out in a solvent. Examples of the solvents used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; amides; esters; nitriles; alcohols; ketones such as acetone and methyl isobutyl ketone hereinafter, MIBK), (hereinafter, collectively referred to as "ketones"); water; and mixed solvents of two or more kinds of the solvents. In the reaction, the compound (M3) is usually used within a range of 1 to 10 molar ratios, based on 1 mole of the compound (A3). In the reaction, as needed, a base may be used. Examples of the base include organic bases; alkali metal carbonates; alkaline earth metal carbonates; alkali metal hydrocarbonates; metal carbonates; metal hydroxides; and metal hydrides. When a base is used in the reaction, the base is usually used within a range of 1 to 10 molar ratios, based on 1 mole of the compound (A3). The reaction temperature of the reaction is usually within a range of -20 to 200°C. The reaction period is usually within a range of 0.1 to 120 hours. When the reaction is completed, the reaction mixtures are mixed with water, and the reaction mixtures are then extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to isolate the compound (I-6). The compound (M5) is a commercially available compound or can be prepared according to a known method.

[0021] Process G A compound represented by formula (I-8) (hereinafter, referred to as "Compound (I-8)") can be prepared by reacting a compound represented by formula (I-6-1) (hereinafter, referred to as "Compound (I-6-1)") with an oxidizing agent. [wherein, r is 1, or 2, and the other symbols are the same as defined above] The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include halogenated hydrocarbons; nitriles; alcohols; water; and mixed solvents of two or more kinds of the solvents. Examples of the oxidizing agent include sodium periodate, m-chloroperoxybenzoic acid (hereinafter, referred to as "mCPBA") and hydrogen peroxide. In the reaction, the oxidizing agent is usually used within a range of 0.5 to 3 molar ratios, based on 1 mole of the compound (I-6-1). When hydrogen peroxide is used as an oxidizing agent, as needed, a base or a catalyst may be added. Examples of the base used in the reaction include sodium carbonate. When a base is used in the reaction, the base is usually used within a range of 0.01 to 1 molar ratio(s) based on 1 mole of the compound (I-6-1). Examples of the catalyst used in the reaction include sodium tungstate. When a catalyst is used in the reaction, the catalyst is usually used within a range of 0.01 to 0.5 molar ratio(s) based on 1 mole of the compound (I-6-1). The reaction temperature of the reaction is usually within a range of -20 to 200°C. The reaction period is usually within a range of 0.1 to 120 hours. When the reaction is completed, the reaction mixtures are mixed with water, and the reaction mixtures are then extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to isolate the compound (I-8).

[0022] Process H A compound represented by formula (I-9) (hereinafter, referred to as "Compound (I-9)") can be prepared by reacting the compound (A3) with a compound represented by formula (M6) (hereinafter, referred to as "Compound (M6)"). [wherein, G1d represents a halogen atom, a cyano group, or a mercapto group, and the other symbols are the same as defined above] The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; amides; esters; nitriles; alcohols; ketones; water; and mixed solvents of two or more kinds of the solvents. In the reaction, the compound (M6) is usually used within a range of 1 to 10 molar ratios, based on 1 mole of the compound (A3). The reaction temperature of the reaction is usually within a range of -20 to 200°C. The reaction period is usually within a range of 0.1 to 120 hours. When the reaction is completed, the reaction mixtures are mixed with water, and the reaction mixtures are then extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to isolate the compound (I-9). The compound (M6) is a commercially available compound or can be prepared according to a known method.

[0023] Process I A compound represented by formula (I-10) (hereinafter, referred to as "Compound (I-10)") can be prepared by reacting a compound represented by formula (A2-1) (hereinafter, referred to as "Compound (A2-1)") with a compound represented by formula (M7) (hereinafter, referred to as "Compound (M7)"). (A2-1 )                                                   (I-10) [wherein, R1f represents a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G1, and the other symbols are the same as defined above] The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include hydrocarbons; ethers; and mixed solvents of two or more kinds of the solvents. In the reaction, the compound (M7) is usually used within a range of 1 to 10 molar ratio(s) based on 1 mole of the compound (A2-1). The reaction temperature of the reaction is usually within a range of -20 to 200°C. The reaction period is usually within a range of 0.1 to 120 hours. When the reaction is completed, the reaction mixtures are mixed with aqueous acidic solution (such as dilute hydrochloric acid), and the reaction mixtures are then extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to isolate the compound (I-10). The compound (A2-1) can be prepared using the compound (A2) instead of the compound (I-12) according to a process K-1, K-2, or K-3.

[0024] Process J A compound represented by formula (I-11) (hereinafter, referred to as "Compound (I-11)") can be prepared by reacting the compound (I-10) with a compound represented by formula (M8) (hereinafter, referred to as "Compound (M8)") in the presence of a base. R1f O O                                  R1f O O (1-10)                                            (1-11 ) [wherein, L2 represents a halogen atom such as a chlorine atom, a bromine atom, and an iodine atom; a leaving group such as a methanesulfonyloxy group, a trifluromethylsulfonyloxy group, a 4-methylphenylsulfonyloxy group, and a phenylsulfonyloxy group; and R1g represents a C1-C3 alkyl group which may be optionally substituted with one or more halogen atoms, and the other symbols are the same as defined above] The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; amides; esters; nitriles; alcohols; ketones; water; and mixed solvents of two or more kinds of the solvents. Examples of the base used in the reaction include organic bases; alkali metal carbonates; alkaline earth metal carbonates; alkali metal hydrocarbonates; metal carbonates; metal hydroxides; and metal hydrides. In the reaction, the compound (M8) is usually used within a range of 1 to 10 molar ratio(s) based on 1 mole of the compound (I-10). The reaction temperature of the reaction is usually within a range of -20 to 200°C. The reaction period is usually within a range of 0.1 to 120 hours. When the reaction is completed, the reaction mixtures are mixed with water, and the reaction mixtures are then extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to isolate the compound (I-11). The compound (M8) is a commercially available compound or can be prepared according to a known method.

[0025] Process K-1 A compound represented by formula (I-13) (hereinafter, referred to as "Compound (I-13)") can be prepared by reacting a compound represented by formula (I-12) (hereinafter, referred to as "Compound (I-12)") in the presence of water and a base. 0   0                             o o R3                                            R3 (1-12)                                  (1-13) [wherein, the symbols are the same as defined above] The reaction is conducted in water or mixed solvents with organic solvent. Examples of the organic solvent include ethers, alcohols, and mixed solvents of two or more kinds of the solvents. Examples of the base used in the reaction include organic bases; alkali metal carbonates; alkaline earth metal carbonates; alkali metal hydrocarbonates; and metal carbonates; metal hydroxides. In the reaction, the base is usually used within a range of 1 to 10 molar ratio(s) based on 1 mole of the compound (I-12). The reaction temperature of the reaction is usually within a range of -20 to 200°C. The reaction period is usually within a range of 0.1 to 120 hours. When the reaction is completed, the reaction mixtures are made acidic with inorganic acids, and the reaction mixtures are then extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to isolate the compound (I-13).

[0026] Process K-2 The compound (I-13) can be also prepared by reacting the compound (I-12) in the presence of a lithium salt and an amine. o o                             o o oi X X                lithium salt Ri II II '^y^OR15a     amine R2"^^                 R2^^ R3                                            R3 (1-12)                                  (1-13) [wherein, the symbols are the same as defined above] The reaction is conducted according to a method described in Tetrahedron letters 2007, 48, 2497-2499.

[0027] Process K-3 The compound (I-13) can be also prepared by reacting the compound (I-12) in the presence of an acid. o o                             o o R3                                            R3 (1-12)                                  (1-13) [wherein, the symbols are the same as defined above] The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; water; and mixed solvents of two or more kinds of the solvents. Examples of the acid used in the reaction include sulfones; inorganic acids; and carbonic acids such as acetic acid and trifluoroacetic acid (hereinafter, collectively referred to as "carbonic acids"). In the reaction, the acid is usually used within a range of 0.001 to 10 molar ratio(s) based on 1 mole of the compound (I-12). The reaction temperature of the reaction is usually within a range of -20 to 150°C. The reaction period is usually within a range of 0.1 to 120 hours. When the reaction is completed, the reaction mixtures are mixed with water, and the reaction mixtures are then extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to isolate the compound (I-13).

[0028] Process L The compound (I-12) can be prepared by reacting the compound (I-13) with a compound represented by formula (M9) (hereinafter, referred to as "Compound (M9)") in the presence of a base. o o                            o o (1-13)                                  (1-12) [wherein, the symbols are the same as defined above] The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; amides; sulfoxides such as 1,3-dimethyl-2-imidazolidinone); sulfoxides such as dimethyl sulfoxide (hereinafter, referred to as "DMSO") (hereinafter, collectively referred to as "sulfoxides"), nitriles; water; and mixed solvents of two or more kinds of the solvents. Examples of the base used in the reaction include organic bases; alkali metal carbonates; alkaline earth metal carbonates; alkali metal hydrocarbonates; metal carbonates; metal alkoxides; metal hydroxides; and metal hydrides. In the reaction, the compound (M9) is usually used within a range of 1 to 10 molar ratio(s), and the base is usually used within a range of 1 to 10 molar ratio(s), based on 1 mole of the compound (I-13). The reaction temperature of the reaction is usually within a range of -20 to 200°C. The reaction period is usually within a range of 0.1 to 120 hours. When the reaction is completed, the reaction mixtures are mixed with water, and the reaction mixtures are then extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to isolate the compound (I-12). The compound (M9) is a commercially available compound or can be prepared according to a known method.

[0029] Process M A compound represented by formula (I-15) (hereinafter, referred to as "Compound (I-15)") can be prepared by a step where the compound (I-13) is reacting with a chlorinating agent to produce a compound represented by formula (IM-14) (hereinafter, referred to as "Compound (IM-14)") (step M-1), and a step where the compound (IM-14) obtained in the step M-1 is reacted with a compound represented by formula (M11) (hereinafter, referred to as "Compound (M11)") in the presence of a base to obtain the compound (I-15) (step M-2). (1-13)                      (IM-14)               (1-15) [wherein, the symbols are the same as defined above0]

[0030] Firstly, the step M-1 is explained. The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; esters; and mixed solvents of two or more kinds of the solvents. Examples of the chlorinating agent used in the reaction include thionyl chloride, oxalyl chloride, and phosphorus oxychloride. The chlorinating agent is usually used within a range of 1 to 10 molar ratio(s), based on 1 mole of the compound (I-13). The reaction may be carried out in the presence of a catalyst. Example of the catalyst includes DMF. When the reaction is carried out in the presence of a catalyst, the catalyst is usually used within a range of 0.01 to 1 molar ratio(s), based on 1 mole of the compound (I-13). The reaction temperature of the reaction is usually within a range of -80 to 150°C. The reaction period is usually within a range of 0.1 to 120 hours. When the reaction is completed, the reaction mixtures are worked up to isolate the compound (IM-14). Also, the reaction mixtures after completion of the reaction may be supplied as itself to the step M-2, or a mixture which is obtained by concentration of the reaction mixtures may be supplied to the step M-2.

[0031] Next, the step M-2 is explained. The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; esters; and mixed solvents of two or more kinds of the solvents. Examples of the base used in the reaction include organic bases; alkaline earth metal carbonates; alkali metal carbonates; alkali metal hydrocarbonates; metal carbonates; and metal hydroxides. In the reaction, the compound (M11) is usually used within a range of 1 to 10 molar ratio(s), and the base is usually used within a range of 1 to 10 molar ratio(s), based on 1 mole of the compound (I-13). The reaction temperature of the reaction is usually within a range of -80 to 150°C. The reaction period is usually within a range of 0.1 to 120 hours. Also, the reaction mixtures after completion of the reaction may be supplied as itself to the step M-2, or a mixture which is obtained by concentration of the reaction mixtures may be supplied to the step M-2. When the reaction is completed, the reaction mixtures are mixed with water, and the reaction mixtures are then extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to isolate the compound (I-15). Here the reaction conditions such as solvents, reaction temperature, and reaction periods between the step M-1 and the step M-2 may be identical to or different from each other. Also, the step M-1 and the step M-2 may be carried out at the same time by mixing the compound (I-13), the chlorinating agent, the base and the compound (M11), or the step M-2 may be carried out after the completion of the step M-1. Furthermore, the step M-2 may be started during the period between the starting time and the completion time of the step M-1.

[0032] Process N A compound represented by formula (I-16) (hereinafter, referred to as "Compound (I-16)"), a compound represented by formula (I-17) (hereinafter, referred to as "Compound (I-17)"), and a compound represented by formula (I-18) (hereinafter, referred to as "Compound (I-18)") can be prepared by reacting the compound (I-12) with a sulfuring agent. o o S 0 S S 0 S - Rh Av“ AV" RS |Vo> R2^ L J N R2^ R2^ N R3 R3 R3 R3 (1-12) (1-16) (1-17) (1-18) [wherein, the symbols are the same as defined above] The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include hydrocarbons, ethers, halogenated hydrocarbons, and mixed solvents of two or more kinds of the solvents. Examples of the sulfuring agent include phosphorus pentasulfide, and 2,4-bis(4-methoxyphenyl)-1,3-dithia-2,4-diphosphetane-2,4-disulfide (hereinafter, referred to as "Lawesson's Reagent"). The reaction may be carried out in the presence of a base. Examples of the base include organic bases; alkali metal carbonates; alkaline earth metal carbonates; alkali metal hydrocarbonates; metal carbonates; metal alkoxides; metal hydroxides; and metal hydrides. When the reaction is carried out in the presence of a base, the base is usually used within a range of 1 to 10 molar ratio(s) based on 1 mole of the compound (I-12). In the reaction, the sulfuring agent is usually carried out within a range of 1 to 10 molar ratio(s) based on 1 mole of the compound (I-12). The reaction temperature of the reaction is usually within a range of -20 to 150°C. The reaction period is usually within a range of 0.1 to 120 hours. When the reaction is completed, the reaction mixtures are mixed with water, and the reaction mixtures are then extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to isolate the compound (I-16), the compound (I-17), or the compound (I-18). The ratio of producing the compound (I-16), the compound (I-17) and the compound (I-18) can be increased or decreased by adjusting the kind of the solvent or the sulfuring agent, the equivalent amount of the sulfuring agent, or the reaction temperature and the reaction period.

[0033] Process O A compound represented by formula (I-13) (hereinafter, referred to as "Compound (I-13)") can be prepared by reacting the compound (I-19) and a diazonium salt (A8) (hereinafter, referred to as "Compound (A8)") in the presence of a base. R3-NH2 ( A6 ) sodium nitrite        N acid               HI   Cl *     N + [wherein, the symbols are the same as defined above] The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include 5 hydrocarbons; ethers; halogenated hydrocarbons; amides; esters; nitriles; alcohols; water; and mixed solvents of two or more kinds of the solvents. Examples of the bases used in the reaction includes organic bases; alkali metal carbonates; alkaline earth metal 10 carbonates; alkali metal hydrocarbonates; metal carbonates such as sodium acetate, potassium acetate, calcium acetate, and magnesium acetate (hereinafter, collectively referred to as "metal carbonates"); metal alkoxides such as sodium methoxide, sodium ethoxide, sodium tert-butoxide, potassium 15 methoxide, sodium tert-butoxide, potassium methoxide, or potassium tert-butoxide (hereinafter, collectively referred to as "metal alkoxides"); metal hydroxides such as sodium hydroxide, potassium hydroxide, calcium hydroxide, and magnesium hydroxide (hereinafter, collectively referred to as "metal hydroxides"); and metal hydrides such as lithium hydride, sodium hydride, potassium hydride, and calcium hydride (hereinafter, collectively referred to as "metal hydrides"). The reaction may be carried out using two or more of the above-mentioned bases. In the reaction, the compound (A6) is usually used within a range of 1 to 10 molar ratio(s), and the base is usually used within a range of 1 to 10 molar ratio(s), based on 1 mole of the compound (I-19). The reaction temperature of the reaction is usually within a range of -80 to 50°C. The reaction period is usually within a range of 0.01 to 120 hours. When the reaction is completed, the reaction mixtures are neutralized with an acid, and the reaction mixtures are then extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to isolate the compound (I-13) of the present invention. Example of the acid used in neutralization includes inorganic acids such as acetic acid, hydrochloric acid and sulfuric acid (hereinafter, collectively referred to as "Inorganic bases"). The reaction for synthesizing the compound (A8) from the compound (A6) in the above-mentioned scheme can be carried out according to a method described in US 2454742 B2.

[0034] Reference Process 1 The compound (A1) can be prepared by reacting a compound represented by formula (A4) (hereinafter, referred to as "Compound (A4)") in the presence of a halogenating agent o O                               0   0 ( A4 )                                                      ( A1 ) [wherein, the symbols are the same as defined above] The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; amides; esters; nitriles; imidazolidines; sulfoxides; and mixed solvents of two or more kinds of the solvents. Examples of the halogenating agent include chlorine, bromine, iodine, N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide, 1,3-dibromo-5,5-dimethylhydantoine, and dibromoisocyanuric acid. In the reaction, the halogenating agent is usually used within a range of 1 to 10 molar ratio(s) based on 1 mole of the compound (A4). The reaction temperature of the reaction is usually within a range of -100 to 200°C. The reaction period is usually within a range of 0.1 to 120 hours. When the reaction is completed, the reaction mixtures are mixed with water, and the reaction mixtures are then extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to isolate the compound (A1).

[0035] Reference Process 2 The compound (A4) can be prepared by reacting a compound represented by formula (A5) (hereinafter, referred to as "Compound (A5)") with the compound (M9) in the presence of a base. ( A5)                                                      (A4 ) [wherein, the symbols are the same as defined above] The reaction can be carried out by using the compound (A5) instead of the compound (I-13) according to the process I.

[0036] Reference Process 3 The compound (A3) can be prepared by reacting the compound (I-5) with a compound represented by formula (M10) (hereinafter, referred to as "Compound (M10)"). [wherein, the symbols are the same as defined above] The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; amides; esters; imidazolidines; sulfoxides; nitriles; water; and mixed solvents of two or more kinds of the solvents. In the reaction, the compound (M10) is usually used within a range of 1 to 10 molar ratio(s), based on 1 mole of the compound (I-5). As needed, a base can be used in the reaction. Examples of the base include organic bases; alkali metal carbonates; alkaline earth metal carbonates; and alkali metal hydrocarbonates. When a base is used in the reaction, the base is usually used within a range of 1 to 10 molar ratio(s), based on 1 mole of the compound (I-5). In the reaction, the compound (M10) is usually used within a range of 1 to 10 molar ratio(s) based on 1 mole of the compound (I-5). The reaction temperature of the reaction is usually within a range of -20 to 200°C. The reaction period is usually within a range of 0.1 to 120 hours. When the reaction is completed, the reaction mixtures 5 are mixed with water, and the reaction mixtures are then extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to isolate the compound (A3). The compound (M10) is a commercially available compound 10 or can be prepared according to a known method.

[0037] Reference Process 4 The compound (A5) can be prepared by using a compound represented by formula (A6) (hereinafter, referred to as 15 "Compound (A6)") and a compound represented by formula (A7) (hereinafter, referred to as "Compound (A7)") according to the scheme below. [wherein, the symbols are the same as defined above] Each reaction described in the above scheme can be carried out according to the method described in US 2454742 B2. The compound (A6) is a commercially available compound or can be prepared according to a known method. The compound (A7) is a commercially available compound or can be prepared according to a known method.

[0038] Reference Process 5 The compound (A2) can be prepared by reacting the compound (A2-1) with the compound (M9) in the presence of a base. o O 0                          0   0   0 ( A2-1 )                                                     ( A2) [wherein, the symbols are the same as defined above] The reaction can be carried out by using the compound (A2-1) instead of the compound (I-13) according to the process L.

[0039] Reference Process 6 The compound (A2-1) can be prepared by using the compound (A6) and a compound represented by formula (A10) (hereinafter, referred to as "Compound (A10)") according to the below-mentioned scheme. 5 [wherein, the symbols are the same as defined above] Each reaction described in the above scheme can be carried out according to a method described in US 2454742 B2. The compound (A10) is a commercially available compound, 10 or can be prepared according to the method described in Journal of the Chemical Society, 1963, 4483-4489, etc.

[0040] Reference Process 7 The compound (A5) can be prepared by using the compound 15    (A3) and the compound (A4) according to the below-mentioned scheme. [wherein, the symbols are the same as defined above] Each reaction described in the above scheme can be carried out according to a method described in The Journal 5 of Organic Chemistry, 1969, 1425-1429, etc.

[0041] Reference Process 8 The compound (I-19) can be prepared by using the compound (A5) and the compound (M12) according to the below-10 mentioned scheme. [wherein, the symbols are the same as defined above] Each reaction described in the above scheme can be carried out according to a method described in Chemistry, a European Journal, 2009, 2826-2845, etc. The compound (M12) is a commercially available compound, or can be prepared according to the method described in Journal of the American Chemical Society, 1962, 4899-4904, etc. The compound (I-19) may be existed as keto - enol tautomers. The compound (I-19) includes each of the ketoenol tautomers, and mixtures of the keto-enol tautomers in an arbitrary ratio thereof.

[0042] The Present compound may be mixed with or used in combination with one or more ingredient(s) selected from the group consisting of the following Group (a), Group (b), Group (c), Group (d), Group (e), and Group (f) (hereinafter referred to as "Present ingredient"). The above-mentioned mixed use or combined use represents that the Present compound and the present ingredient are used simultaneously, separately, or at time intervals with each other. When the Present compound is used simultaneously with the Present ingredient, the Present compound and the Present ingredient may be contained in separate formulations or contained in one formulation. One aspect of the present invention provides a composition comprising one or more ingredient(s) selected from the group consisting of Group (d) and Group (f), and the Present compound (hereinafter referred to as "Composition A").

[0043] Group (a) is a group consisting of acetylcholinesterase inhibitors (for example, carbamate insecticides and organophosphate insecticides), GABA-gated chloride channel blockers (for example, phenylpyrazole insecticides), sodium channel modulators (for example, pyrethroid insecticides), nicotinic acetylcholine receptor competitive modulators (for example, neonicotinoid insecticides), nicotinic acetylcholine receptor allosteric modulators, glutamate-gated chloride channel allosteric modulators (for example, macrolide insecticides), juvenile hormone mimics, multisite inhibitors, chordotonal organ TRPV channel modulators, mite growth inhibitors, microbial disruptors of insect midgut membranes, inhibitors of mitochondrial ATP synthase, uncouplers of oxidative phosphorylation, nicotinic acetylcholine receptor channel blockers (for example, nereistoxin insecticides), inhibitors of chitin biosynthesis, moulting disruptors, ecdysone receptor agonists, octopamine receptor agonists, mitochondrial complexes I, II, III, and IV electron transport inhibitors, voltage-dependent sodium channel blockers, inhibitors of acetyl CoA carboxylase, ryanodine receptor modulators (for example, diamide insecticides), chordotonal organ modulators, and microbial insecticides, and other insecticidal active ingredients, miticidal active ingredients, and nematicidal active ingredients. These ingredients are described in the classification on the basis of action mechanism by IRAC.

[0044] Group (b) is a group consisting of nucleic acids synthesis inhibitors (for example, phenylamide fungicides and acylamino  acid fungicides), cell  division and cytoskeleton inhibitors (for example, MBC fungicides), respiration inhibitors (for example, QoI fungicides, and QiI fungicides), amino acids synthesis and protein synthesis inhibitors (for example, anilino-pyrimidine fungicides), signal transduction inhibitors, lipid synthesis and membrane synthesis inhibitors, sterol biosynthesis inhibitors (for example, DMI fungicides such as triazole fungicides), cell wall biosynthesis inhibitors, melanin synthesis inhibitors, plant defense inducers, fungicides with multi-site contact activity, microbial fungicides, and other fungicidal active ingredients. These ingredients are described in the classification on the basis of action mechanism by FRAC.

[0045] Group (c) is a group of plant growth regulatory ingredients (including mycorrhizal fungi and root nodule bacteria).

[0046] Group (d) is a group of a phytotoxicity reducing ingredient.

[0047] Group (e) is a synergist that enhance its efficacy when used in combination with other agents.

[0048] Group (f) is a group consisting of acetyl-CoA carboxylase (ACCase) inhibitors, acetolactate synthase (ALS) inhibitors, photosynthesis (photosystem II) inhibitors, photosystem I electron transfer agents, protoporphyrinogen oxidase (PPO) inhibitors, phytoene desaturase (PDS) inhibitors, 4-hydroxyphenylpyruvate dioxygenase (4-HPPD) inhibitors, carotenoid biosynthesis inhibitors, EPSP synthase inhibitors, glutamine synthetase inhibitors, dihydropteroate synthase inhibitors, microtubule polymerization inhibitors, mitosis / microtubule formation inhibitors, inhibitors of very long-chain fatty acids (VLCFA), cellulose synthesis inhibitors, uncouplers, lipid synthesis inhibitors, indole acetic acid-like activators, auxin transport inhibitors, and other herbicidal active ingredients. These ingredients are described in the classification on the basis of action mechanism by HRAC.

[0049] Examples of combinations of the present ingredient and the compound of the present invention are recited as follows. For example, the "alanycarb + SX" indicates a combination of alanycarb and SX. The abbreviation "SX" means to any one of the compounds of the present invention selected from the compound classes SX1 to SX12 and the present compounds 1 to 314. Also, any of the present ingredients as described below are a known ingredient, and can be obtained from a commercially available drug or can be prepared according to a known method. When the present ingredient represents a microorganism, the present ingredient can be obtained from a microorganism depositary authority. The number in parentheses represents CAS RN (registered trademark).

[0050] A combination of the present ingredient in the abovementioned Group (a) and the compound of the present invention: abamectin  + SX, acephate  +  SX,  acequinocyl  +  SX, acetamiprid +  SX, acetoprole  +  SX,  acrinathrin  +  SX, acynonapyr + SX, afidopyropen  +  SX,  afoxolaner  +  SX, alanycarb + SX, aldicarb + SX, allethrin + SX, alpha-cypermethrin + SX, alpha-endosulfan  + SX, aluminium phosphide + SX, amitraz + SX, azadirachtin + SX, azamethiphos + SX, azinphos-ethyl + SX, azinphos-methyl + SX, azocyclotin + SX, Celastrus angulatus (bark of Celastrus angulatus) + SX, bendiocarb + SX, benfluthrin + SX, benfuracarb + SX, bensultap + SX, benzoximate + SX, benzpyrimoxan + SX, beta-cyfluthrin + SX, beta-cypermethrin + SX, bifenazate + SX, bifenthrin + SX, bioallethrin + SX, bioresmethrin + SX, bistrifluron + SX, borax + SX, boric acid + SX, broflanilide + SX, bromopropylate + SX, buprofezin + SX, butocarboxim + SX, butoxycarboxim + SX, cadusafos + SX, calcium phosphide + SX, carbaryl + SX, carbofuran + SX, carbosulfan + SX, cartap hydrochloride + SX, cartap + SX, chinomethionat + SX, chlorantraniliprole + SX, chlordane + SX, chlorethoxyfos + SX, chlorfenapyr + SX, chlorfenvinphos + SX, chlorfluazuron + SX, chlormephos + SX, chloropicrin + SX, chlorpyrifos + SX, chlorpyrifos-methyl + SX, chromafenozide + SX, clofentezine + SX, clothianidin + SX, concanamycin A + SX, coumaphos + SX, cryolite + SX, cyanophos + SX, cyantraniliprole + SX, cybenzoxasulfyl + SX, cyclaniliprole + SX, cyclobutrifluram + SX, cycloprothrin + SX, cycloxaprid + SX, cyenopyrafen + SX, cyetpyrafen + SX, cyflumetofen + SX, cyfluthrin + SX, cyhalodiamide + SX, cyhalothrin + SX, cyhexatin + SX, cypermethrin + SX, cyphenothrin + SX, cyproflanilide + SX, cyromazine + SX, dazomet + SX, deltamethrin + SX, demeton-S-methyl + SX, diafenthiuron + SX, diazinon + SX, dichlorvos + SX, dicloromezotiaz + SX, dicofol + SX, dicrotophos + SX, diflovidazin + SX, diflubenzuron + SX, dimefluthrin + SX, dimethoate + SX, dimethylvinphos + SX, dimpropyridaz + SX, dinotefuran + SX, disodium octaborate + SX, disulfoton + SX, DNOC (2-methyl-4,6-dinitrophenol) + SX, doramectin + SX, dried leaves of Dryopteris filix-mas + SX, emamectin-benzoate + SX, empenthrin + SX, endosulfan + SX, EPN (O-ethyl O-(4-nitrophenyl)phenylphosphonothioate) + SX, epsilon-metofluthrin + SX, epsilon-momfluorothrin + SX, esfenvalerate + SX, ethiofencarb + SX, ethion + SX, ethiprole + SX, ethoprophos + SX, etofenprox + SX , etoxazole + SX, extract of Artemisia absinthium + SX, extract of Azadirachta indica + SX, extract of Cassia nigricans + SX, extract of clitoria ternatea + SX, extract of Symphytum officinale + SX, extract of Chenopodium ambrosioides + SX, extract of Tanacetum vulgare + SX, extract of Urtica dioica + SX, extract of Viscum album + SX, famphur + SX, fenamiphos + SX, fenazaquin + SX, fenbutatin oxide + SX, fenitrothion + SX, fenmezoditiaz + SX, fenobucarb + SX, fenoxycarb + SX, fenpropathrin + SX, fenpyroximate + SX, fenthion + SX, fenvalerate + SX, fipronil + SX, flometoquin + SX, flonicamid + SX, fluacrypyrim + SX, fluazaindolizine + SX, fluazuron + SX, flubendiamide + SX, fluchlordiniliprole + SX, flucycloxuron + SX, flucythrinate + SX, fluensulfone + SX, flufenoprox + SX, flufenoxuron + SX, flufiprole + SX, flumethrin + SX, flupentiofenox + SX, flupyradifurone + SX, flupyrimin + SX, flupyroxystrobin + SX, fluralaner + SX, fluvalinate + SX, fluxametamide + SX, formetanate + SX, fosthiazate + SX, furamethrin + SX, furathiocarb + SX, gamma-cyhalothrin + SX, GS-omega / kappa HXTX-Hv1a peptide + SX, halfenprox + SX, halofenozide + SX, heptafluthrin + SX, heptenophos + SX, hexaflumuron + SX, hexythiazox + SX, potassium salt of hop beta acid + SX, hydramethylnon + SX, hydroprene + SX, imicyafos + SX, imidacloprid + SX, imidaclothiz + SX, imiprothrin + SX, indazapyroxamet + SX, indoxacarb + SX, isocycloseram + SX, isofenphos + SX, isoflualanam + SX, isoprocarb + SX, isopropyl-O-(methoxyaminothiophosphoryl) salicylate + SX, isoxathion + SX, ivermectin + SX, kadethrin + SX, kappa-tefluthrin + SX, kappa-bifenthrin + SX, kinoprene + SX, lambda-cyhalothrin + SX, ledprona + SX, lenoremycin + SX, lepimectin + SX, lime sulfur + SX, lotilaner + SX, lufenuron + SX, machine oil + SX, malathion + SX, mecarbam + SX, meperfluthrin + SX, metaflumizone + SX, metam + SX, methamidophos + SX, methidathion + SX, methiocarb + SX, methomyl + SX, methoprene + SX, methoxychlor + SX, methoxyfenozide + SX, methyl bromide + SX, metofluthrin + SX, metolcarb + SX, metoxadiazone + SX, mevinphos + SX, milbemectin + SX, milbemycin oxime + SX, mivorilaner + SX, modoflaner + SX, momfluorothrin + SX, monocrotophos + SX, moxidectin + SX, naled + SX, nicofluprole + SX, nicotine + SX, nicotine-sulfate + SX, nitenpyram + SX, novaluron + SX, noviflumuron + SX, oil of the seeds of Chenopodium anthelminticum + SX, omethoate + SX, oxamyl + SX, oxazosulfyl + SX, oxydemeton-methyl + SX, parathion + SX, parathion-methyl + SX, permethrin + SX, phenothrin + SX, phenthoate + SX, phorate + SX, phosalone + SX, phosmet + SX, phosphamidon + SX, phosphine + SX, phoxim + SX, pioxaniliprole + SX, piperflanilide + SX, pirimicarb + SX, pirimiphos-methyl + SX, prallethrin + SX, profenofos + SX, profluthrin + SX, propargite + SX, propetamphos + SX, propoxur + SX, propylene glycol alginate + SX, prothiofos + SX, pyflubumide + SX, pymetrozine + SX, pyraclofos + SX, pyrethrins + SX, pyridaben + SX, pyridalyl + SX, pyridaphenthion + SX, pyrifluquinazone + SX, pyrimidifen + SX, pyriminostrobin + SX, pyriprole + SX, pyriproxyfen + SX, quinalphos + SX, resmethrin + SX, rotenone + SX, ryanodine + SX, sarolaner + SX, selamectin + SX, sigma-cypermethrin + SX, silafluofen + SX, sodium borate + SX, sodium metaborate + SX, spidoxamat + SX, spinetoram + SX, spinosad + SX, spirobudifen + SX, spirodiclofen + SX, spiromesifen + SX, spiropidion + SX, spirotetramat + SX, sulfiflumin + SX, sulfluramid + SX, sulfotep + SX, sulfoxaflor + SX, sulfur + SX, sulfuryl fluoride + SX, tartar emetic + SX, tau-fluvalinate + SX, tebufenozide + SX, tebufenpyrad + SX, tebupirimfos + SX, teflubenzuron + SX, tefluthrin + SX, temephos + SX, terbufos + SX, terpene constituents of the extract of chenopodium ambrosioides near ambrosioides + SX, tetrachlorantraniliprole + SX, tetrachlorvinphos + SX, tetradifon + SX, tetramethrin + SX, tetramethylfluthrin + SX, tetraniliprole + SX, theta-cypermethrin + SX, thiacloprid + SX, thiamethoxam + SX, thiocyclam + SX, thiodicarb + SX, thiofanox + SX, thiometon + SX, thiosultap-disodium + SX, thiosultap-monosodium + SX, tiapyrachlor + SX, tigolaner + SX, tiorantraniliprole + SX, tioxazafen + SX, tolfenpyrad + SX, tralomethrin + SX, transfluthrin + SX, triazamate + SX, triazophos + SX, trichlorfon + SX, trifluenfuronate + SX, triflumezopyrim + SX, triflumuron + SX, trimethacarb + SX, tyclopyrazoflor + SX, umifoxolaner + SX, vadescana + SX, vamidothion + SX, wood extract of Quassia amara + SX, XMC (3,5-dimethylphenyl N-methylcarbamate) + SX, xylylcarb + SX, zeta-cypermethrin + SX, zinc phosphide + SX, 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl)benzamide (1241050-20-3) + SX, 3-methoxy-N-(5- { 5-(trifluoromethyl)-5-[3-(trifluoromethyl)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}indan-1-yl)propanamide (1118626-57-5)  + SX, N- {  4- chloro-3-[(1-cyanocyclopropyl)carbamoyl]phenyl}-1-methyl-4-(methanesulfonyl)-3-(1,1,2,2,2-pentafluoroethyl)-1H-pyrazole-3-carboxamide (1400768-21-9) + SX, N-[3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl]-2-(methanesulfonyl)propanamide (2396747-83-2)  + SX, N-[4- chloro-2-(pyridin-3-yl)-1,3-thiazol-5-yl]-N-ethyl-3- (methanesulfonyl)propanamide + SX, 1,4-dimethyl-2-[2-(pyridin-3-yl)-2H-indazol-5-yl]-1,2,4-triazolidine-3,5-dione (2171099-09-3) + SX, 2-isopropyl-5-[(3,4,4-trifluoro-3-buten-1-yl)sulfonyl]-1,3,4-thiadiazole (2058052-95-0)  + SX,             N-({2-fluoro-4-[(2S,3S)-2-hydroxy-3-(3,4,5- trichlorophenyl)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl}methyl)cyclopropanecarboxamide + SX, 7-fluoro-N-[1-(methylsulfanyl)-2-methylpropan-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, 7-fluoro-N-[1-(methanesulfinyl)-2-methylpropan-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX,       7-fluoro-N-[1- (methanesulfonyl)-2-methylpropan-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide         +         SX,          N-[1- (difluoromethyl)cyclopropyl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, 2,9-dihydro-9-(methoxymethyl)-2-(pyridin-3-yl)-10H-pyrazolo[3,4-f]pyrido[2,3- b][1,4]oxazepin-10-one (2607927-97-7)   + SX, Bacillus thuringiensis CrY1Ab protein + SX, Bacillus thuringiensis CrY1Ac protein + SX, Bacillus thuringiensis CrY1Fa protein + SX, Bacillus thuringiensis CrY1A.105 protein + SX, Bacillus thuringiensis Cry2Ab protein + SX, Bacillus thuringiensis Vip3A protein + SX, Bacillus thuringiensis mCry3A protein + SX, Bacillus thuringiensis Cry3Ab protein + SX, Bacillus thuringiensis Cry3Bb protein + SX, Bacillus thuringiensis Cry34Ab1 / Cry35Ab1 protein + SX, Adoxophyes orana GV(granulovirus) strain BV-0001 + SX, Anticarsia gemmatalis MNPV(multiple nucleocapsid nucleopolyhedrovirus) + SX, Autographa californica MNPV + SX, Cydia pomonella GV strain V15 + SX, Cydia pomonella GV strain V22 + SX, Cryptophlebia leucotreta GV + SX, Dendrolimus punctatus cypovirus + SX, Helicoverpa armigera NPV(nucleopolyhedrovirus) strain BV-0003 + SX, Helicoverpa zea NPV + SX, Lymantria dispar NPV + SX, Mamestra brassicae NPV + SX, Mamestra configurata NPV + SX, Neodiprion abietis NPV + SX, Neodiprion lecontei NPV + SX, Neodiprion sertifer NPV + SX, Nosema locustae + SX, Orgyia pseudotsugata NPV + SX, Pieris rapae GV + SX, Plodia interpunctella GV + SX, Spodoptera exigua MNPV + SX, Spodoptera littoralis MNPV + SX, Spodoptera litura NPV + SX, Arthrobotrys dactyloides + SX, Bacillus firmus strain GB-126 + SX, Bacillus firmus strain I-1582 + SX, Bacillus firmus strain NCIM2637 + SX, Bacillus megaterium + SX, Bacillus sp. strain AQ175 + SX, Bacillus sp. strain AQ177 + SX, Bacillus sp. strain AQ178 + SX, Bacillus sphaericus strain 2362 serotype H5a5b + SX, Bacillus sphaericus strain ABTS1743 + SX, Bacillus thuringiensis strain AQ52 + SX, Bacillus thuringiensis strain BD#32 + SX, Bacillus thuringiensis strain CR371 + SX, Bacillus thuringiensis subsp. Aizawai strain ABTS-1857 + SX, Bacillus thuringiensis subsp. Aizawai strain AM65-52 + SX, Bacillus thuringiensis subsp. Aizawai strain GC-91 + SX, Bacillus thuringiensis subsp. Aizawai strain NB200 + SX, Bacillus thuringiensis subsp. Aizawai Serotype strain H-7 + SX, Bacillus thuringiensis subsp. Kurstaki strain ABTS351 + SX, Bacillus thuringiensis subsp. Kurstaki strain BMP123 + SX, Bacillus thuringiensis subsp. Kurstaki strain CCT1306 + SX, Bacillus thuringiensis subsp. Kurstaki strain EG2348 + SX, Bacillus thuringiensis subsp. Kurstaki strain EG7841 + SX, Bacillus thuringiensis subsp. Kurstaki strain EVB113-19 + SX, Bacillus thuringiensis subsp. Kurstaki strain F810 + SX, Bacillus thuringiensis subsp. Kurstaki strain HD-1 + SX, Bacillus thuringiensis subsp. Kurstaki strain PB54 + SX, Bacillus thuringiensis subsp. Kurstaki strain SA-11 + SX, Bacillus thuringiensis subsp. Kurstaki strain SA-12 + SX, Bacillus thuringiensis subsp. Tenebriosis strain NB176 + SX, Bacillus thuringiensis subsp. Thuringiensis strain MPPL002 + SX, Bacillus thuringiensis subsp. morrisoni + SX, Bacillus thuringiensis var. colmeri + SX, Bacillus thuringiensis var. darmstadiensis strain 2491 + SX, Bacillus thuringiensis var. dendrolimus + SX, Bacillus thuringiensis var. galleriae + SX, Bacillus thuringiensis var. israelensis strain BMP144 + SX, Bacillus thuringiensis var. israelensis serotype strain H-14 + SX, Bacillus thuringiensis var. japonensis strain buibui + SX, Bacillus thuringiensis var. san diego strain M-7 + SX, Bacillus thuringiensis var. 7216   + SX, Bacillus thuringiensis var. aegypti + SX, Bacillus thuringiensis var. T36 + SX, Beauveria bassiana strain ANT-03 + SX, Beauveria bassiana strain ATCC74040 + SX, Beauveria bassiana strain GHA + SX, Beauveria brongniartii + SX, Burkholderia rinojensis strain A396 + SX, Chromobacterium subtsugae strain PRAA4-1T + SX, Dactyllela ellipsospora + SX, Dectylaria thaumasia + SX, Hirsutella minnesotensis + SX, Hirsutella rhossiliensis + SX, Hirsutella thompsonii + SX, Lagenidium giganteum + SX, Lecanicillium lecanii strain KV01 + SX, Lecanicillium lecanii conidia of strain DAOM198499 + SX, Lecanicillium lecanii conidia of strain DAOM216596 + SX, Lecanicillium muscarium strain Ve6 + SX, Metarhizium anisopliae strain F52 + SX, Metarhizium anisopliae var. acridum + SX, Metarhizium anisopliae var. anisopliae BIPESCO 5 / F52 + SX, Metarhizium flavoviride + SX, Monacrosporium phymatopagum + SX, Paecilomyces fumosoroseus Apopka strain 97 + SX, Paecilomyces lilacinus strain 251 + SX, Paecilomyces tenuipes strain T1 + SX, Paenibacillus popilliae + SX, Pasteuria nishizawae strain Pn1 + SX, Pasteuria penetrans + SX, Pasteuria usgae + SX, Pasteuria thornei + SX, Serratia entomophila + SX, Verticillium chlamydosporium + SX, Verticillium lecani strain NCIM1312 + SX, Wolbachia pipientis + SX.

[0051] A combination of the present ingredient in the above mentioned Group (b) and the compound of the present invention: acibenzolar-S-methyl + SX, aldimorph + SX, ametoctradin + SX, aminopyrifen + SX, amisulbrom + SX, anilazine + SX, azaconazole + SX, azoxystrobin + SX, basic copper sulfate + SX, benalaxyl + SX, benalaxyl-M + SX, benodanil + SX, benomyl + SX, benthiavalicarb + SX, benthiavalicarb-isopropyl + SX, benzovindiflupyr + SX, bifemetstrobin + SX, binapacryl + SX, biphenyl + SX, bitertanol + SX, bixafen + SX, blasticidin-S + SX, Bordeaux mixture + SX, boscalid + SX, bromothalonil + SX, bromuconazole + SX, bupirimate + SX, captafol + SX, captan + SX, carbendazim + SX, carboxin + SX, carpropamid + SX, chinomethionat + SX, chitin + SX, chloroinconazide + SX, chloroneb + SX, chlorothalonil + SX, chlozolinate + SX, colletochlorin B + SX, copper(II) acetate + SX, copper(II) hydroxide + SX, copper oxychloride + SX, copper(II) sulfate + SX, coumoxystrobin + SX, cyazofamid + SX, cyflufenamid + SX, cymoxanil + SX, cyproconazole + SX, cyprodinil + SX, dichlobentiazox + SX, dichlofluanid + SX, diclocymet + SX, diclomezine + SX, dicloran + SX, diethofencarb + SX, difenoconazole + SX, diflumetorim + SX, dimethachlone + SX, dimethirimol + SX, dimethomorph + SX, dimoxystrobin + SX, diniconazole + SX, diniconazole-M + SX, dinocap + SX, dipotassium hydrogenphosphite + SX, dipymetitrone + SX, dithianon + SX, dodecylbenzenesulphonic acid bisethylenediamine copper(II) salt + SX, dodemorph + SX, dodine + SX, edifenphos + SX, enoxastrobin + SX, epoxiconazole + SX, etaconazole + SX, ethaboxam + SX, ethirimol + SX, etridiazole + SX, extract of Allium sativum + SX, extract of the cotyledons of lupine plantlets ("BLAD") + SX, extract of Equisetum arvense + SX, extract of Melaleuca alternifolia + SX, extract of Reynoutria sachalinensis + SX, extract of Tropaeolum majus + SX, famoxadone + SX, fenamidone + SX, fenaminstrobin + SX, fenarimol + SX, fenbuconazole + SX, feneptamidoquin + SX, fenfuram + SX, fenhexamid + SX, fenopyramid + SX, fenoxanil + SX, fenpiclonil + SX, fenpicoxamid + SX, fenpropidin + SX, fenpropimorph + SX, fenpyrazamine + SX, fentin acetate + SX, fentin chloride + SX, fentin hydroxide + SX, ferbam + SX, ferimzone + SX, florylpicoxamid + SX, fluazinam + SX, flubeneteram + SX, fludioxonil + SX, flufenoxadiazam + SX, flufenoxystrobin + SX, fluindapyr + SX, flumetylsulforim + SX, flumorph + SX, fluopicolide + SX, fluopyram + SX, fluopimomide + SX, fluoroimide + SX, fluoxapiprolin + SX, fluoxastrobin + SX, fluoxytioconazole + SX, fluquinconazole + SX, flusilazole + SX, flusulfamide + SX, flutianil + SX, flutolanil + SX, flutriafol + SX, fluxapyroxad + SX, folpet + SX, fosetyl + SX, fosetyl-aluminium + SX, fuberidazole + SX, furalaxyl + SX, furametpyr + SX, galquin + SX, guazatine + SX, hexaconazole + SX, hymexazole + SX, imazalil + SX, imibenconazole + SX, minoctadine + SX, iminoctadine triacetate + SX, inpyrfluxam + SX, iodocarb + SX, ipconazole + SX, ipfentrifluconazole + SX, ipflufenoquin + SX, iprobenfos + SX, iprodione + SX, iprovalicarb + SX, isofetamid + SX, isoflucypram + SX, isoprothiolane + SX, isopyrazam + SX, isotianil + SX, kasugamycin + SX, kresoxim-methyl + SX, laminarin + SX, leaves and bark of Quercus + SX, mancozeb + SX, mandestrobin + SX, mandipropamid + SX, maneb + SX, mefentrifluconazole + SX, mepanipyrim + SX, mepronil + SX, meptyldinocap + SX, metalaxyl + SX, metalaxyl-M + SX, metarylpicoxamid + SX, metconazole + SX, methasulfocarb + SX, metiram + SX, metominostrobin + SX, metrafenone + SX, metyltetraprole + SX, myclobutanil + SX, naftifine + SX, nuarimol + SX, octhilinone + SX, ofurace + SX, orysastrobin + SX, oxadixyl + SX, oxathiapiprolin + SX, oxine-copper + SX, oxolinic acid + SX, oxpoconazole + SX, oxpoconazole fumarate + SX, oxycarboxin + SX, oxytetracycline + SX, pefurazoate + SX, penconazole + SX, pencycuron + SX, penflufen + SX, penthiopyrad + SX, phenamacril + SX, phosphorous acid + SX, phthalide + SX, picarbutrazox + SX, picoxystrobin + SX, piperalin + SX, polyoxins + SX, potassium hydrogencarbonate + SX, potassium dihydrogenphosphite + SX, probenazole + SX, prochloraz + SX, procymidone + SX, propamidine + SX, propamocarb + SX, propiconazole + SX, propineb + SX, proquinazid + SX, prothiocarb + SX, prothioconazole + SX, pydiflumetofen + SX, pyraclostrobin + SX, pyrametostrobin + SX, pyraoxystrobin + SX, pyrapropoyne + SX, pyraziflumid + SX, pyrazophos + SX, pyribencarb + SX, pyributicarb + SX, pyridachlometyl + SX, pyrifenox + SX, pyrimethanil + SX, pyrimorph + SX, pyriofenone + SX, pyrisoxazole + SX, pyroquilon + SX, Quillaja extract + SX, quinconazole + SX, quinofumelin + SX, quinoxyfen + SX, quintozene + SX, Saponins of Chenopodium quinoa + SX, seboctylamine + SX, sedaxane + SX, silthiofam + SX, simeconazole + SX, sodium hydrogencarbonate + SX, spiroxamine + SX, streptomycin + SX, sulfur + SX, tebuconazole + SX, tebufloquin + SX, teclofthalam + SX, tecnazene + SX, terbinafine + SX, tetraconazole + SX, thiabendazole + SX, thifluzamide + SX, thiophanate + SX, thiophanate-methyl + SX, thiram + SX, thymol + SX, tiadinil + SX, tolclofos-methyl + SX, tolfenpyrad + SX, tolprocarb + SX, tolylfluanid + SX, triadimefon + SX, triadimenol + SX, triazoxide + SX,  triclopyricarb + SX,  tricyclazole + SX, tridemorph + SX, trifloxystrobin + SX, triflumizole + SX, triforine +  SX,  triticonazole +  SX,  validamycin  +  SX, valifenalate + SX, vinclozolin + SX, yellow mustard powder + SX, zinc thiazole + SX, zineb + SX, ziram + SX, zoxamide + SX, N'-[4-({3-[(4-chlorophenyl)methyl]-1,2,4-thiadiazol-5-yl}oxy)-2,5-dimethylphenyl]-N-ethyl-N-methylmethanimidamide (1202781-91-6) + SX, N'-{4-[(4,5-dichlorothiazol-2-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methylmethanimidamide (929908-57-6)  + SX, N'-(2,5-dimethyl-4-phenoxyphenyl)-N- ethyl-N-methylmethanimidamide (1052688-31-9) + SX, N'-[5- chloro-4-(2-fluorophenoxy)-2-methylphenyl]-N-ethyl-N- methylmethanimidamide (2055589-28-9) + SX, N'-[2-chloro-4-(2-fluorophenoxy)-5-methylphenyl]-N-ethyl-N- methylmethanimidamide (2055756-21-1) + SX, N'-(2-chloro-4-phenoxy-5-methylphenyl)-N-ethyl-N-methylmethanimidamide (2062599-39-5)    + SX, N'-[4-(1-hydroxY1-phenyl-2,2,2- trifluoroethyl)-2-methyl-5-methoxyphenyl]-N-isopropyl-N-methylmethanimidamide (2101814-55-3) + SX, N'-[5-bromo-6-(1- methyl-2-propoxyethoxy)-2-methylpyridin-3-yl]-N-ethyl-N-methylmethanimidamide (1817828-69-5)  + SX, 4-(2-bromo-4- fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H- pyrazol-5-amine (1362477-26-6)  + SX, 2-[6-(3-fluoro-4- methoxyphenyl)-5-methylpyridin-2-yl]quinazoline (1257056 97-5)  + SX, ethyl (2Z)-3-amino-2-cyano-3-phenylacrylate (39491-78-6)   + SX, N-[(2-chlorothiazol-5-yl)methyl]-N- ethyl-6-methoxy-3-nitropyridin-2-amine (1446247-98-8) + SX, 5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4- triazol-1-ylmethyl)cyclopentan-1-ol (1394057-11-4) + SX, (1R, 2S, 5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-06-2) + SX, (1S,  2R, 5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2- methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-07-3) + SX, 2-(chloromethyl)-5-(4-fluorobenzyl)-2- methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1394057-13-6) + SX, (1R, 2S, 5S)-2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4-triazol-1- ylmethyl)cyclopentan-1-ol (1801930-08-4) + SX, (1S, 2R, 5R)-2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4- triazol-1-ylmethyl)cyclopentan-1-ol (1801930-09-5)  + SX, methyl 3-[(4-chlorophenyl)methyl]-2-hydroxY1-methyl-2-(1H- 1,2,4-triazol-1-ylmethyl)cyclopentan-1-carboxylate (1791398-02-1)  + SX, 1-(2,4-difluorophenyl)-2-(1H-1,2,4- triazol-1-yl)-1-[1-(4-bromo-2,6- difluorophenoxy)cyclopropyl]ethanol (2019215-86-0) + SX, 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-[1-(4- chloro-2,6-difluorophenoxy)cyclopropyl]ethanol (2019215-848)  + SX, 1-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2- hydroxypropyl]-1H-imidazole-5-carbonitrile (2018316-13-5) + SX, 1-[2-(1-chlorocyclopropyl)-3-(2,3-difluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile (2018317-25-2) + SX, 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)pyridin-3-yl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol (2082661-43-4) + SX, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)pyridin-3-yl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol (2082660-27-1)   + SX, methyl       ({2-methyl-5-[1-(4-methoxy-2-methylphenyl)-1H- pyrazol-3-yl]phenyl}methyl)carbamate (1605879-98-8) + SX, 2- (difluoromethyl)-N-[1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1616239-21-4)    + SX, 2- (difluoromethyl)-N-[3-ethyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1847460-02-9) + SX, 2-(difluoromethyl)-N-[3-propyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1847460-05-2)   + SX, (2E,3Z)-5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}-2- (methoxyimino)-N,3-dimethylpent-3-enamide (1445331-27-0) + SX,        (2E,3Z)-5-{[1-(2,4-dichlorophenyl)-1H-pyrazol-3- yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide (1445331-54-3)       +       SX,       5-chloro-4-({2-[6-(4- chlorophenoxy)pyridin-3-yl]ethyl}amino)-6-methylpyrimidine (1605340-92-8)       + SX,       4,4-dimethyl-2-({4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl}methyl)isoxazolidin-3-one (2098918-25-1)  + SX, 5,5-dimethyl-2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)isoxazolidin-3-one (2098918-26-2) + SX, N-ethyl-2-methyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N,2-dimethoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl}methyl)propanamide + SX, N-methoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl}methyl)cyclopropanecarboxamide + SX, N-methoxy-N'-methyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl}methyl)urea + SX, N'-ethyl-N-methoxy-N-({4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX,        N,N'-dimethoxy-N-({4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl}methyl)urea + SX, N-acetyl-2-(ethanesulfonyl)-N-[2-(methoxycarbonyl)-4-(trifluoromethoxy)phenyl]-4-(trifluoromethyl)benzamide (2043675-28-9) + SX, 3-(4-bromo-7-fluoroindol-1-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, 3-(7-bromoindol-1-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, 3-(7-bromo-4-fluoroindol-1-yl)butan-2-yl           N-[(3-hydroxy-4-methoxypyridin-2- yl)carbonyl]-L-alaninate + SX, 3-(3,5-dichloropyridin-2-yl)butan-2-yl             N-[(3-hydroxy-4-methoxypyridin-2- yl)carbonyl]-L-alaninate + SX, 3-(3,5-dichloropyridin-2-yl)butan-2-yl N-{[3-(acetoxymethoxy)-4-methoxypyridin-2-yl]carbonyl}-L-alaninate + SX, (1S)-1-[1-(naphthalen-1-yl)cyclopropyl]ethyl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, (1S)-1-[1-(naphthalen-1-yl)cyclopropyl]ethyl N-[(3-acetoxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, (1S)-1-[1-(naphthalen-1-yl)cyclopropyl]ethyl              N-{[3-(acetoxymethoxy)-4- methoxypyridin-2-yl]carbonyl}-L-alaninate + SX, N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)cyclopropanecarboxamide + SX, N-allyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl}methyl)acetamide + SX, N-allyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl}methyl)propanamide + SX, N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl}methyl)propanamide + SX, 3,3,3-trifluoro-N-({2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl}methyl)propanamide + SX, 3,3,3-trifluoro-N-({3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl}methyl)propanamide + SX, 3,3,3-trifluoro-N-({2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl}methyl)propanamide + SX, N-({2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl}methyl)butanamide + SX, N-methoxy-N-methyl-N'-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl}methyl)urea + SX, N,N-diethyl-N'-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N-methyl-N'-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, 1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)pyrrolidin-2-one + SX, 1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl}methyl)piperidin-2-one     +     SX,     4-({4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl}methyl)morpholin-3-one     +     SX,     2-({4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl}methyl)isoxazolidin-3-one + SX, 3,3-dimethyl-1- ({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl}methyl)piperidin-2-one + SX, 2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1,2-oxazinan-3-one + SX, 1-({3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)azepan-2-one + SX, 4,4-dimethyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)pyrrolidin-2-one + SX, 5-methyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl}methyl)pyrrolidin-2-one + SX, ethyl 1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxylate + SX, N-methyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N-propyl)-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N-methoxY1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N-methoxy-N-methyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N,N-dimethyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-1,2,4-triazol-3-amine       +       SX,       N-methyl-4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + SX, methyl 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propanoate + SX, ethyl 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1- yl)propanoate + SX, methyl 2-[2-(trifluoromethyl)-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1- yl)propanoate + SX, 1-(2,3-dimethylpyridin-5-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 1-[2-(difluoromethyl)-3-methylpyridin-5-yl]-4,4-difluoro-3,3- dimethyl-3,4-dihydroisoquinoline + SX, 2,2-difluoro-N-[6-({[1-(1-methyl-1H-tetrazol-5-yl)benzimidazol-2- yl]oxy}methyl)pyridin-2-yl]-2-phenoxyacetamide + SX, 1-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluorophenyl)-2- hydroxypropyl]-1H-imidazole-5-carbonitrile + SX, ethyl 1-[(4-{[2-(trifluoromethyl)-1,3-dioxolan-2- yl]methoxy}phenyl)methyl]-1H-pyrazole-4-carboxylate + SX, ethyl 1-[(4-{[(1Z)-2-ethoxy-3,3,3-trifluoro-1-propen-1-yl]oxy}phenyl)methyl]-1H-pyrazole-4-carboxylate + SX, 6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)-N-[2-(2,4- dimethylphenyl)-2,2-difluoroethyl]-5-methylpyridazine-4- carboxamide + SX, 6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)-N-[2-(3,4-dimethylphenyl)-2,2- difluoroethyl]-5-methylpyridazine-4-carboxamide + SX, 6-chloro-N-[2-(2-chloro-4-methylphenyl)-2,2-difluoroethyl]-3-(3-cyclopropyl-2-fluorophenoxy)-5-methylpyridazine-4- carboxamide + SX, 2-[cyano(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX,             2-[cyano(2,6-difluoropyridin-4-yl)amino]-N- (spiro[3.4]octan-1-yl)-5-methylthiazole-4-carboxamide + SX, 2-[cyano(2,6-difluoropyridin-4-yl)amino]-N-hexyl-5- methylthiazole-4-carboxamide + SX, 2-[acetyl(2,6- difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5- methylthiazole-4-carboxamide       +       SX,       2-[(2- methoxyacetyl)(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-[(2-methylpropanoyl)(2,6-difluoropyridin-4-yl)amino]-N- (2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX,             2-[(2,6-difluoropyridin-4-yl)amino]-N-(2,2- dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-{[(oxetan-3-yl)carbonyl](2,6-difluoropyridin-4-yl)amino}-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX,       2-{[(oxolan-3-yl)carbonyl](2,6-difluoropyridin-4- yl)amino}-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4- carboxamide + SX, 2-{[(oxan-4-yl)carbonyl](2,6- difluoropyridin-4-yl)amino}-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2- fluorophenyl)ethyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2,6- difluorophenyl)ethyl]pyrimidin-2-amine    +    SX,    5-[5- (difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(3,5- difluorophenyl)ethyl]pyrimidin-2-amine    +    SX,    5-[5- (difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(6- chloropyridin-3-yl)ethyl]pyrimidin-2-amine + SX, 5-[5- (difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2- fluorophenyl)cyclopropyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2,6- difluorophenyl)cyclopropyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2-fluoro-3- methoxyphenyl)cyclopropyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-{[1-(2,6- difluorophenyl)cyclopropyl]oxy}pyrimidine + SX, 3-[3-(3-cyclopropyl-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2,4-dimethylphenyl)methyl]-5,6-dihydro-4H-1,2,4- oxadiazine + SX, (5S)-3-[3-(3-cyclopropyl-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2,4-dimethylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, 3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(4-bromo-2- methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, 3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, (5S)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, (5R)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, N-((2S)-1-{3-[2-(5-fluoro-2-methoxyphenyl)-2-hydroxyethyl]-5-[(E)-1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}-3-methylbutan-2-yl)-2- methylpropanamide + SX, N-((2S)-1-{3-[2-(5-fluoro-2-methoxyphenyl)-2-hydroxyethyl]-5-[(E)-1- (isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}-3-methylbutan-2-yl)-2,2-dimethylpropanamide + SX, N-((2S)-1-{3-[2-(5-fluoro-2-methoxyphenyl)-2-hydroxyethyl]-5-[(E)-1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6- dihydropyrimidin-1(2H)-yl}propan-2-yl)-2-methylpropanamide + SX, N-((2S)-1-{3-[2-(2-methoxyphenyl)-2-hydroxyethyl]-5-[(E)-1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6- dihydropyrimidin-1(2H)-yl}propan-2-yl)-2-methylpropanamide + SX, N-((2S)-1-{3-[2-(5-fluoro-2-methoxyphenyl)-2-(2-cyanoethoxy)ethyl]-5-[1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}propan-2-yl)-2- methylpropanamide + SX, methyl ({5-[1-(2,6-difluoro-4-isopropylphenyl)-1H-pyrazol-3-yl]-2- methylphenyl}methyl)carbamate + SX, methyl ({5-[1-(2,6-difluoro-4-cyclopropylphenyl)-1H-pyrazol-3-yl]-2- methylphenyl}methyl)carbamate + SX, methyl ({5-[1-(2,6-difluoro-4-methoxyphenyl)-1H-pyrazol-3-yl]-2- methylphenyl}methyl)carbamate + SX, methyl (Z)-2-(5-cyclopentyl-2-methylphenoxy)-3-methoxyprop-2-enoate + SX, methyl (Z)-2-(5-cyclohexyl-2-methylphenoxy)-3-methoxyprop-2-enoate + SX, methyl (Z)-2-[(3-isopropyl-1H-pyrazol-1-yl)-2-methylphenoxy]-3-methoxyprop-2-enoate + SX, 1-(4,5-dimethyl-1H-benzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl- 3,4-dihydroisoquinoline + SX, 1-(4,5-dimethyl-1H-benzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-3,4- dihydroisoquinoline + SX, 1-(pyrazolo[1,5-a]pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-6-fluoro-3,3- dimethylisoquinolin-4(3H)-one + SX, methyl (2Z)-3-methoxy-2-[(4-methyl[1,1'-biphenyl]-3-yl)oxy]prop-2-enoate + SX, N-[2-(pyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)isoxazole-3-carboxamide   +   SX,   N-[2-(6- chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)isoxazole-3-carboxamide   +   SX,   N-[2-(6- cyanopyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)isoxazole-3-carboxamide + SX, N-[(2S)-2-(6-chloro-4-methoxypyridin-2-yl)-2-(1-methylpyrazol-4- yl)propyl]-5-(2,4-difluorophenyl)isoxazole-3-carboxamide + SX,        N-[(2R)-2-(6-chloro-4-methoxypyridin-2-yl)-2-(1- methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)isoxazole-3-carboxamide, N-[2-{6-[(1E)-(methoxyimino)ethyl]pyridin-2-yl}-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4- difluorophenyl)isoxazole-3-carboxamide + SX, N-[2-(5-methylpyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)isoxazole-3-carboxamide + SX, N-[2-(6-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-dichlorophenyl)isoxazole-3-carboxamide + SX, Methyl 6-[2-{[5-(2,4-dichlorophenyl)isoxazole-3-carbonyl]amino}-1- methyl-1-(1-methylpyrazol-4-yl)ethyl]pyridine-3-carboxylate + SX, N-[2-(6-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(3,5-difluoropyridin-2-yl)isoxazole-3- carboxamide + SX, N-[2-(6-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-3-(2,4-difluorophenyl)-1,2,4- oxadiazole-5-carboxamide + SX, N-[2-(6-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)- 1,3,4-thiadiazole-2-carboxamide + SX, N-[2-(5-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)-1,3,4-thiadiazole-2-carboxamide + SX, N-[2-(6-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(3,5-difluoropyridin-2-yl)-1,3,4-thiadiazole-2-carboxamide + SX, N-[2-(6-cyanopyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(3,5-difluoropyridin-2-yl)-1,3,4-thiadiazole- 2-carboxamide + SX, N-[2-(6-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,6-difluoropyridin-3-yl)- 1,3,4-thiadiazole-2-carboxamide,                         [4- (difluoromethoxy)phenyl]methyl               4-[(N-ethyl-N- methylamino)methylidene]amino-2,5-dimethylbenzoate, Agrobacterium radiobactor strain K1026 + SX, Agrobacterium radiobactor strain K84 + SX, Bacillus amyloliquefaciens strain PTA-4838 (Aveo(trademark) EZ Nematicide) + SX, Bacillus amyloliquefaciens strain AT332 + SX, Bacillus amyloliquefaciens strain B3 + SX, Bacillus amyloliquefaciens strain D747 + SX, Bacillus amyloliquefaciens strain DB101 + SX, Bacillus amyloliquefaciens strain DB102 + SX, Bacillus amyloliquefaciens strain GB03 + SX, Bacillus amyloliquefaciens strain FZB24 + SX, Bacillus amyloliquefaciens strain FZB42 + SX, Bacillus amyloliquefaciens strain IN937a + SX, Bacillus amyloliquefaciens strain MBI600 + SX, Bacillus amyloliquefaciens strain QST713 + SX, Bacillus amyloliquefaciens isolate strain B246  + SX, Bacillus amyloliquefaciens strain F727 + SX, Bacillus amyloliquefaciens subsp. plantarum strain D747 + SX, Bacillus licheniformis s train HB- 2   + SX, Bacillus licheniformis strain SB3086 + SX, Bacillus pumilus strain AQ717 + SX, Bacillus pumilus strain BUF-33 + SX, Bacillus pumilus strain GB34 + SX, Bacillus pumilus strain QST2808 + SX, Bacillus simplex strain CGF2856 + SX, Bacillus subtilis strain AQ153 + SX, Bacillus subtilis strain AQ743 + SX, Bacillus subtilis strain BU1814 + SX, Bacillus subtilis strain D747 + SX, Bacillus subtilis strain DB101 + SX, Bacillus subtilis strain FZB24 + SX, Bacillus subtilis strain GB03 + SX, Bacillus subtilis strain HAI0404 + SX, Bacillus subtilis strain IAB / BS03 + SX, Bacillus subtilis strain MBI600 + SX, Bacillus subtilis strain QST30002 / AQ30002 + SX, Bacillus subtilis strain QST30004 / AQ30004 + SX, Bacillus subtilis strain QST713 + SX, Bacillus subtilis strain QST714 + SX, Bacillus subtilis var. Amyloliquefaciens strain FZB24 + SX, Bacillus subtilis strain Y1336 + SX, Burkholderia cepacia + SX, Burkholderia cepacia type Wisconsin strain J82 + SX, Burkholderia cepacia type Wisconsin strain M54 + SX, Candida oleophila strain O + SX, Candida saitoana + SX, Chaetomium cupreum + SX, Clonostachys rosea + SX, Coniothyrium minitans strain CGMCC8325 + SX, Coniothyrium minitans strain CON / M / 91-8 + SX, cryptococcus albidus + SX, Erwinia carotovora subsp. carotovora strain CGE234M403 + SX, Fusarium oxysporum strain Fo47 + SX, Gliocladium catenulatum strain J1446 + SX, Paenibacillus polymyxa strain AC-1 + SX, Paenibacillus polymyxa strain BS-0105 + SX, Pantoea agglomerans strain E325 + SX, Phlebiopsis gigantea strain VRA1992 + SX, Pseudomonas aureofaciens strain TX1 + SX, Pseudomonas chlororaphis strain 63-28 + SX, Pseudomonas chlororaphis strain AFS009 + SX, Pseudomonas chlororaphis strain MA342 + SX, Pseudomonas fluorescens strain 1629RS + SX, Pseudomonas fluorescens strain A506 + SX, Pseudomonas fluorescens strain CL145A + SX, Pseudomonas fluorescens strain G7090 + SX, Pseudomonas sp. strain CAB-02 + SX, Pseudomonas syringae strain 742RS + SX, Pseudomonas syringae strain MA-4 + SX, Pseudozyma flocculosa strain PF-A22UL + SX, Pseudomonas rhodesiae strain HAI-0804 + SX, Pythium oligandrum strain DV74 + SX, Pythium oligandrum strain M1 + SX, Streptomyces griseoviridis strain K61 + SX, Streptomyces lydicus strain WYCD108US + SX, Streptomyces lydicus strain WYEC108 + SX, Talaromyces flavus strain SAY-Y-94-01 + SX, Talaromyces flavus strain V117b + SX, Trichoderma asperellum strain ICC012 + SX, Trichoderma asperellum SKT-1 + SX, Trichoderma asperellum strain T25 + SX, Trichoderma asperellum strain T34 + SX, Trichoderma asperellum strain TV1 + SX, Trichoderma atroviride strain CNCM 1-1237 + SX, Trichoderma atroviride strain LC52 + SX, Trichoderma atroviride strain IMI 206040 + SX, Trichoderma atroviride strain SC1 + SX, Trichoderma atroviride strain SKT-1 + SX, Trichoderma atroviride strain T11 + SX, Trichoderma gamsii strain ICC080 + SX, Trichoderma harzianum strain 21 + SX, Trichoderma harzianum strain DB104 + SX, Trichoderma harzianum strain DSM 14944 + SX, Trichoderma harzianum strain ESALQ-1303 + SX, Trichoderma harzianum strain ESALQ-1306 + SX, Trichoderma harzianum strain IIHR-Th-2 + SX, Trichoderma harzianum strain ITEM908 + SX, Trichoderma harzianum strain kd + SX, Trichoderma harzianum strain MO1 + SX, Trichoderma harzianum strain SF + SX, Trichoderma harzianum strain T22 + SX, Trichoderma harzianum strain T39 + SX, Trichoderma harzianum strain T78 + SX, Trichoderma harzianum strain TH35 + SX, Trichoderma polysporum strain IMI206039 + SX, trichoderma stromaticum + SX, Trichoderma virens strain G-41 + SX, Trichoderma virens strain GL-21 + SX, Trichoderma viride + SX, Variovorax paradoxus strain CGF4526 + SX, Harpin protein + SX.

[0052] A combination of the present ingredient in the abovementioned Group (c) and the compound of the present invention: 1-methylcyclopropene + SX, 1,3-diphenylurea + SX, 2,3,5-triiodobenzoic acid + SX, IAA ((1H-indol-3-yl)acetic acid) + SX, IBA (4-(1H-indol-3-yl)butyric acid) + SX, MCPA (2-(4-chloro-2-methylphenoxy)acetic acid) + SX, MCPB (4-(4-chloro-2-methylphenoxy)butyric acid) + SX, 4-CPA (4-chlorophenoxyacetic acid) + SX, 5-aminolevulinic acid hydrochloride + SX, 6-benzylaminopurine + SX, abscisic acid + SX, AVG (aminoethoxyvinylglycine) + SX, anisiflupurin + SX, ancymidol + SX, butralin + SX, calcium carbonate + SX, calcium chloride + SX, calcium formate + SX, calcium peroxide + SX, calcium polysulfide + SX, calcium sulfate + SX, chlormequat-chloride + SX, chlorpropham + SX, choline chloride + SX, cloprop + SX, cyanamide + SX, cyclanilide + SX, daminozide + SX, decan-1-ol + SX, dichlorprop + SX, dikegulac + SX, dimethipin + SX, diquat + SX, ethephon + SX, ethychlozate + SX, flumetralin + SX, flurprimidol + SX, forchlorfenuron + SX, formononetin + SX, Gibberellin A + SX, Gibberellin A3 + SX, inabenfide + SX, Kinetin + SX, lipochitooligosaccharide SP104 + SX, maleic hydrazide + SX, mefluidide + SX, mepiquat-chloride + SX, oxidized glutathione + SX, paclobutrazol + SX, pendimethalin + SX, prohexadione-calcium + SX, prohydrojasmon + SX, pyraflufen-ethyl + SX, sintofen + SX, sodium 1-naphthaleneacetate + SX, sodium cyanate + SX, thidiazuron + SX, triapenthenol + SX, tribufos + SX, trinexapac-ethyl + SX, uniconazole-P + SX, 2-(naphthalen-1-yl)acetamide + SX, [4-oxo-4-(2-phenylmethyl)amino]bytyric acid + SX, methyl 5-(trifluoromethyl)benzo[b]thiophene-2-carboxylate + SX, 3-[(6-chloro-4-phenylquinazolin-2-yl]amino]propane-1-ol + SX, Claroideoglomus etunicatum + SX, Claroideoglomus claroideum + SX, Funneliformis mosseae + SX, Gigaspora margarita + SX, Gigaspora rosea + SX, Glomus aggregatum + SX, Glomus deserticola + SX, Glomus monosporum + SX, Paraglomus brasillianum + SX, Rhizophagus clarus + SX, Rhizophagus intraradices RTI-801 + SX, Rhizophagus irregularis DAOM 197198 + SX, Azorhizobium caulinodans + SX, Azospirillum amazonense + SX, Azospirillum brasilense XOH + SX, Azospirillum brasilense Ab-V5 + SX, Azospirillum brasilense Ab-V6 + SX, Azospirillum caulinodans + SX, Azospirillum halopraeferens + SX, Azospirillum irakense + SX, Azospirillum lipoferum + SX, Bradyrhizobium elkanii SEMIA 587 + SX, Bradyrhizobium elkanii SEMIA 5019 + SX, Bradyrhizobium japonicum TA-11 + SX, Bradyrhizobium japonicum USDA 110 + SX, Bradyrhizobium liaoningense + SX, Bradyrhizobium lupini + SX, Delftia acidovorans RAY209 + SX, Mesorhizobium ciceri + SX, Mesorhizobium huakii + SX, Mesorhizobium loti + SX, Rhizobium etli + SX, Rhizobium galegae + SX, Rhizobium leguminosarum bv. Phaseoli + SX, Rhizobium leguminosarum bv. Trifolii + SX, Rhizobium leguminosarum bv. Viciae + SX, Rhizobium trifolii + SX, Rhizobium tropici + SX, Sinorhizobium fredii + SX, Sinorhizobium meliloti + SX, Zucchini Yellow Mosaik Virus weak strain + SX.

[0053] A combination of the present ingredient in the abovementioned Group (d) and the compound of the present invention: allidochlor + SX, benoxacor + SX, cloquintocet + SX, cloquintocet-mexyl + SX, cyometrinil + SX, cyprosulfamide + SX, dichlormid + SX, dicyclonone + SX, dimepiperate + SX, disulfoton + SX, dymron + SX, fenchlorazole + SX, fenchlorazole-ethyl + SX, fenclorim + SX, flurazole + SX, furilazole + SX, fluxofenim + SX, hexim + SX, isoxadifen + SX, isoxadifen-ethyl + SX, Jiecaowan + SX, Jiecaoxi + SX, mecoprop + SX, mefenpyr + SX, mefenpyr-ethyl + SX, mefenpyr-diethyl + SX, mephenate + SX, metcamifen + SX, oxabetrinil + SX, 1,1,8-naphthalic anhydride + SX, octane-1,8-diamine+ SX, AD-67 (4-(dichloroacetyl)-1-oxa-4-azaspiro [4.5] decane) + SX, CL-304415 (4-carboxy-3,4-dihydro-2H-1-benzopyran-4-acetic acid) + SX, CSB (1-bromo-4-[(chloromethyl)sulfonyl]benzene) + SX, DKA-24 (2,2-dichloro- N-[2-oxo-2-(2-propenylamino)ethyl]-N-(2-propenyl)acetamide) + SX, MG191 (2-(dichloromethyl)-2-methyl-1,3-dioxolane) + SX, MG-838 (2-propenyl 1-oxa-4-azaspiro[4.5]decane-4-carbodithioate) + SX, PPG-1292 (2,2-dichloro-N-(1,3-dioxan-2-ylmethyl)-N-(2-propenyl)acetamide) + SX, R28725   (3- (dichloroacetyl)-2,2-dimethyl-1,3-oxazolidine) + SX, R29148 (3-(dichloroacetyl)-2,2,5-trimethyl-1,3-oxazolidine) + SX, TI-35 (1-(dichloroacetyl)azepane) + SX.

[0054] A combination of the present ingredient in the abovementioned Group (e) and the compound of the present invention: 1-dodecyl-1H-imidazole + SX, N-(2-ethylhexyl)-8,9,10-trinorborn-5-ene-2,3-dicarboximide + SX, bucarpolate + SX, N,N-dibutyl-4-chlorobenzenesulfonamide + SX, dietholate + SX, diethylmaleate + SX, Jiajizengxiaolin + SX, octachlorodipropyl ether + SX, perbutin + SX, piperonyl butoxide + SX, piperonyl cyclonene + SX, piprotal + SX, propyl isome + SX, safroxan + SX, sesamex + SX, sesamolin + SX, sulfoxide + SX, Verbutin + SX, DMC (1,1-bis(4-chlorophenyl)ethanol) + SX, FDMC (1,1-bis(4-chlorophenyl)-2,2,2-trifluoroethanol) + SX, ETN (1,2-epoxY1,2,3,4-tetrahydronaphthalene) + SX, ETP (1,1,1-trichloro-2,3-expoxypropane) + SX, PSCP (phenylsaligenin cyclic phosphate) + SX, TBPT (S,S,S-tributyl phosphorotrithioate) + SX, TPP (triphenyl phosphate) + SX.

[0055] A combination of the present ingredient in the abovementioned Group (f) and the compound of the present invention: 2,3,6-TBA (2,3,6-trichlorobenzoic acid) + SX, 2,3,6-TBA-dimethylammonium + SX, 2,3,6-TBA-lithium + SX, 2,3,6-TBA-potassium + SX, 2,3,6-TBA-sodium + SX, 2,4-D + SX, 2,4-D choline salt + SX, 2,4-D-biproamine + SX, 2,4-D-doboxyl + SX, 2,4-D-2-ethylhexyl + SX, 2,4-D-3-butoxypropyl + SX, 2,4-D-ammonium + SX, 2,4-D-butotyl + SX, 2,4-D-butyl + SX, 2,4-D-diethylammonium + SX, 2,4-D-dimethylammonium + SX, 2,4-D-diolamine + SX, 2,4-D-dodecylammonium + SX, 2,4-D-ethyl + SX, 2,4-D-heptylammonium + SX, 2,4-D-isobutyl + SX, 2,4-D-isooctyl + SX, 2,4-D-isopropyl + SX, 2,4-D-isopropylammonium + SX, 2,4-D-lithium + SX, 2,4-D-mepty + SX, 2,4-D-methyl + SX, 2,4-D-octyl + SX, 2,4-D-pentyl + SX, 2,4-D-propyl + SX, 2,4-D-sodium + SX, 2,4-D-tefuryl + SX, 2,4-D-tetradecylammonium + SX, 2,4-D-triethylammonium + SX, 2,4-D-tris(2-hydroxypropyl)ammonium + SX, 2,4-D-trolamine + SX, 2,4-DB+ SX, 2,4-DB choline salt + SX, 2,4-DB-biproamine + SX, 2,4-DB-butyl + SX, 2,4-DB-dimethylammonium + SX, 2,4-DB-isoctyl + SX, 2,4-DB-potassium + SX, 2,4-DB-sodium + SX, acetochlor + SX, acifluorfen + SX, acifluorfen-sodium + SX, aclonifen + SX, ACN (2-amino-3-chloronaphthalene-1,4-dione) + SX, alachlor + SX, alloxydim + SX, ametryn + SX, amicarbazone + SX, amidosulfuron + SX, aminocyclopyrachlor + SX, aminocyclopyrachlor-methyl + SX, aminocyclopyrachlor-potassium + SX, aminopyralid + SX, aminopyralid choline salt + SX, aminopyralid-potassium + SX, aminopyralid-tripromine + SX, amiprophos-methyl + SX, amitrole + SX, anilofos + SX, asulam + SX, atrazine + SX, azafenidin + SX, azimsulfuron + SX, beflubutamid + SX, benazolin-ethyl + SX, bencarbazone + SX, benfluralin + SX, benfuresate + SX, benquitrione + SX, bensulfuron + SX, bensulfuron-methyl + SX, bensulide + SX, bentazon + SX, benthiocarb + SX, benzfendizone + SX, benzobicyclon + SX, benzofenap + SX, benzthiazuron + SX, bialaphos + SX, bicyclopyrone + SX, bifenox + SX, bipyrazone + SX, bispyribac + SX, bispyribac-sodium + SX, bixlozone + SX, bromacil + SX, bromobutide + SX, bromofenoxim + SX, bromoxynil + SX, bromoxynil-octanoate + SX, butachlor + SX, butafenacil + SX, butamifos + SX, butroxydim + SX, butylate + SX, cafenstrole + SX, carbetamide + SX, carfentrazone + SX, carfentrazone-ethyl + SX, chlomethoxyfen + SX, chloramben + SX, chloridazon + SX, chlorimuron + SX, chlorimuron-ethyl + SX, chlorobromuron + SX, chlorotoluron + SX, chloroxuron + SX, chlorpropham + SX, chlorsulfuron + SX, chlorthal-dimethyl + SX, chlorthiamid + SX, cinflubrolin + SX, cinidon + SX, cinidon-ethyl + SX, cinmethylin + SX, cinosulfuron + SX, clethodim + SX, clodinafop + SX, clodinafop-propargyl + SX, clomazone + SX, clomeprop + SX, clopyralid + SX, clopyralid choline salt + SX, clopyralid-methyl + SX, clopyralid-olamine + SX, clopyralid-potassium + SX, clopyralid-tris(2-hydroxypropyl)ammonium + SX, cloransulam + SX, cloransulam-methyl + SX, cumyluron + SX, cyanazine + SX, cycloate + SX, cyclopyranil + SX, cyclopyrimorate + SX, cyclosulfamuron + SX, cycloxydim + SX, cyhalofop + SX, cyhalofop-butyl + SX, cypyrafluone + SX, dalapon + SX, dazomet + SX, desmedipham + SX, desmetryn + SX, di-allate + SX, dicamba + SX, dicamba choline salt + SX, dicamba-biproamine + SX, dicamba -trolamine + SX, dicamba-diglycolamine + SX, dicamba-dimethylammonium + SX, dicamba-diolamine + SX, dicamba-isopropylammonium + SX, dicamba-methyl + SX, dicamba-olamine + SX, dicamba-potassium + SX, dicamba-sodium + SX, dichlobenil + SX, dichlorprop choline salt + SX, dichlorprop-biproamine + SX, dichlorprop-2-ethylhexyl + SX, dichlorprop-butotyl + SX, dichlorpropdimethylammonium + SX, dichlorprop-ethylammonium + SX, dichlorprop-isoctyl + SX, dichlorprop-methyl + SX, dichlorprop-P + SX, dichlorprop-P choline salt + SX, dichlorprop-P-biproamine + SX, dichlorprop-P-etexyl + SX, dichlorprop-P-dimethylammonium + SX, dichlorprop-potassium + SX, dichlorprop-sodium + SX, diclofop + SX, diclofop-methyl + SX, diclosulam + SX, difenoxuron + SX, difenzoquat + SX, difenzoquat metilsulfate + SX, diflufenican + SX, diflufenzopyr + SX, diflufenzopyr-sodium + SX, dimefuron + SX, dimepiperate + SX, dimepyrolimet + SX, dimesulfazet + SX, dimethachlor + SX, dimethametryn + SX, dimethenamid + SX, dimethenamid-P + SX, dinitramine + SX, dinoseb + SX, dinoterb + SX, dioxopyritrione + SX, diphenamid + SX, diquat-dibromide + SX, DSMA (disodium methylarsonate) + SX, dithiopyr + SX, diuron + SX, DNOC (2-methyl-4,6-dinitrophenol) + SX, epyrifenacil + SX, esprocarb + SX, ethalfluralin + SX, ethametsulfuron + SX, ethametsulfuron-methyl + SX, ethidimuron + SX, ethofumesate + SX, ethoxyfen-ethyl + SX, ethoxysulfuron + SX, etobenzanid + SX, fenoxaprop + SX, fenoxaprop-ethyl + SX, fenoxaprop-P + SX, fenoxaprop-P-ethyl + SX, fenoxasulfone + SX, fenpyrazone + SX, fenquinotrione + SX, fentrazamide + SX, fenuron + SX, feproxydim + SX, flamprop-M + SX, flazasulfuron + SX, florasulam + SX, florpyrauxifen + SX, florpyrauxifen-benzyl + SX, fluazifop + SX, fluazifop-butyl + SX, fluazifop-P + SX, fluazifop-P-butyl + SX, fluazolate + SX, flucarbazone + SX, flucarbazone-sodium + SX, flucetosulfuron + SX, fluchloraminopyr + SX, fluchloraminopyr-tefuryl + SX, flufenacet + SX, flufenauxirim + SX, flufenauxirim-metotyl + SX, flufenazopyr + SX, flufenoximacil + SX, flufenpyr + SX, flufenpyr-ethyl + SX, flumetsulam + SX, flumetsulam + SX, flumiclorac + SX, flumiclorac-pentyl + SX, flumioxazin + SX, fluometuron + SX, fluoroglycofen-ethyl + SX, flupoxam + SX, flupropanate + SX, flupyrsulfuron + SX, flupyrsulfuron-methyl-sodium + SX, flurenol + SX, fluridone + SX, flurochloridone + SX, fluroxypyr + SX, fluroxypyr-butometyl + SX, fluroxypyr-meptyl + SX, flurtamone + SX, flusulfinam + SX, fluthiacet + SX, fluthiacet-methyl + SX, fomesafen + SX, fomesafen-sodium + SX, foramsulfuron + SX, fosamine + SX, glufosinate + SX, glufosinate-ammonium + SX, glufosinate-P + SX, glufosinate-P-ammonium + SX, glufosinate-P-sodium + SX, glyphosate + SX, glyphosate choline salt + SX, glyphosate-isopropylammonium + SX, glyphosate-biproamine + SX, glyphosate-ammonium + SX, glyphosate-diammonium + SX, glyphosate-potassium + SX, glyphosate-sodium + SX, glyphosate-trimesium + SX, halauxifen + SX, halauxifen-benzyl + SX, halauxifen-methyl + SX, halosafen + SX, halosulfuron + SX, halosulfuron-methyl + SX, haloxyfop + SX, haloxyfop-etotyl + SX, haloxyfop-methyl + SX, haloxyfop-P + SX, haloxyfop-P-etotyl + SX, haloxyfop-P-methyl + SX, hexazinone + SX, icafolin + SX, icafolin-methyl + SX, imazamethabenz + SX, imazamethabenz-methyl + SX, imazamox + SX, imazamox-ammonium + SX, imazamox-sodium + SX, imazapic + SX, imazapic-ammonium + SX, imazapyr + SX, imazapyr-ammonium + SX, imazapyr-isopropylammonium + SX, imazaquin + SX, imazaquin-ammonium + SX, imazethapyr + SX, imazethapyr-ammonium + SX, imazosulfuron + SX, indanofan + SX, indaziflam + SX, indolauxipyr + SX, indolauxipyr- cyanomethyl + SX, iodosulfuron + SX, iodosulfuron-methyl-sodium + SX, iofensulfuron + SX, iofensulfuron-sodium + SX, ioxynil + SX, ioxynil-octanoate + SX, ipfencarbazone + SX, iptriazopyrid + SX, isoproturon + SX, isouron + SX, isoxaben + SX, isoxachlortole + SX, isoxafenacil + SX, isoxaflutole + SX, lactofen + SX, lenacil + SX, linuron + SX, maleic hydrazide + SX, MCPA choline salt + SX, MCPA-biproamine + SX, MCPA-etexyl + SX, MCPA-butotyl + SX, MCPA-butyl + SX, MCPA-dimethylammonium + SX, MCPA-diolamine + SX, MCPA-ethyl + SX, MCPA-isobutyl + SX, MCPA-isoctyl + SX, MCPA-isopropyl + SX, MCPA-methyl + SX, MCPA-olamine + SX, MCPA-sodium + SX, MCPA-trolamine + SX, MCPB (4-(4-chloro-2-methylphenoxy)butanoic acid) + SX, MCPB choline salt)+ SX, MCPB-biproamine + SX, MCPB-ethyl + SX, MCPB-methyl + SX, MCPB-sodium + SX, mecoprop choline salt + SX, mecoprop-biproamine + SX, mecoprop-2-ethylhexyl + SX, mecoprop-dimethylammonium + SX, mecoprop-diolamine + SX, mecoprop-ethadyl + SX, mecoprop-isoctyl + SX, mecoprop-methyl + SX, mecoprop-potassium + SX, mecoprop-sodium + SX, mecoprop-trolamine + SX, mecoprop-P + SX, mecoprop-P choline salt + SX, mecoprop-P-2-ethylhexyl + SX, mecoprop-P-dimethylammonium + SX, mecoprop-P-isobutyl + SX, mecoprop-P-potassium + SX, mefenacet + SX, mesosulfuron + SX, mesosulfuron-methyl + SX, mesotrione + SX, metam + SX, metamifop + SX, metamitron + SX, metazachlor + SX, metazosulfuron + SX, methabenzthiazuron + SX, methiozolin + SX, methyldymron + SX, metobromuron + SX, metolachlor + SX, metoxuron + SX, metosulam + SX, metproxybicyclone + SX, metribuzin + SX, metsulfuron + SX, metsulfuron-methyl + SX, molinate + SX, monolinuron + SX, naproanilide + SX, napropamide + SX, napropamide-M + SX, naptalam + SX, neburon + SX, nicosulfuron + SX, norflurazon + SX, oleic acid + SX, orbencarb + SX, orthosulfamuron + SX, oryzalin + SX, oxadiargyl + SX, oxadiazon + SX, oxasulfuron + SX, oxaziclomefone + SX, oxyfluorfen + SX, paraquat + SX, paraquat-dichloride + SX, pebulate + SX, pelargonic acid + SX, pendimethalin + SX, penoxsulam + SX, pentanochlor + SX, pentoxazone + SX, pethoxamid + SX, phenisopham + SX, phenmedipham + SX, picloram, picolinafen + SX, picolinafen + SX, pinoxaden + SX, piperophos + SX, pretilachlor + SX, primisulfuron + SX, primisulfuron-methyl + SX, prochlorosulfone + SX, prodiamine + SX, profluazol + SX, profoxydim + SX, prometon + SX, prometryn + SX, propachlor + SX, propanil + SX, propaquizafop + SX, propazine + SX, propham + SX, propisochlor + SX, propoxycarbazone + SX, propoxycarbazone-sodium + SX, propyrisulfuron + SX, propyzamide + SX, prosulfocarb + SX, prosulfuron + SX, pyraclonil + SX, pyraquinate + SX, pyrasulfotole + SX, pyrazolynate + SX, pyrazosulfuron + SX, pyrazosulfuron-ethyl + SX, pyrazoxyfen + SX, pyribenzoxim + SX, pyributicarb + SX, pyridafol + SX, pyridate + SX, pyriflubenzoxim + SX, pyriftalid + SX, pyriminobac + SX, pyriminobac-methyl + SX, pyrimisulfan + SX, pyrithiobac + SX, pyrithiobac-sodium + SX, pyroxasulfone + SX, pyroxsulam + SX, quinclorac + SX, quinmerac + SX, quizalofop + SX, quizalofop-ethyl + SX, quizalofop-tefuryl + SX, quizalofop-P + SX, quizalofop-P-ethyl + SX, quizalofop-P-tefuryl + SX, rimisoxafen + SX, rimsulfuron + SX, saflufenacil + SX, sethoxydim + SX, EPTC (S-ethyl N,N-dipropylcarbamothioate) + SX, siduron + SX, simazine + SX, simetryn + SX, S-metolachlor + SX, MSMA (sodium hydrogen methylarsonate) + SX, sulcotrione + SX, sulfentrazone + SX, sulfometuron + SX, sulfometuron-methyl + SX, sulfosulfuron + SX, swep + SX, TCA (2,2,2-trichloroacetic acid) + SX, TCA-ammonium + SX, TCA-calcium + SX, TCA-ethadyl + SX, TCA-magnesium + SX, TCA-sodium + SX, tebutam + SX, tebuthiuron + SX, tefuryltrione + SX, tembotrione + SX, tepraloxydim + SX, terbacil + SX, terbumeton + SX, terbuthylazine + SX, terbutryn + SX, tetflupyrolimet + SX, thaxtomin A + SX, thenylchlor + SX, thiazopyr + SX, thidiazimin + SX, thiencarbazone + SX, thiencarbazone-methyl + SX, thifensulfuron + SX, thifensulfuron-methyl + SX, tiafenacil + SX, tiocarbazil + SX, tolpyralate + SX, topramezone + SX, tralkoxydim + SX, triafamone + SX, tri-allate + SX, triasulfuron + SX, triaziflam + SX, tribenuron + SX, tribenuron-methyl) + SX, triclopyr + SX, triclopyr-butotyl + SX, triclopyr-ethyl + SX, triclopyr-triethylammonium + SX, tridiphane + SX, trietazine + SX, trifloxysulfuron + SX, trifloxysulfuron-sodium + SX, trifludimoxazin + SX, trifluralin + SX, triflusulfuron + SX, triflusulfuron-methyl + SX, tripyrasulfone + SX, tritosulfuron + SX, vernolate + SX, 4-(4-fluorophenyl)-6-[(2-hydroxy-6-oxo-1-cyclohexen-1-yl)carbonyl]-2-methyl-1,2,4-triazine-3,5(2H,4H)-dione + SX, 2-chloro-N-(1-methyl-1H-tetrazol-5-yl)-3-(methylthio)-4-(trifluoromethyl)benzamide + SX, 2-methyl-N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-(methanesulfonyl)-4-(trifluoromethyl)benzamide + SX, 1-  {  2-chloro-6-[(5- chloropyrimidin-2-yl)oxy]phenyl}-4,4,4-trifluorobutan-1-one (2052297-97-7) + SX.

[0056] The ratio of the Present compound to the Present ingredient includes, but not limited thereto, as a ratio by weight (the Present compound : the Present ingredient) 1,000:1 to 1:1,000, 500:1 to 1:500, 100:1 to 1:100, 50:1, 20:1, 10:1, 9:1, 8:1, 7:1, 6:1, 5:1, 4:1, 3:1, 2:1, 1:1, 1:2, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9, 1:10, 1:20, 1:50, and the others.

[0057] Specific examples of subject to be controlled of the compound of the present invention include the followings, but are not limited to them. Urticaceae weeds: small nettle (Urtica urens); Polygonaceae weeds: black bindweed (Polygonum convolvulus), pale persicaria (Polygonum lapathifolium), Pennsylvania smartweed (Polygonum pensylvanicum), redshank (Polygonum persicaria), bristly lady's-thumb (Polygonum longisetum), knotgrass (Polygonum aviculare), equal-leaved knotgrass (Polygonum arenastrum), Japanese knotweed (Polygonum cuspidatum), Japanese dock (Rumex japonicus), curly dock (Rumex crispus), blunt-leaved dock (Rumex obtusifolius), common sorrel (Rumex acetosa); Portulacaceae weeds:   common  purslane   (Portulaca oleracea; Caryophyllaceae weeds: common chickweed (Stellaria media), water chickweed (Stellaria aquatica), common mouseear (Cerastium holosteoides), sticky mouse-ear (Cerastium glomeratum), corn spurrey (Spergula arvensis), five-wound catchfly (Silene gallica); Molluginaceae weeds: carpetweed (Mollugo verticillate); Chenopodiaceae weeds: common lambsquarters (Chenopodium album), Indian goosefoot (Chenopodium ambrosioides), kochia (Bassia scoparia), spiny saltwort (Salsola kali), Orach (Atriplex spp.).

[0058] Amaranthaceae weeds: redroot pigweed (Amaranthus retroflexus), slender amaranth (Amaranthus viridis), livid amaranth (Amaranthus lividus), spiny amaranth (Amaranthus spinosus), smooth pigweed (Amaranthus hybridus), Palmer amaranth (Amaranthus palmeri), green pigweed (Amaranthus patulus,) waterhemp (Amaranthus tuberculatus = Amaranthus rudis = Amaranthus tamariscinus), prostrate pigweed (Amaranthus blitoides), large-fruit amaranth (Amaranthus deflexus), mucronate amaranth (Amaranthus quitensis), alligator weed (Alternanthera philoxeroides), sessile alligator weed (Alternanthera sessilis), perrotleaf (Alternanthera tenella); Papaveraceae weeds: common poppy (Papaver rhoeas), field poppy (Papaver dubium), Mexican prickle poppy (Argemone Mexicana); Brassicaceae weeds: wild radish (Raphanus raphanistrum), radish (Raphanus sativus), wild mustard (Sinapis arvensis), shepherd's purse (Capsella bursa-pastoris), white mustard (Brassica juncea), oilseed rape (Brassica napus), pinnate tansy mustard (Descurainia pinnata), marsh yellowcress (Rorippa islandica), yellow fieldcress (Rorippa sylvestris), field pennycress (Thlaspi arvense), turnip weed (Myagrum rugosum), Virginia pepperweed (Lepidium virginicum), slender wartcress (Coronopus didymus); Capparaceae weeds: African cabbage (Cleome affinis).

[0059] Fabaceae weeds: Indian joint vetch (Aeschynomene indica), zigzag joint vetch (Aeschynomene rudis), hemp sesbania (Sesbania exaltata), sickle pod (Cassia obtusifolia), coffee senna (Cassia occidentalis), Florida beggar weed (Desmodium tortuosum), wild groundnut (Desmodium adscendens), Illinois tick trefoil (Desmodium illinoense), white clover (Trifolium repens), kudzu (Pueraria lobata), narrowleaf vetch (Vicia angustifolia), hairy indigo (Indigofera hirsuta), Indigofera truxillensis, common cowpea (Vigna sinensis); Oxalidaceae weeds: creeping wood sorrel (Oxalis corniculata), European wood sorrel (Oxalis stricta), purple shamrock (Oxalis oxyptera); Geraniaceae weeds: Carolina geranium (Geranium carolinense), common storksbill (Erodium cicutarium); Euphorbiaceae weeds: sun spurge (Euphorbia helioscopia), annual spurge (Euphorbia maculata), prostrate spurge (Euphorbia humistrata), Hungarian spurge (Euphorbia esula), wild poinsettia (Euphorbia heterophylla), hyssop-leaf sandmat (Euphorbia brasiliensis), Asian copperleaf (Acalypha australis), tropic croton (Croton glandulosus), lobed croton (Croton lobatus), long-stalked phyllanthus (Phyllanthus corcovadensis), castor bean (Ricinus communis).

[0060] Malvaceae weeds: velvetleaf (Abutilon theophrasti), arrow-leaf sida (Sida rhombifolia), heart-leaf sida (Sida cordifolia), prickly sida (Sida spinosa), Sida glaziovii, Sida santaremnensis, bladder weed (Hibiscus trionum), spurred anoda (Anoda cristata), spine-seeded false-mallow (Malvastrum coromandelianum); Onagraceae weeds: Ludwigia epilobioides, long-fruited primrose willow (Ludwigia octovalvis), winged water primrose (Ludwigia decurrens), common evening-primrose (Oenothera biennis), cutleaf evening-primrose (Oenothera laciniata); Sterculiaceae weeds: Florida waltheria (Waltheria indica); Violaceae weeds: field violet (Viola arvensis), wild violet (Viola tricolor); Cucurbitaceae weeds: bur cucumber (Sicyos angulatus), wild cucumber (Echinocystis lobata), bitter balsam apple (Momordica charantia); Lythraceae weeds: Ammannia multiflora, eared redstem (Ammannia auriculata), scarlet toothcup (Ammannia coccinea), purple loosestrife (Lythrum salicaria), Indian toothcup (Rotala indica); Elatinaceae weeds: three-stamen waterwort (Elatine triandra), California waterwort (Elatine californica).

[0061] Apiaceae weeds: Chinese celery (Oenanthe javanica), wild carrot (Daucus carota), carrot fern (Conium maculatum); Araliaceae weeds:   lawn pennywort (Hydrocotyle sibthorpioides), floating pennywort (Hydrocotyle ranunculoides); Ceratophyllaceae weeds: common hornwort (Ceratophyllum demersum); Cabombaceae weeds:    carolina fanwort (Cabomba caroliniana); Haloragaceae weeds:    Brazilian water milfoil (Myriophyllum aquaticum), whorled water milfoil (Myriophyllum verticillatum), water milfoils (Myriophyllum spicatum, Myriophyllum heterophyllum etc.); Sapindaceae weeds:     heartseed (Cardiospermum halicacabum); Primulaceae weeds: scarlet pimpernel   (Anagallis arvensis); Asclepiadaceae weeds: common milkweed   (Asclepias syriaca), honeyvine milkweed (Ampelamus albidus); Rubiaceae weeds: catchweed bedstraw (Galium aparine), Galium spurium var. echinospermon, broadleaf buttonweed (Spermacoce latifolia), Brazil calla lily (Richardia brasiliensis), broadleaf buttonweed (Borreria alata).

[0062] Convolvulaceae weeds: Japanese morning glory (Ipomoea nil), ivy-leaf morning glory (Ipomoea hederacea), tall morning glory (Ipomoea purpurea), entire-leaf morning glory (Ipomoea hederacea var. integriuscula), pitted morning glory (Ipomoea lacunosa), three-lobe morning glory (Ipomoea triloba), blue morning glory (Ipomoea acuminata), scarlet morning glory (Ipomoea hederifolia), red morning glory (Ipomoea coccinea), cypress-vine morning glory (Ipomoea quamoclit), Ipomoea grandifolia, Ipomoea aristolochiaefolia, Cairo morning glory (Ipomoea cairica), field bindweed (Convolvulus arvensis), Japanese false bindweed (Calystegia hederacea), Japanese bindweed (Calystegia japonica), ivy woodrose (Merremia hederacea), hairy woodrose (Merremia aegyptia), roadside woodrose (Merremia cissoides), smallflower morning glory (Jacquemontia tamnifolia); Boraginaceae weeds: field forget-me-not (Myosotis arvensis); Lamiaceae weeds: purple deadnettle (Lamium purpureum), common henbit (Lamium amplexicaule), lion's ear (Leonotis nepetaefolia), wild spikenard (Hyptis suaveolens), Hyptis lophanta, Siberian motherwort (Leonurus sibiricus), fieldnettle betony (Stachys arvensis).

[0063] Solanaceae weeds: jimsonweed (Datura stramonium), black nightshade (Solanum nigrum), American black nightshade (Solanum americanum), eastern black nightshade (Solanum ptycanthum), hairy nightshade (Solanum sarrachoides), S buffalo bur (olanum rostratum), soda-apple nightshade (Solanum aculeatissimum), sticky nightshade (Solanum sisymbriifolium), horse nettle (Solanum carolinense), cutleaf groundcherry (Physalis angulata), smooth groundcherry (Physalis subglabrata), apple of Peru (Nicandra physalodes); Scrophulariaceae weeds: ivyleaf speedwell (Veronica hederaefolia), common speedwell (Veronica persica), corn speedwell (Veronica arvensis), common false pimpernel (Lindernia procumbens), false pimperne (Lindernia dubia), Lindernia angustifolia, round-leaf water hyssop (Bacopa rotundifolia), dopatrium (Dopatrium junceum), Gratiola japonica; Plantaginaceae weeds: Asiatic plantain (Plantago asiatica), narrow-leaved plantain (Plantago lanceolata), broadleaf plantain (Plantago major), marsh water starwort (Callitriche palustris).

[0064] Asteraceae weeds: common cocklebur (Xanthium pensylvanicum), large cocklebur (Xanthium occidentale), Canada cocklebur (Xanthium italicum), common sunflower (Helianthus annuus), wild chamomile (Matricaria chamomilla), scentless chamomile (Matricaria perforata), corn marigold (Chrysanthemum segetum), rayless mayweed (Matricaria matricarioides), Japanese mugwort (Artemisia princeps), common mugwort (Artemisia vulgaris), Chinese mugwort (Artemisia verlotorum), tall goldenrod (Solidago altissima), common dandelion (Taraxacum officinale), hairy galinsoga (Galinsoga ciliata), small-flower galinsoga (Galinsoga parviflora), common groundsel (Senecio vulgaris), flower-of-souls (Senecio brasiliensis), Senecio grisebachii, fleabane (Conyza bonariensis), Guernsey fleabane (Conyza sumatrensis), marestail (Conyza canadensis), common ragweed (Ambrosia artemisiifolia), giant ragweed (Ambrosia trifida), three-cleft bur-marigold (Bidens tripartita), hairy beggarticks (Bidens pilosa), common beggarticks (Bidens frondosa), greater beggarticks (Bidens subalternans), Canada thistle (Cirsium arvense), black thistle (Cirsium vulgare), blessed milkthistle (Silybum marianum), musk thistle (Carduus nutans), prickly lettuce (Lactuca serriola), annual sowthistle (Sonchus oleraceus), spiny sowthistle (Sonchus asper), beach creeping oxeye (Wedelia glauca), perfoliate blackfoot (Melampodium perfoliatum), red tasselflower (Emilia sonchifolia), wild marigold (Tagetes minuta), para cress (Blainvillea latifolia), coat buttons (Tridax procumbens), Bolivian coriander (Porophyllum ruderale), Paraguay starbur (Acanthospermum austral), bristly starbur (Acanthospermum hispidum), balloon vine (Cardiospermum halicacabum), tropic ageratum (Ageratum conyzoides), common boneset (Eupatorium perfoliatum), fireweed (Erechtites hieracifolia), American cudweed (Gamochaeta spicata), linear-leaf cudweed (Gnaphalium spicatum), Jaegeria hirta, ragweed parthenium (Parthenium hysterophorus), small yellow crownbeard (Siegesbeckia orientalis), lawn burweed (Soliva sessilis), white eclipta (Eclipta prostrata), American false daisy (Eclipta alba), spreading sneezeweed (Centipeda minima).

[0065] Alismataceae weeds: dwarf arrowhead (Sagittaria pygmaea), threeleaf arrowhead (Sagittaria trifolia), arrowhead (Sagittaria sagittifolia), giant arrowhead (Sagittaria montevidensis), Sagittaria aginashi, channelled water plantain (Alisma canaliculatum), common water plantain (Alisma plantago-aquatica); Limnocharitaceae weeds: Sawah flowering rush (Limnocharis flava); Hydrocharitaceae weeds: American frogbit (Limnobium spongia), Florida elodea (Hydrilla verticillata), common water nymph (Najas guadalupensis); Araceae weeds: Nile cabbage (Pistia stratiotes); Lemnaceae weeds: three-nerved duckweed (Lemna aoukikusa, Lemna paucicostata, Lemna aequinoctialis), common duckmeat (Spirodela polyrhiza), Wolffia spp.; Potamogetonaceae weeds: roundleaf pondweed (Potamogeton distinctus), pondweeds (Potamogeton crispus, Potamogeton illinoensis, Stuckenia pectinata, etc.); Liliaceae weeds: wild onion (Allium canadense), wild garlic (Allium vineale), Chinese garlic (Allium macrostemon); Pontederiaceae weeds: common water hyacinth (Eichhornia crassipes), blue mud plantain (Heteranthera limosa), Monochoria korsakowii, heartshape false pickerelweed (Monochoria vaginalis); Liliaceae weeds: common dayflower (Commelina communis), tropical spiderwort (Commelina benghalensis), erect dayflower (Commelina erecta), Asian spiderwort (Murdannia keisak).

[0066] Poaceae weeds: common barnyardgrass (Echinochloa crus-galli), early barnyardgrass (Echinochloa oryzicola), barnyard grass (Echinochloa crus-galli var. formosensis), late watergrass (Echinochloa oryzoides), jungle rice (Echinochloa colona), Gulf cockspur (Echinochloa crus-pavonis), green foxtail (Setaria viridis), giant foxtail (Setaria faberi), yellow foxtail (Setaria glauca), knotroot foxtail (Setaria geniculata), southern crabgrass (Digitaria ciliaris), large crabgrass (Digitaria sanguinali), Jamaican crabgrass (Digitaria horizontalis), sourgrass (Digitaria insularis), goosegrass (Eleusine indica), annual bluegrass (Poa annua), rough-stalked meadowgrass (Poa trivialis), Kentucky bluegrass (Poa pratensis), short-awn foxtail (Alopecurus aequalis), blackgrass (Alopecurus myosuroides), wild oat (Avena fatua), Johnsongrass (Sorghum halepense), shataken (grain sorghum; Sorghum vulgare), quackgrass (Agropyron repens), Italian ryegrass (Lolium multiflorum), perennial ryegrass (Lolium perenne), bomugi (rigid ryegrass; Lolium rigidum), rescue brome (Bromus catharticus), downy brome (Bromus sterilis), Japanese brome grass (Bromus japonicus), cheat (Bromus secalinus), cheatgrass (Bromus tectorum), foxtail barley (Hordeum jubatum), jointed goatgrass (Aegilops cylindrica), reed canarygrass (Phalaris arundinacea), little-seed canary grass (Phalaris minor), silky bentgrass (Apera spica-venti), fall panicum (Panicum dichotomiflorum), Texas panicum (Panicum texanum), guineagrass (Panicum maximum), broadleaf signalgrass (Brachiaria platyphylla), Congo signal grass (Brachiaria ruziziensis), Alexander grass (Brachiaria plantaginea), Surinam grass (Brachiaria decumbens), palisade grass (Brachiaria brizantha), creeping signalgrass (Brachiaria humidicola), southern sandbur (Cenchrus echinatus), field sandbur (Cenchrus pauciflorus), woolly cupgrass (Eriochloa villosa), feathery pennisetum (Pennisetum setosum), Rhodes grass (Chloris gayana), feathertop Rhodes grass (Chloris virgata), India lovegrass (Eragrostis pilosa), Natal grass (Rhynchelytrum repens), crowfoot grass (Dactyloctenium aegyptium), winkle grass (Ischaemum rugosum), swamp millet (Isachne globosa), common rice (Oryza sativa), bahiagrass (Paspalum notatum), coastal sand paspalum (Paspalum maritimum), mercergrass (Paspalum distichum), kikuyugrass (Pennisetum clandestinum), West Indies pennisetum (Pennisetum setosum), itch grass (Rottboellia cochinchinensis), Asian sprangletop (Leptochloa chinensis), salt-meadow grass (Leptochloa fascicularis), Christmas-tree grass (Leptochloa filiformis), Amazon sprangletop (Leptochloa panicoides), Japanese cutgrass (Leersia japonica), Leersia sayanuka, cutgrass (Leersia oryzoides), Glyceria leptorrhiza, sharpscale mannagrass (Glyceria acutiflora), great watergrass (Glyceria maxima), redtop (Agrostis gigantea), carpet bent (Agrostis stolonifera), Bermuda grass (Cynodon dactylon), cocksfoot (Dactylis glomerata), centipede grass (Eremochloa ophiuroides), tall fescue (Festuca arundinacea), red fescue (Festuca rubra), lalang (Imperata cylindrica), Chinese fairy grass (Miscanthus sinensis), switchgrass (Panicum virgatum), Japanese lawngrass (Zoysia japonica).

[0067] Cyperaceae weeds: Asian flatsedge (Cyperus microiria), rice flatsedge (Cyperus iria), hedgehog cyperus (Cyperus compressus), small-flowered nutsedge (Cyperus difformis), lax-flat sedge (Cyperus flaccidus), Cyperus globosus, Cyperus nipponicus, fragrant flatsedge (Cyperus odoratus), mountain nutsedge (Cyperus serotinus), purple nutsedge (Cyperus rotundus), yellow nutsedge (Cyperus esculentus), pasture spike sedge (Kyllinga gracillima), green kyllinga (Kyllinga brevifolia), grasslike fimbristylis (Fimbristylis miliacea), annual fringerush (Fimbristylis dichotoma), slender spikerush (Eleocharis acicularis), Eleocharis kuroguwai, Japanese bulrush (Schoenoplectiella hotarui), hardstem bulrush (Schoenoplectiella juncoides), Schoenoplectiella wallichii, rough-seed bulrush (Schoenoplectiella mucronatus), Schoenoplectiella triangulatus, Schoenoplectiella nipponicus, triangular clubrush (Schoenoplectiella triqueter), Bolboschoenus koshevnikovii, river bulrush (Bolboschoenus fluviatilis); Equisetaceae weeds: field horsetail (Equisetum arvense), marsh horsetail (Equisetum palustre); Salviniaceae weeds: floating fern (Salvinia natans); Azollaceae weeds: Japanese mosquitofern (Azolla japonica), feathered mosquito fern (Azolla pinnata); Marsileaceae weeds: clover fern (Marsilea quadrifolia); Others: Filamentous algae (Pithophora, Cladophora), Bryophyta, Marchantiophyta, Anthocerotophyta, Cyanobacteria, Pteridophyta. sucker of perennial crop (such as pome fruits, stone fruits, berry fruits, nuts, citrus fruits, hops, grapes).

[0068] For the above weeds, intraspecific mutations are not particularly limited. In other words, they also include those that have reduced susceptibility (also called "resistance") to a particular herbicide. The reduced susceptibility may be due to a mutation at the target site (active site mutation) or due to factors other than the active site mutation (non-active site mutation). The active site mutation includes those that result in amino acid substitutions in the protein as target site due to mutations in the nucleic acid sequence parts (open reading frame) that correspond to the amino acid sequence of the protein, and those that result in overexpression of the protein as targe site due to mutations such as a deletion of suppressor sequences in the promoter region, an amplification of enhancer sequences, or an increase in the copy number of the gene, etc. Factors that cause reduced susceptibility due to nonactive site mutations include an increased metabolism, a poor absorption, a poor transport, and an excretion from the system, and the like. Examples of factors that cause increased metabolism include an increased activity of metabolic enzymes such as cytochrome P450 monooxygenase (CYP), aryl acylamidase (AAA), esterase, glutathione S-transferase (GST), and cyanoalanine nitrilase. Examples of excretion from the system include a transport to the vacuole by ABC transporters. Examples of herbicide resistant weeds include the followings. Glyphosate resistance: Examples of weeds with reduced susceptibility due to active site mutations include weeds with any one of or a plurality of the following amino acid substitutions in the EPSPS gene. ThR102Ile, Pro106Ser, Pro106Ala, Pro106Leu, and Pro106Thr. In particular, those with both ThR102Ile and Pro106Ser, and those with both ThR102Ile and Pro106Thr are included. Glyphosate-resistant Eleusine indica, Lolium multiflorum, Lolium rigidum, Lolium perenne, Bidens subalternans, etc., which have these active site mutations, are effectively controlled. Similarly, an example of glyphosate resistance involving the active site include those which have an increase in the copy number of the EPSPS gene (PNAS, 2018 115 (13) 3332-3337). The present invention controls effectively glyphosate-resistant Amaranthus palmeri, Amaranthus tuberculatus (= Amaranthus rudis = Amaranthus tamariscinus), Bassia scoparia, etc., which have an increase in the copy number of the EPSPS gene. Examples of weeds with reduced susceptibility due to non-active site mutations include Conyza canadensis, Conyza smatrensis, and Conyza bonariensis, etc., which are resistant to glyphosate due to the involvement of ABC transporters, and these can be effectively controlled by the present invention. In addition, Echinochloa colona that has reduced susceptibility to glyphosate due to increased expression of aldo-keto reductase as non-active site mutations is known (see Plant PhysiologY181, 1519-1534), and these can be controlled effectively by the present invention. ALS-inhibited herbicide resistance: Examples of weeds with reduced susceptibility due to active site mutations include weeds with any one of or a plurality of the following amino acid substitutions in the ALS gene. Pro197His, Pro197Ala, Asp376Gln, Trp574Met, Gly645Asp. Ala122Thr, Pro197Thr, Pro197Ile, Asp376Asn, Ser653Thr, The present Ala122Val, Pro197Arg, Ala205Val, Arg377His, Ser653Asn, invention Ala122Tyr, Pro197Leu, Ala205Phe, Pro197Ser, Pro197Gln, Asp376Glu, Trp574Gly, Gly654Glu, Trp574Leu, Ser635Ile, can effectively control ALS inhibitor-resistant weeds that have these active site mutations, such as Amaranthus retroflexus, Amaranthus hybridus, Amaranthus palmeri, Amaranthus tuberculatus (= Amaranthus rudis = Amaranthus tamariscinus), Bassia scoparia, etc. Examples of weeds with reduced susceptibility due to non active site mutations include weeds that have become resistant to ALS inhibitors due to the involvement of CYP or GST, and these can be controlled effectively by the present invention. As examples of these, Lolium rigidum which have overexpression of CYP81A10 and CYP81A1v1, Echinochloa oryzicola which have overexpression of CYP81A12 and CYP81A21, and Alopecurus myosuroides which have overexpression of GSTF1 and GSTU2, are known. ACCase inhibitor resistance: Examples of weeds with reduced susceptibility due to active site mutations include weeds with mutations in the ACCase gene that cause any one of or a plurality of the following amino acid substitutions. Ile1781Ala, Ile1781Leu, Ile1781Val, Ile1781Thr, Leu1818Phe, Trp1999Cys, Trp1999Leu, Trp1999Ser, Ala2004Val, Trp2027Cys, Trp2027Leu, Ile2041Asn, Ile2041Asp, Ile2041Val, Ile2041Thr, Asp2078Gly, Asp2078Glu, Cys2088Arg, Cys2088Phe, Gly2096Ala, Gly2096Ser. The present invention controls effectively ACCase-resistant weeds that have these active site mutations. Similarly, an example of ACCase inhibitor resistance involving the active site include those that have increased expression of the ACCase gene (Pest Manag. Sci. 2017 Nov; 73(11):2227-2235). Examples of weeds with reduced susceptibility due to non-active site mutations include weeds that have become resistant to ACCase inhibitors due to the involvement of CYP or GST, and these can be controlled effectively by the present invention. As examples of these, Lolium rigidum which have overexpression of CYP81A10 or CYP81A1v1, Echinochloa oryzicola which have overexpression of CYP81A12, CYP81A21, or CYP709C69, and Alopecurus myosuroides which have overexpression of GSTF1 and GSTU2, are known. PPO inhibitor resistance: Examples of weeds with reduced susceptibility due to active site mutations include weeds with mutations in the PPO gene that causes any one of a plurality of amino acid substitutions. These mutations have known or predicted to be resistance mutations to carfentrazone-ethyl, fomesafen, or lactofen. Arg128Leu, Arg128Met, Arg128Gly, Arg128His, Arg128Ala, Arg128Cys, Arg128Glu, Arg128Ile, Arg128Lys, Arg128Asn, Arg128Gln, Arg128Ser, Arg128Thr, Arg128Val, Arg128Tyr, Gly210 deficiency, Ala210 deficiency, Gly210Thr, Ala210Thr, Gly211 deficiency, GlY114Glu, SeR149Ile, Val361Ala, Gly399Ala (all amino acid numbers are standardized to the PPO2 sequence of Amaranthus palmeri.). Generally, the PPO genes of weeds are present as the PPO1 gene and the PPO2 gene, and the above-mentioned mutations may be present in either the PPO1 gene, the PPO2 gene, or both. Preferable examples of the mutations include those having mutations in the PPO2 gene. For example, Arg128Met means that there is a mutation in the 128th amino acid. In the PPO2 gene of Ambrosia artemisiifolia, the mutation corresponds to the 98th amino acid (Weed Science 60, 335-344), and is known to be an expression of Arg98Leu, but this Arg98 is the same as Arg128 described herein. In the PPO genes of the weeds to be targeted by the present invention, Arg128Met and Arg128Gly are known from Amaranthus palmeri (Pest Management Science 73, 1559-1563), and furthermore, Arg128Gly is known as PPO2 from Amaranthus tuberculatus (= Amaranthus rudis = Amaranthus tamariscinus) (Pest Management Science, 2019; 75: 3235-3244), Arg128Ile and Arg128Lys are known as PPO2 from Amaranthus tuberculatus (= Amaranthus rudis = Amaranthus tamariscinus) (Pest Management Science, 2019; 75: 3235-3244), Arg128His are known as Arg132His of PPO2 from Lolium rigidum (WSSA annual meeting, 2018), GlY114Glu, SeR149Ile, Val361Ala and Gly399Ala are known as PPO2 from Amaranthus palmeri (Frontiers in Plant Science 10, Article 568 and Plants 2023, 12(9), 1886), and Ala210Thr is known as Ala212Thr of PPO1 from Eleusine indica (Pest Management Science, doi: 10.1002 / ps.5703). The present invention can control effectively PPO inhibitor-resistant weeds having these active site mutations, but the PPO inhibitor-resistant weeds to be controlled are not limited thereto. That is, not only Amaranthus palmeri which have mutations of Arg128Leu, Arg128Met, Arg128Gly, Arg128His, Arg128Ala, Arg128Cys, Arg128Glu, Arg128Ile, Arg128Lys, Arg128Asn, Arg128Gln, Arg128Ser, Arg128Thr, Arg128Val, Arg128Tyr, Gly210 deficiency, Ala210 deficiency, Gly210Thr, Ala210Thr, Gly211 deficiency, GlY114Glu, SeR149Ile or Gly399Ala in PPO1 or PPO2, but also Amaranthus tuberculatus (= Amaranthus rudis = Amaranthus tamariscinus) which have the same mutations, Ambrosia artemisiifolia which have the same mutations, and Euphorbia heterophylla which have the same mutations, etc., can be effectively controlled. Examples of weeds with reduced susceptibility due to non-active site mutations include Amaranthus tuberculatus (= Amaranthus rudis = Amaranthus tamariscinus) etc., which has become resistant to carfentrazone-ethyl (PLOS ONE, doi: 10.1371 / journal.pone.0215431) as Amaranthus tuberculatus (= Amaranthus rudis = Amaranthus tamariscinus) or Amaranthus palmeri which have become resistant to PPO inhibitors due to the involvement of CYP or GST. These can be controlled effectively by the present invention. Auxin herbicide resistance: Examples of active site mutations include mutations that cause Gly-Asn in a degron region of AUX / IAA gene. An example of a site-specific mutation is a Gly-Asn mutation in the degron region of the AUX / IAA gene. The present invention can control effectively Bassia scoparia, Amaranthus palmeri, or Amaranthus tuberculatus (= Amaranthus rudis = Amaranthus tamariscinus) which have the mutations. As examples of nonactive site mutations, dicamba-resistant Amaranthus palmeri and 2,4-D-resistant Amaranthus tuberculatus (= Amaranthus rudis = Amaranthus tamariscinus), which are suggested to be involved by CYP, are known, and these can be controlled effectively by the present invention. The same can be said for non-active site mutations involving GST. HPPD inhibitor resistance: Examples of those with HPPD inhibitor resistance involving the active site include those which have increased expression of the HPPD gene (Frontiers in Plant Science, 2017, 8: 555). Examples of weeds with reduced susceptibility due to non-active site mutations include Amaranthus tuberculatus (= Amaranthus rudis = Amaranthus tamariscinus) or Amaranthus palmeri, which have become resistant to HPPD inhibitors due to the involvement of CYP or GST, but these can be controlled effectively by the present invention. As examples of these, Amaranthus palmeri which has overexpression of CYP72A219, CYP81B, or CYP81E8 is known. Photosystem II inhibitor resistance: Examples of weeds with reduced susceptibility due to active site mutations include weeds with mutations in the psbA gene that cause any one of or a plurality of the following amino acid substitutions. Val219Ile, SeR264Gly, SeR264Ala, Phe274Val. The present invention can control effectively Amaranthus palmeri or Amaranthus tuberculatus (= Amaranthus rudis = Amaranthus tamariscinus), which have these active site mutations and are resistant to photosystem II inhibitors. Examples of weeds with reduced susceptibility due to nonactive site mutations include Amaranthus palmeri or Amaranthus tuberculatus (= Amaranthus rudis = Amaranthus tamariscinus) etc., which are resistant to photosystem II inhibitors due to the involvement of CYP, GST, or AAA, but these can be controlled effectively by the present invention. As examples of these, Lolium rigidu which has overexpressions of CYP71R4 is known. Glutamate synthetase inhibitor resistance: Examples of weeds that have reduced susceptibility due to active site mutations include weeds with a mutation causing an amino acid substitution of Asp171Asn in the glutamine synthetase gene. The present invention can control effectively Amaranthus palmeri or Amaranthus tuberculatus (= Amaranthus rudis = Amaranthus tamariscinus) etc., that have this mutation and are resistant to glutamine synthetase inhibitors. Examples of weeds with glutamate synthase inhibitor resistance involving the active site include those having an increase in the copy number of the glutamate synthase gene (Weed Science, 2022, 70.4: 370-379). Examples of weeds with reduced susceptibility due to non-active site mutations include Amaranthus palmeri or Amaranthus tuberculatus (= Amaranthus rudis = Amaranthus tamariscinus), etc., which have become resistant to glufosinate due to the involvement of CYP or GST, and these can be controlled effectively by the present invention. As an example of the weeds, Amaranthus palmeri which has an overexpression of CYP72A219, CYP81B or CYP81E8 are known. Resistant weeds that "have in combination of" ("stacked with") resistance to two or more of the above groups (optionally selected group 2, optionally selected group 3, optionally selected group 4, optionally selected group 5, optionally selected group 6, group 7, group 8) are also effectively controlled. As an example of a stacked resistant weed, Amaranthus tuberculatus (= Amaranthus rudis = Amaranthus tamariscinus), which is resistant to all of photosystem II inhibitors, HPPD inhibitors, 2,4-D, PPO inhibitors, ALS inhibitors and glyphosate, are known, and these can also be controlled effectively. The above stacks may be based on a combination of active site mutations, a combination of non-active site mutations, or a combination of active site mutations and non-active site mutations.

[0069] The Present compound (that is, the compound of the Present invention) or the Composition A is usually used by mixing it with inert carrier(s) such as solid carrier(s), liquid carrier(s), and gaseous carrier(s), and surfactant(s), and the like, and as needed, adding thereto auxiliary agent(s) for formulation such as binder(s), dispersant(s), and stabilizer(s) to be formulated into an aqueous suspension formulation, an oily suspension formulation, an oil solution, an emulsifiable concentrate, an emulsion formulation, a microemulsion formulation, a microcapsule formulation, a wettable powder, a granular wettable powder, a dust formulation, a granule, a tablet, an aerosol formulation, a resin formulation, or the like. In addition to these formulations, the Present compound or the Composition A may be used by formulating it into a dosage form described in Manual on development and use of FAO and WHO Specifications for pesticides, FAO Plant Production and Protection Papers-271-276, prepared by the FAO / WHO Joint Meeting on Pesticide Specifications, 2016, ISSN:0259-2517. These formulations usually comprise 0.0001 to 99% by weight ratio of the Present compound or the Composition A.

[0070] Examples of the solid carrier include fine powders and granules of clays (for example, pyrophyllite clay and kaolin clay), talc, calcium carbonate, diatomaceous earth, zeolite, bentonite, acid white clay, attapulgite, white carbon, ammonium sulfate, vermiculite, perlite, pumice, silica sand, chemical fertilizers (for example, ammonium sulfate, ammonium phosphate, ammonium nitrate, urea, and ammonium chloride), and the others; as well as resins (for example, polyethylene, polypropylene, polyester, polyurethane, polyamide, and polyvinyl chloride).

[0071] Examples of the liquid carrier include water, alcohols (for example, ethanol, cyclohexanol, benzyl alcohol, propylene glycol, and polyethylene glycol), ketones (for example, acetone and cyclohexanone), aromatic hydrocarbons (for example, xylene, phenyl xylyl ethane, and methylnaphthalene), aliphatic hydrocarbons (for example, hexane and cyclohexane), esters (for example, ethyl acetate, methyl oleate, and propylene carbonate), nitriles (for example, acetonitrile), ethers (for example, ethylene glycol dimethyl ether), amides (for example, N,N-dimethylformamide and N,N-dimethyloctanamide), sulfoxides (for example, dimethyl sulfoxide), lactams (for example, N-methylpyrrolidone and N-octylpyrrolidone), fatty acids (for example, oleic acid), and vegetable oils (for example, soybean oil).

[0072] Examples of the gaseous carrier include fluorocarbon, butane gas, LPG (liquefied petroleum gas), dimethyl ether, nitrogen, and carbon dioxide.

[0073] Examples of the surfactant include nonionic surfactants (for example, polyoxyethylene alkyl ethers, polyoxyethylene alkyl aryl ethers, and polyethylene glycol fatty acid esters), and anionic surfactants (for example, alkyl sulfonates, alkyl aryl sulfonates, and alkyl sulfates).

[0074] Examples of the other auxiliary agent for formulation include binders, dispersants, colorants, and stabilizers, and the specific examples thereof include polysaccharides (for example, starch, gum arabic, cellulose derivatives, and alginic acid), lignin derivatives, water-soluble synthetic polymers (for example, polyvinyl alcohol, polyvinyl pyrrolidone, and polyacrylic acids), acidic isopropyl phosphate, and dibutylhydroxytoluene.

[0075] Moreover, some adjuvants can be employed to improve or help the efficacy of the Present compound. The specific examples thereof include Nimbus (registered trademark), Assist (registered trademark), Aureo (registered trademark), Iharol (registered trademark), Silwet L-77 (registered trademark), BreakThru (registered trademark), SundanceII (registered trademark), Induce (registered trademark), Penetrator (registered trademark), AgriDex (registered trademark), Lutensol A8 (registered trademark), NP-7 (registered trademark), Triton (registered trademark), Nufilm (registered trademark), Emulgator NP7 (registered trademark), Emulad (registered trademark), TRITON X 45 (registered trademark), AGRAL 90 (registered trademark), AGROTIN (registered trademark), ARPON (registered trademark), EnSpray N (registered trademark), and BANOLE (registered trademark).

[0076] The Preset compound can be used in an agricultural land where the useful plants are grown to control weeds in the agricultural land. Examples of the useful plants include the followings.

[0077] corn (dent corn, flint corn, flour corn, popcorn, waxy corn, sweet corn, and field corn), rice (long grain rice, short grain rice, medium grain rice, japonica rice, tropical japonica rice, indica rice, javanica rice, paddy rice, upland rice, floating rice, direct-seeded rice, transplanted rice, and glutinous rice), wheat (bread wheat (hard wheat, soft wheat, medium wheat, red wheat, and white wheat), durum wheat, spelt wheat, and club wheat, winter wheat and spring wheat of them), barley (two-rowed barley (= barley for brewery), six-rowed barley, hull-less barley, and pearl barley, winter barley and spring barley of them), rye (winter rye and spring rye), triticale (winter triticale and spring triticale), oat (winter oat and spring oat), sorghum, cotton (upland cotton and Pima cotton), soybean (ripe seed harvest soybean, green soybeans, and early harvest soybeans, indeterminate type, determinate type, and semi-determinate type of them), peanut, buckwheat, beet (beets for sugar production, beets for feed, beets for root vegetable, beets for leaf vegetable, and beets for fuel), rapeseed (winter rapeseed and spring rapeseed), canola (winter canola and spring canola), sunflower (sunflowers for oil extraction, edible sunflowers, and sunflowers for ornamental purpose), sugar cane, tobacco, tea, mulberry, solanaceous vegetables (for example, eggplant, tomato, pimento, pepper, and potato), cucurbitaceous vegetables (for example, cucumber, pumpkin, zucchini, water melon, and melon), cruciferous vegetables (for example, Japanese radish, white turnip, horseradish, kohlrabi, Chinese cabbage, cabbage, leaf mustard, broccoli, and cauliflower), asteraceous vegetables (for example, burdock, crown daisy, artichoke, and lettuce), liliaceous vegetables (for example, welsh onion, onion, garlic, and asparagus), ammiaceous vegetables (for example, carrot, parsley, celery, and parsnip), chenopodiaceous vegetables (for example, spinach and Swiss chard), lamiaceous vegetables (for example, perilla, mint, and basil), strawberry, sweet potato, glutinous yam, eddoe, pomaceous fruits (for example, apple, pear, Japanese pear, Chinese white pear, Chinese quince, and quince), stone fleshy fruits (for example, peach, plum, nectarine, Japanese apricot (Prunus mume), cherry fruit, apricot, and prune), citrus fruits (for example, Citrus unshiu, orange, lemon, lime, and grapefruit), nuts (for example, chestnuts, walnuts, hazelnuts, almond, pistachio, cashew nuts, and macadamia nuts), berry fruits (for example, blueberry, cranberry, blackberry, and raspberry), grapes, Japanese persimmon, fig, olive, Japanese plum, banana, coffee, date palm, coconuts, ornamental plants, forest plants, turfs, grasses, and the others.

[0078] The above plants are not specifically limited as long as they are generally cultivated cultivars. The above plants also include plants which may be produced by natural breeding, plants which may be generated by mutation, F1 hybrid plants, and genetically modified crops. Examples of the genetically modified crops include plants which have resistance to HPPD (4-hydroxyphenylpyruvate dioxygenase enzyme) inhibitors such as isoxaflutole, ALS (acetolactate synthase) inhibitors such as imazethapyr and thifensulfuron-methyl, EPSP (5- enolpyruvylshikimate-3-phosphate synthase) inhibitors, glutamine synthetase inhibitors, PPO (protoporphyrinogen oxidase) inhibitors, or herbicide such as bromoxynil and dicamba; plants which can synthesize a selective toxin known in Bacillus spp. such as Bacillus thuringiensis or the like; and plants which can synthesize a gene fragment or the like which is partially identical to an endogenous gene derived from a harmful insect, and induce a gene silencing (RNAi; RNA interference) in the target harmful insect to achieve a specific insecticidal activity.

[0079] The method for controlling weeds of the present invention comprises the step of applying an effective amount of the Present compound to a weed or a place where the weed grows or will grow. In the method for controlling weeds of the present invention, the Present compound is usually used in an amount of 5 to 5,000 g, preferably 10 to 1,000 g, per 10,000 m2 of area to be controlled weeds. When the Present compound or composition A is applied, a spraying device can be used. Examples of devices used for application include hand-cranked sprayers, power sprayers, punkul sprayers, manned aircraft (for example, manned helicopters), unmanned aircraft (for example, radio-controlled helicopters, drones), tractors, planters, etc. Also, the Present compound or the composition A may be applied by hand without using a spraying device.

[0080] In the method for controlling weeds of the present invention, the Present compound is usually used in the form of the herbicide composition. Examples of the methods for controlling weeds of the present invention include a method of applying the herbicide composition of the present invention to the foliage of weeds, a method of applying the herbicide composition of the present invention to the soil surface where weeds grow or will grow, a method of mixing the herbicide composition of the present invention into the soil where weeds grow, and a method of applying the herbicide composition of the present invention to the surface water of flooded paddy fields where weeds grow or will grow. Examples of spraying of the herbicide composition of the present invention include a uniform surface application or a spot treatment by selective spraying. Even when a small amount of the herbicide composition of the present invention is sprayed in a place where weeds do not grow or where there is no risk of weeds growing due to scattering, or transpiration, etc., it is included in spot treatment as long as it is not a uniform surface application. Also, spot treatment is not considered to be only when all areas in a contiguous cultivation area of useful plants where weeds are growing or where weeds are likely to grow are selectively treated. In other words, even if part of the cultivation area is treated over a surface application, or par...

Claims

1. A compound represented by formula (I):X1 X2I R3[whereinR1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G1, a C4-C8 alkyl group which may be optionally substituted with one or more substituents selected from Group G1, a C2-C8 alkenyl group which may be optionally substituted with one or more substituents selected from Group G1, a C2-C8 alkynyl group which may be optionally substituted with one or more substituents selected from Group G1, a C3-C8 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G2, a three(3) - eight(8) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G2 {a heteroatom which constitutes the three(3) - eight(8) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfuratom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G1, OR16, S(O)mR17, or NR18R19,R2 represents a C1-C8 chain hydrocarbon group which may5 be optionally substituted with one or more substituents selected from Group G3, a C3-C8 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G4, a halogen atom, a cyano group, OR10, C(=Z1)R11, C(=Z1)OR12, C(=Z1)NR11R12, S(O)pR13, or10     NR11R14,R3 represents a phenyl group which may be optionally substituted with one or more substituents selected from Group G5, a five(5) - six(6) membered aromatic heterocyclic group which may be optionally substituted with one or more15 substituents selected from Group G5, an aromatic fused heterocyclic group which may be optionally substituted with one or more substituents selected from Group G5, or any group represented by the following formula,(II)(III)(• represents a binding position to a nitrogen atom)a combination of G7a, G7b and G7c represents:a combination wherein G7a represents C=O or CR26aR27a,  G7brepresents C=O or CR26bR27b, and G7c represents C=O or CR26cR27c, a combination wherein G7a represents C=O or CR26aR27a,  G7brepresents C=O or CR26bR27b, and G7c represents NR28c, an oxygen atom, sulfur atom, S=O, or S=O2,a combination wherein G7a represents C=O or CR26aR27a, G7b represents NR28b, an oxygen atom, a sulfur atom, S=O, or S=O2, and G7c represents C=O or CR26cR27c,a combination wherein G7a represents NR28a , an oxygen atom, a sulfur atom, S=O, or S=O2, G7b represents C=O or CR26bR27b, and G7c represents C=O or CR26cR27c, or,a combination wherein G7a represents NR28a, an oxygen atom, a sulfur atom, S=O, or S=O2, G7b represents C=O or CR26bR27b, and G7c represents NR28c, an oxygen atom, a sulfur atom, S=O, or S=O2,a combination of G7d, G7e, G7f and G7g representsa combination wherein G7d represents C=O or CR26dR27d, G7e represents C=O or CR26eR27e, G7f represents C=O or CR26fR27f, and G7g represents C=O or CR26gR27g,a combination wherein G7d represents C=O or CR26dR27d, G7e represents C=O or CR26eR27e, G7f represents C=O or CR26fR27f, and G7g represents NR28g, an oxygen atom, a sulfur atom, S=O, or S=O2,a combination wherein G7d represents C=O or CR26dR27d, G7e represents C=O or CR26eR27e, G7f represents NR28f, an oxygen atom, a sulfur atom, S=O, or S=O2, and G7g represents C=O or CR26gR27g,a combination wherein G7d represents C=O or CR26dR27d, G7e represents NR28e, an oxygen atom, a sulfur atom, S=O, or S=O2, G7f represents C=O or CR26fR27f, and G7g represents C=O or CR26gR27g,a combination wherein G7d represents C=O or CR26dR27d, G7e represents NR28e, an oxygen atom, a sulfur atom, S=O, or S=O2, G7f represents C=O or CR26fR27f, and G7g represents NR28g , an oxygen atom, a sulfur atom, S=O, or S=O2,a combination wherein G7d represents NR28d, an oxygen atom, a sulfur atom, S=O, or S=O2, G7e represents C=O or CR26eR27e, G7f represents C=O or CR26fR27f, and G7g represents C=O or CR26gR27g, a combination wherein G7d represents NR28d, an oxygen atom, a sulfur atom, S=O, or S=O2, G7e represents C=O or CR26eR27e, G7f represents C=O or CR26fR27f, and G7g represents NR28g, an oxygen atom, a sulfur atom, S=O, or S=O2, or,a combination wherein G7d represents NR28d, an oxygen atom, a sulfur atom, S=O, or S=O2, G7e represents C=O or CR26eR27e, and G7f represents NR28f, an oxygen atom, a sulfur atom, S=O, or S=O2, and G7g represents C=O or CR26gR27g,X1 and X2 are identical to or different from each other, and each represents an oxygen atom or a sulfur atom,Y1 represents OR15 or SR15,Z1 and Z2 are identical to or different from each other, and each represents an oxygen atom or a sulfur atom,m, p and q each independently represents 0, 1, or 2,R10, R13 and R23 are identical to or different from each other, and each represents a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, or a phenyl group which may be optionally substituted with one or more substituents selected from Group G6,R11 and R21 are identical to or different from each other, and each represents, a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, a phenyl group which may be optionally substituted with one or more substituents selected from Group G6, or a hydrogen atom,R12, R16, R19, R20 and R22 are identical to or different from each other, and each represents a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom,R14, R17, R18 and R24 are identical to or different fromeach other, and each represents a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more halogen atoms, or a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms,R15 represents a C1-C10 chain hydrocarbon group which may be optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, a benzyl group which may be optionally substituted with one or more substituents selected from Group G6, or a hydrogen atom,R25 represents a C1-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G56,R26a, R26b, R26c, R26d, R26e, R26f, R26g, R27a, R27b, R27c, R27d, R27e, R27f, and R27g are identical to or different from each other, and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom,R28a, R28b, R28c, R28d, R28e, R28f, and R28g are identical to or different from each other, and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, or a (C1-C3 alkyl)carbonyl group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom,R29a, R29b, R29c, R29d, R29e, and R29f are identical to ordifferent from each other and each represents a C1-C3 alkyl group which may be optionally substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom,R57 represents a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G571, or a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom,R58 represents a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G571, or a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom;Group G1 is a group consisting of a C1-C3 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group which may be optionally substituted with one or more halogen atom, a C1-C3 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a halogen atom, a cyano group, a hydroxy group, and a mercapto group;Group G2 is a group consisting of a C1-C3 alkyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group which may be optionallysubstituted with one or more halogen atoms, a C1-C3 alkylthio group which may be optionally substituted with one or more halogen atom, a C1-C3 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, an oxo group, a thioxo group, a halogen atom, a cyano group, a hydroxy group, and a mercapto group;Group G3 is a group consisting of a C1-C3 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group which may be optionally substituted with one or more halogen atom, a C1-C3 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a halogen atom, a cyano group, a hydroxy group, and a mercapto group;Group G4 is a group consisting of a C1-C3 alkyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group which may be optionally substituted with one or more halogen atom, a C1-C3 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group which may be optionally substitutedwith one or more halogen atoms, an oxo group, a thioxo group, a halogen atom, a cyano group, a hydroxy group, and a mercapto group;Group G5 is a group consisting of a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G54, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more substituents selected from Group G52, a OR20 group, a OR25 group, C(=Z2)R21, C(=Z2)OR22, C(=Z2)NR21R22, C(R57)=N-OR58, S(O)qR23, NR20R24, a phenyl group which may be optionally substituted with one or more substituents selected from Group G52, a three(3) - ten(10) membered heterocyclic group which may be optionally substituted with one or more substituents selected from Group G52, a nitro group, a halogen atom, a SF5 group and a cyano group;Group G6 is a group consisting of a C1-C3 alkyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group which may be optionally substituted with one or more halogen atom, a C1-C3 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a halogen atom, a cyano group,a nitro group, a hydroxy group, and a mercapto group;Group G52 is a group consisting of a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkylthio group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkyl) carbonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkoxy)carbonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)carbonyl group which may be optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)carbonyl group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)sulfonyl group which may be optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)sulfonyl group which may be optionally substituted with one or more halogen atoms, a cyano group, a nitro group, a hydroxy group, an amino group, a formyl group, a halogen atom, and a SF5 group;Group G54 is a group consisting of a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkylthio group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkyl) carbonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkoxy)carbonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)carbonyl group which may be optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)carbonyl group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)sulfonyl group which may be optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)sulfonyl group which may be optionally substituted with one or more halogen atoms, a cyano group, a nitro group, a hydroxy group, an amino group, a formyl group, a halogen atom, and a SF5 group;Group G56 is a group consisting of a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group which may beoptionally substituted with one or more halogen atoms, a C1-C6 alkylthio group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkyl) carbonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkoxy)carbonyl group which may be optionally substituted with  one  or  more  halogen  atoms,  a  (C1-C6alkylamino)carbonyl group which may be   optionallysubstituted with  one  or  more  halogen  atoms,  a  (C2-C8dialkylamino)carbonyl group which may be optionally substituted  with  one  or  more  halogen  atoms,  a  C1-C6alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)sulfonyl group which may be optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)sulfonyl group which may be optionally substituted with one or more halogen atoms, C(R561)=N-OR562, a cyano group, a nitro group, a hydroxy group, an amino group, a formyl group, and a SF5 group;R561 represents a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, a phenyl group which may be optionally substituted with one or more halogen atoms, an aromatic heterocyclic group which may be optionallysubstituted with one or more halogen atoms, or a hydrogen atom;R562 represents a C1-C6 chain hydrocarbon group which may be optionally substituted with one or more halogen atoms, or a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom;Group G571 is a group consisting of a C3-C6 alicyclic hydrocarbon group which may be optionally substituted with one or more halogen atoms, a phenyl group which may be optionally substituted with one or more halogen atoms, a five(5) - six(6) membered heterocyclic group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkylthio group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkyl) carbonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkoxy)carbonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino )carbonyl group which may be optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino )carbonyl group which may be optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C6alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)sulfonyl group which may be optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)sulfonyl group which may be optionally substituted with one or more halogen atoms, a cyano group, a nitro group, a hydroxy group, an amino group, a formyl group, a halogen atom, and a SF5 group.] or a salt thereof.

2. The compound according to claim 1 or a salt thereof, whereinR3 represents a phenyl group which may be optionally substituted with one or more substituents selected from Group G5, or a five(5) - six(6) membered aromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G5, andGroup G5 is a group consisting of a C1-C3 alkyl group which may be optionally substituted with one or more halogen atoms, a OR20 group, C(=Z2)R21, C(=Z2)OR22, C(=Z2)NR21R22, S(O)qR23, NR20R24, a nitro group, a halogen atom, and a cyano group.

3. The compound according to claim 1 or 2 or a salt thereof, whereinX1 and X2 represents an oxygen atom.

4. The compound according to any one of claims 1 to3 or a salt thereof, whereinY1 represents a OR15 group.

5. The compound according to any one of claims 1 to 4 or a salt thereof, whereinR2 represents a C1-C4 alkyl group which may be optionally substituted with one or more substituents selected from Group G3, a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G4, a halogen atom, a cyano group, OR10, or S(O)pR13,R10  represents  a  C1-C3  alkyl  group  which  may  beoptionally substituted with one or more halogen atoms,R13  represents  a  C1-C3  alkyl  group  which  may  beoptionally substituted with one or more halogen atoms.

6. The compound according to claim 5 or a salt thereof, whereinR2 represents a C1-C3 alkyl group which may be optionally substituted with one or more halogen atoms.

7. The compound according to any one of claims 1 to 6 or a salt thereof, whereinR1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from GroupG11, a C4-C6 alkyl group which may be optionally substituted with one or more substituents selected from Group G11, a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G21, a three(3) - six(6) membered nonaromatic heterocyclic group which may be optionally substituted with one or more substituents selected from Group G21 {the heteroatom(s) which constitutes of the three(3) - six(6) membered nonaromatic heterocyclic group represents an oxygen atom or a sulfur atom}, a straight chain C1-C3 alkyl group which is substituted with one or more substituents selected from Group G11, OR16, S(O)mR17, or NR18R19,R16, R17 and R18 are identical to or different from each other, and each represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms,R19 represents a C1-C6 alkyl group which may be optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be optionally substituted with one or more halogen atoms, or a hydrogen atom,Group G11 is a group consisting of a C1-C3 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group which may be optionally substituted with one or more halogen atom, a C1-C3alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a halogen atom, and a cyano group; andGroup G21 is a group consisting of a C1-C3 alkyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group which may be optionally substituted with one or more halogen atom, a C1-C3 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a halogen atom, and a cyano group.

8. The compound according to claim 7 or a salt thereof, whereinR1 represents an isopropyl group which may be optionally substituted with one or more substituents selected from Group G11, a butyl group which may be optionally substituted with one or more substituents selected from G11, an ethyl group which is substituted with one or more substituents selected from G11, a n-propyl group which is substituted with one or more substituents selected from G11, a C3-C6 cycloalkyl group which may be optionally substituted with one or more substituents selected from Group G21, or a three(3) - six(6)membered saturated heterocyclic group which may be optionally substituted with one or more substituents selected from Group G21 {the heteroatom(s) which constitutes of the three(3) - six(6) membered saturated heterocyclic group represents an oxygen atom};Group G11 is a group consisting of a C1-C3 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group which may be optionally substituted with one or more halogen atom, a C1-C3 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a halogen atom, and a cyano group; andGroup G21 is a group consisting of a C1-C3 alkyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group which may be optionally substituted with one or more halogen atom, a C1-C3 alkylsulfinyl group which may be optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group which may be optionally substituted with one or more halogen atoms, a halogen atom, and a cyano group.

9. The compound according to claim 8 or a salt thereof, whereinR1 represents an isopropyl group, or a sec-butyl group.

10. The compound according to any one of claims 1 to 9 or a salt thereof, wherein,R3 represents a phenyl group which may be optionally substituted with one to three substituents selected from Group G5, or a five(5) - six(6) membered aromatic heterocyclic group which may be optionally substituted with one to three substituents selected from Group G5.

11. The compound according to any one of claims 1 to 9 or a salt thereof, whereinR3 represents a phenyl group which is substituted with one to three substituents selected from Group G5, or a five(5) - six(6) membered aromatic heterocyclic group which may be optionally substituted with one to three substituents selected from Group G5.

12. The compound according to any one of claims 1 to 9 or a salt thereof, whereinR3 represents a phenyl group which may be optionally substituted with one to three substituents selected from Group G5.

13. The compound according to any one of claims 1 to 9 or a salt thereof, whereinR3 represents a phenyl group which is substituted with one to three substituents selected from Group G5.

14. The compound according to claim 13 or a salt thereof, whereinR3 represents a phenyl group which is substituted with one to two substituents selected from Group G5.

15. The compound according to claim 14 or a salt thereof, whereinR3 represents a phenyl group which is substituted with one to two substituents selected from the group consisting of a cyano group, a halogen atom, a C1-C3 alkyl group, a C1-C3 haloalkyl group, and a C3-C6 cycloalkyl group.

16. The compound according to any one of claims 1 to 9 or a salt thereof, whereinR3 represents a five(5) - six(6) membered aromatic heterocyclic group which may be optionally substituted with one to two substituents selected from Group G5.

17. The compound according to claim 16 or a salt thereof, whereinR3 represents a five(5) membered aromatic heterocyclic group which may be optionally substituted with one to twosubstituents selected from the group consisting of a halogen atom, a C1-C3 alkyl group, a C1-C3 haloalkyl group and a C3-C6 cycloalkyl group.

18. The compound according to claim 16 or a salt thereof, whereinR3 represents a six(6) membered aromatic heterocyclic group which may be optionally substituted with one substituent selected from the group consisting of a halogen atom, a C1-C3 alkyl group, a C1-C3 haloalkyl group and a C3-C6 cycloalkyl group.

19. The compound according to any one of claims 1 or 3 to 9 or a salt thereof, whereinR3 represents any group represented by the following formula:

20. thereof,wherein,The compound according to claim 19 or a salt10R3 represents any group represented by theformula:B-1B-2

21. The compound according to claim 19 thereof, whereinR3 represents a group represented by the formula:B-1

22. thereof, whereinThe compound according to claim 19R3 representsa group represented by thefollowingor a saltfollowingor a saltfollowingformula:

23. The compound according to any one of claims 1 or 3 to 9 or a salt thereof, whereinR3 represents an aromatic fused heterocyclic group which may be optionally substituted with one or more substituents selected from Group G5.

24. The compound according to claim 23 or a salt thereof, whereinR3 represents an eight (8) - ten(10) membered aromatic fused heterocyclic group which may be optionally substituted with one or more substituents selected from a halogen atom, a C1-C3 alkyl group, a C1-C3 haloalkyl group and a C3-C6 cycloalkyl group.

25. A herbicide composition comprising the compound according to any one of claims 1 to 24 or a salt thereof and an inert carrier.

26. A method for controlling weeds which comprises a step of applying the compound according to any one of claims 1 to 24 or a salt thereof to a weed or a soil where a weed is grown.

27. Use of the compound according to claims 1 to 24 for controlling a weed.

28. A composition comprising one or more ingredients selected from Group (d) and Group (f) and the5 compound according to any one of claims 1 to 24 or a salt thereof:Group (d): a phytotoxicity reducing ingredient:Group (f): a herbicidal active ingredient.